% alzhub.org library filter
% Source: https://alzhub.org/research?about=side-effects
% 471 entries, in the order the page lists them. Built from alzhub.org's own records.
% 2 entries have no readable author in the source record and carry no author field.

@article{pascuallucas2025-41058018,
  author  = {Pascual-Lucas, M. and Lacosta, A. M. and Montañés, M. and Canudas, J. and Loscos, J. and Monleón, I. and Allué, J. A. and Sarasa, L. and others},
  title   = {{Safety, tolerability, immunogenicity, and efficacy of ABvac40 active immunotherapy against Aβ40 in patients with mild cognitive impairment or very mild Alzheimer's disease: A randomized, double-blind, placebo-controlled phase 2 study}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2025},
  doi     = {10.1002/alz.70776},
  pmid    = {41058018},
  url     = {https://doi.org/10.1002/alz.70776}
}

@article{shulman2023-38012285,
  author  = {Shulman, M. and Kong, J. and O'Gorman, J. and Ratti, E. and Rajagovindan, R. and Viollet, L. and Huang, E. and Sharma, S. and others},
  title   = {{TANGO: a placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer's disease}},
  journal = {Nature aging},
  year    = {2023},
  doi     = {10.1038/s43587-023-00523-w},
  pmid    = {38012285},
  url     = {https://doi.org/10.1038/s43587-023-00523-w}
}

@article{yunusa2019-30901041,
  author  = {Yunusa, I. and Alsumali, A. and Garba, A. E. and Regestein, Q. R. and Eguale, T.},
  title   = {{Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of Dementia: A Network Meta-analysis}},
  journal = {JAMA network open},
  year    = {2019},
  doi     = {10.1001/jamanetworkopen.2019.0828},
  pmid    = {30901041},
  url     = {https://doi.org/10.1001/jamanetworkopen.2019.0828}
}

@article{dantas2024-37978096,
  author  = {Dantas, J. M. and Mutarelli, A. and Navalha, D. D. P. and Dagostin, C. S. and Romeiro, P. H. C. L. and Felix, N. and Nogueira, A. and Batista, S. and others},
  title   = {{Efficacy of anti-amyloid-ß monoclonal antibody therapy in early Alzheimer's disease: a systematic review and meta-analysis}},
  journal = {Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology},
  year    = {2024},
  doi     = {10.1007/s10072-023-07194-w},
  pmid    = {37978096},
  url     = {https://doi.org/10.1007/s10072-023-07194-w}
}

@article{tariot2026-41579901,
  author  = {Tariot, Pierre N and Lopera, Francisco S and Ríos-Romenets, Silvia and Sink, Kaycee M and Giraldo-Chica, Margarita and Acosta-Baena, Natalia and Villegas, Gustavo and Espinosa, Alejandro and others},
  title   = {{Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial}},
  journal = {The Lancet. Neurology},
  year    = {2026},
  doi     = {10.1016/s1474-4422(25)00426-0},
  pmid    = {41579901},
  url     = {https://doi.org/10.1016/s1474-4422(25)00426-0}
}

@article{burns2021-34146512,
  author  = {Burns, Daniel K and Alexander, Robert C and Welsh-Bohmer, Kathleen A and Culp, Meredith and Chiang, Carl and O'Neil, Janet and Evans, Rebecca M and Harrigan, Patrick and others},
  title   = {{Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial}},
  journal = {The Lancet. Neurology},
  year    = {2021},
  doi     = {10.1016/s1474-4422(21)00043-0},
  pmid    = {34146512},
  url     = {https://doi.org/10.1016/s1474-4422(21)00043-0}
}

@article{avgerinos2021-33831607,
  author  = {Avgerinos, K. I. and Ferrucci, L. and Kapogiannis, D.},
  title   = {{Effects of monoclonal antibodies against amyloid-β on clinical and biomarker outcomes and adverse event risks: A systematic review and meta-analysis of phase III RCTs in Alzheimer's disease}},
  journal = {Ageing research reviews},
  year    = {2021},
  doi     = {10.1016/j.arr.2021.101339},
  pmid    = {33831607},
  url     = {https://doi.org/10.1016/j.arr.2021.101339}
}

@article{qiao2024-38429615,
  author  = {Qiao, Y. and Gu, J. and Yu, M. and Chi, Y. and Ma, Y.},
  title   = {{Comparative Efficacy and Safety of Monoclonal Antibodies for Cognitive Decline in Patients with Alzheimer's Disease: A Systematic Review and Network Meta-Analysis}},
  journal = {CNS drugs},
  year    = {2024},
  doi     = {10.1007/s40263-024-01067-2},
  pmid    = {38429615},
  url     = {https://doi.org/10.1007/s40263-024-01067-2}
}

@article{toda2024-39350371,
  author  = {Toda, Y. and Iwatsubo, T. and Nakamura, Y. and Matsuda, N. and Miyata, M. and Jin, M. and Chen, T. and Kuribayashi, K. and others},
  title   = {{Japanese Subgroup Analyses from EMERGE and ENGAGE, Phase 3 Clinical Trials of Aducanumab in Patients with Early Alzheimer's Disease}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2024},
  doi     = {10.14283/jpad.2024.106},
  pmid    = {39350371},
  url     = {https://doi.org/10.14283/jpad.2024.106}
}

@article{menegazdealmeida2024-38879828,
  author  = {Menegaz de Almeida, A. and Leite, M. and Lopes, L. M. and Gomes Lima, P. and Siegloch Barros, M. L. and Rocha Pinheiro, S. and Í, Andrade and Viana, P. and others},
  title   = {{Gantenerumab for early Alzheimer's disease: a systematic review and meta-analysis}},
  journal = {Expert review of neurotherapeutics},
  year    = {2024},
  doi     = {10.1080/14737175.2024.2367016},
  pmid    = {38879828},
  url     = {https://doi.org/10.1080/14737175.2024.2367016}
}

@article{zimmer2025-40063015,
  author  = {Zimmer, J. A. and Ardayfio, P. and Wang, H. and Khanna, R. and Evans, C. D. and Lu, M. and Sparks, J. and Andersen, S. and Lauzon, S. and Nery, E. S. M. and others},
  title   = {{Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease: Secondary Analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical Trials}},
  journal = {JAMA Neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2025.0065},
  pmid    = {40063015},
  url     = {https://doi.org/10.1001/jamaneurol.2025.0065}
}

@article{rashad2022-36611492,
  author  = {Rashad, A. and Rasool, A. and Shaheryar, M. and Sarfraz, A. and Sarfraz, Z. and Robles-Velasco, K. and Cherrez-Ojeda, I.},
  title   = {{Donanemab for Alzheimer's Disease: A Systematic Review of Clinical Trials}},
  journal = {Healthcare (Basel, Switzerland)},
  year    = {2022},
  doi     = {10.3390/healthcare11010032},
  pmid    = {36611492},
  url     = {https://doi.org/10.3390/healthcare11010032}
}

@article{chen2024-38567735,
  author  = {Chen, T. and O'Gorman, J. and Castrillo-Viguera, C. and Rajagovindan, R. and Curiale, G. G. and Tian, Y. and Patel, D. and von Rosenstiel, P. and others},
  title   = {{Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumab}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2024},
  doi     = {10.1002/alz.13755},
  pmid    = {38567735},
  url     = {https://doi.org/10.1002/alz.13755}
}

@article{hsu2025-40316479,
  author  = {Hsu, C. W. and Hsu, T. W. and Kao, Y. C. and Lin, Y. H. and Thompson, T. and Carvalho, A. F. and Stubbs, B. and Tseng, P. T. and others},
  title   = {{The efficacy and safety of anti-amyloid monoclonal antibody versus acetylcholinesterase inhibitor with an in-depth analysis across genotypes and disease stages: a systematic review and meta-analysis}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100195},
  pmid    = {40316479},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100195}
}

@article{matsunaga2015-25860130,
  author  = {Matsunaga, S. and Kishi, T. and Iwata, N.},
  title   = {{Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis}},
  journal = {PloS one},
  year    = {2015},
  doi     = {10.1371/journal.pone.0123289},
  pmid    = {25860130},
  url     = {https://doi.org/10.1371/journal.pone.0123289}
}

@article{bateman2025-40120616,
  author  = {Bateman, Randall J and Li, Yan and McDade, Eric M and Llibre-Guerra, Jorge J and Clifford, David B and Atri, Alireza and Mills, Susan L and Santacruz, Anna M and others},
  title   = {{Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial}},
  journal = {The Lancet. Neurology},
  year    = {2025},
  doi     = {10.1016/s1474-4422(25)00024-9},
  pmid    = {40120616},
  url     = {https://doi.org/10.1016/s1474-4422(25)00024-9}
}

@article{kehoe2021-34687634,
  author  = {Kehoe, Patrick Gavin and Turner, Nicholas and Howden, Beth and Jarutyte, Lina and Clegg, Shona Louise and Malone, Ian Brian and Barnes, Josephine and Nielsen, Casper and others},
  title   = {{Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial}},
  journal = {The Lancet. Neurology},
  year    = {2021},
  doi     = {10.1016/s1474-4422(21)00263-5},
  pmid    = {34687634},
  url     = {https://doi.org/10.1016/s1474-4422(21)00263-5}
}

@article{schneider2005-16234500,
  author  = {Schneider, L. S. and Dagerman, K. S. and Insel, P.},
  title   = {{Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials}},
  journal = {JAMA},
  year    = {2005},
  doi     = {10.1001/jama.294.15.1934},
  pmid    = {16234500},
  url     = {https://doi.org/10.1001/jama.294.15.1934}
}

@article{winblad2008-18322263,
  author  = {Winblad, B. and Gauthier, S. and Scinto, L. and Feldman, H. and Wilcock, G. K. and Truyen, L. and Mayorga, A. J. and Wang, D. and others},
  title   = {{Safety and efficacy of galantamine in subjects with mild cognitive impairment}},
  journal = {Neurology},
  year    = {2008},
  doi     = {10.1212/01.wnl.0000303815.69777.26},
  pmid    = {18322263},
  url     = {https://doi.org/10.1212/01.wnl.0000303815.69777.26}
}

@article{hannestad2021-33967047,
  author  = {Hannestad, Jonas and Duclos, Tiffanie and Chao, Whitney and Koborsi, Katie and Klutzaritz, Vicki and Beck, Brian and Patel, Ashok K and Scott, James and others},
  title   = {{Safety and Tolerability of GRF6019 Infusions in Severe Alzheimer's Disease: A Phase II Double-Blind Placebo-Controlled Trial}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2021},
  doi     = {10.3233/jad-210011},
  pmid    = {33967047},
  url     = {https://doi.org/10.3233/jad-210011}
}

@article{costa2022-34942135,
  author  = {Costa, Alberto C S and Brandão, Ana C and Boada, Richard and Barrionuevo, Veridiana L and Taylor, Hudson G and Roth, Elizabeth and Stasko, Melissa R and Johnson, Mark W and others},
  title   = {{Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trial}},
  journal = {The Lancet. Neurology},
  year    = {2022},
  doi     = {10.1016/s1474-4422(21)00369-0},
  pmid    = {34942135},
  url     = {https://doi.org/10.1016/s1474-4422(21)00369-0}
}

@article{cummings2026-c800c391,
  author  = {Cummings, J. L. and Atri, A. and Scheltens, P. and others},
  title   = {{Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (EVOKE and EVOKE+): two phase 3, randomised, placebo-controlled trials}},
  journal = {The Lancet},
  year    = {2026},
  doi     = {10.1016/s0140-6736(26)00459-9},
  pmid    = {41865758},
  url     = {https://doi.org/10.1016/s0140-6736(26)00459-9}
}

@article{ostrowitzki2022-36121669,
  author  = {Ostrowitzki, S. and Bittner, T. and Sink, K. M. and Mackey, H. and Rabe, C. and Honig, L. S. and Cassetta, E. and Woodward, M. and others},
  title   = {{Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.2909},
  pmid    = {36121669},
  url     = {https://doi.org/10.1001/jamaneurol.2022.2909}
}

@article{moayyedi2019-31152740,
  author  = {Moayyedi, P. and Eikelboom, J. W. and Bosch, J. and Connolly, S. J. and Dyal, L. and Shestakovska, O. and Leong, D. and Anand, S. S. and others},
  title   = {{Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin}},
  journal = {Gastroenterology},
  year    = {2019},
  doi     = {10.1053/j.gastro.2019.05.056},
  pmid    = {31152740},
  url     = {https://doi.org/10.1053/j.gastro.2019.05.056}
}

@article{cummings2025-39780249,
  author  = {Cummings, J. L. and Atri, A. and Feldman, H. H. and Hansson, O. and Sano, M. and Knop, F. K. and Johannsen, P. and León, T. and others},
  title   = {{evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2025},
  doi     = {10.1186/s13195-024-01666-7},
  pmid    = {39780249},
  url     = {https://doi.org/10.1186/s13195-024-01666-7}
}

@article{penninkilampi2017-28025724,
  author  = {Penninkilampi, R. and Brothers, H. M. and Eslick, G. D.},
  title   = {{Safety and Efficacy of Anti-Amyloid-β Immunotherapy in Alzheimer's Disease: A Systematic Review and Meta-Analysis}},
  journal = {Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology},
  year    = {2017},
  doi     = {10.1007/s11481-016-9722-5},
  pmid    = {28025724},
  url     = {https://doi.org/10.1007/s11481-016-9722-5}
}

@article{shim2026-41352683,
  author  = {Shim, G. H. and Lau, E. C. Y. and Huynh, A. L. H. and Lu, C. Y. and Tan, E. C. K.},
  title   = {{Influence of patient characteristics on efficacy and safety of anti-amyloid monoclonal antibodies in Alzheimer's disease: A systematic review and meta-analysis}},
  journal = {Ageing research reviews},
  year    = {2026},
  doi     = {10.1016/j.arr.2025.102981},
  pmid    = {41352683},
  url     = {https://doi.org/10.1016/j.arr.2025.102981}
}

@article{greeley2025-40912996,
  author  = {Greeley, David and Nash, Marshall and Herskowitz, Brad and Kim, Fred and Rock, James and Prins, Neils and Kim, SangYun and Xi, Tianyang and others},
  title   = {{A phase 2 randomized, placebo-controlled study on the efficacy and safety of AR1001, a phosphodiesterase-5 inhibitor, in patients with mild-to-moderate Alzheimer's disease}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100337},
  pmid    = {40912996},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100337}
}

@article{rosenbloom2021-33719017,
  author  = {Rosenbloom, Michael and Barclay, Terry R and Kashyap, Bhavani and Hage, Lyndsay and O'Keefe, Lauren R and Svitak, Aleta and Pyle, Maria and Frey, William and others},
  title   = {{A Phase II, Single-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Therapeutic Efficacy of Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease}},
  journal = {Drugs \& aging},
  year    = {2021},
  doi     = {10.1007/s40266-021-00845-7},
  pmid    = {33719017},
  url     = {https://doi.org/10.1007/s40266-021-00845-7}
}

@article{wilkinson2014-25297016,
  author  = {Wilkinson, David and Windfeld, Kristian and Colding-Jørgensen, Eskild},
  title   = {{Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial}},
  journal = {The Lancet. Neurology},
  year    = {2014},
  doi     = {10.1016/s1474-4422(14)70198-x},
  pmid    = {25297016},
  url     = {https://doi.org/10.1016/s1474-4422(14)70198-x}
}

@article{maher2011-21954480,
  author  = {Maher, A. R. and Maglione, M. and Bagley, S. and Suttorp, M. and Hu, J. H. and Ewing, B. and Wang, Z. and Timmer, M. and others},
  title   = {{Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis}},
  journal = {JAMA},
  year    = {2011},
  doi     = {10.1001/jama.2011.1360},
  pmid    = {21954480},
  url     = {https://doi.org/10.1001/jama.2011.1360}
}

@article{jeremic2023-37423541,
  author  = {Jeremic, D. and Navarro-López, J. D. and Jiménez-Díaz, L.},
  title   = {{Efficacy and safety of anti-amyloid-β monoclonal antibodies in current Alzheimer's disease phase III clinical trials: A systematic review and interactive web app-based meta-analysis}},
  journal = {Ageing research reviews},
  year    = {2023},
  doi     = {10.1016/j.arr.2023.102012},
  pmid    = {37423541},
  url     = {https://doi.org/10.1016/j.arr.2023.102012}
}

@article{teng2022-35696185,
  author  = {Teng, E. and Manser, P. T. and Pickthorn, K. and Brunstein, F. and Blendstrup, M. and Sanabria Bohorquez, S. and Wildsmith, K. R. and Toth, B. and others},
  title   = {{Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.1375},
  pmid    = {35696185},
  url     = {https://doi.org/10.1001/jamaneurol.2022.1375}
}

@article{ketter2017-28269765,
  author  = {Ketter, N. and Brashear, H. R. and Bogert, J. and Di, J. and Miaux, Y. and Gass, A. and Purcell, D. D. and Barkhof, F. and others},
  title   = {{Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2017},
  doi     = {10.3233/jad-160216},
  pmid    = {28269765},
  url     = {https://doi.org/10.3233/jad-160216}
}

@article{kavirajan2007-17689146,
  author  = {Kavirajan, H. and Schneider, L. S.},
  title   = {{Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials}},
  journal = {The Lancet. Neurology},
  year    = {2007},
  doi     = {10.1016/s1474-4422(07)70195-3},
  pmid    = {17689146},
  url     = {https://doi.org/10.1016/s1474-4422(07)70195-3}
}

@article{ballard2009-19138567,
  author  = {Ballard, C. and Hanney, M. L. and Theodoulou, M. and Douglas, S. and McShane, R. and Kossakowski, K. and Gill, R. and Juszczak, E. and others},
  title   = {{The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial}},
  journal = {The Lancet. Neurology},
  year    = {2009},
  doi     = {10.1016/s1474-4422(08)70295-3},
  pmid    = {19138567},
  url     = {https://doi.org/10.1016/s1474-4422(08)70295-3}
}

@article{koh2021-33771205,
  author  = {Koh, Seong-Ho and Kwon, Hyuk Sung and Choi, Seong Hye and Jeong, Jee Hyang and Na, Hae Ri and Lee, Chan Nyoung and Yang, YoungSoon and Lee, Ae Young and others},
  title   = {{Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer's disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial}},
  journal = {Alzheimer's research \& therapy},
  year    = {2021},
  doi     = {10.1186/s13195-021-00803-w},
  pmid    = {33771205},
  url     = {https://doi.org/10.1186/s13195-021-00803-w}
}

@article{craft2020-32568367,
  author  = {Craft, S. and Raman, R. and Chow, T. W. and Rafii, M. S. and Sun, C. K. and Rissman, R. A. and Donohue, M. C. and Brewer, J. B. and others},
  title   = {{Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2020},
  doi     = {10.1001/jamaneurol.2020.1840},
  pmid    = {32568367},
  url     = {https://doi.org/10.1001/jamaneurol.2020.1840}
}

@article{salloway2025-39556389,
  author  = {Salloway, S. and Wojtowicz, J. and Voyle, N. and Lane, C. A. and Klein, G. and Lyons, M. and Rossomanno, S. and Mazzo, F. and others},
  title   = {{Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2024.3937},
  pmid    = {39556389},
  url     = {https://doi.org/10.1001/jamaneurol.2024.3937}
}

@article{gray2015-25621434,
  author  = {Gray, S. L. and Anderson, M. L. and Dublin, S. and Hanlon, J. T. and Hubbard, R. and Walker, R. and Yu, O. and Crane, P. K. and others},
  title   = {{Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study}},
  journal = {JAMA internal medicine},
  year    = {2015},
  doi     = {10.1001/jamainternmed.2014.7663},
  pmid    = {25621434},
  url     = {https://doi.org/10.1001/jamainternmed.2014.7663}
}

@article{salloway2018-30129411,
  author  = {Salloway, S. and Marshall, G. A. and Lu, M. and Brashear, H. R.},
  title   = {{Long-Term Safety and Efficacy of Bapineuzumab in Patients with Mild-to-Moderate Alzheimer's Disease: A Phase 2, Open-Label Extension Study}},
  journal = {Current Alzheimer research},
  year    = {2018},
  doi     = {10.2174/1567205015666180821114813},
  pmid    = {30129411},
  url     = {https://doi.org/10.2174/1567205015666180821114813}
}

@article{neve2024-39177596,
  author  = {Neve, A. and Das, B. and Wojtowicz, J. and Huang, Z. and Bullain, S. and Watkin, M. and Lott, D. and Bittner, T. and others},
  title   = {{Long-Term Safety of Gantenerumab in Participants with Alzheimer's Disease: A Phase III, Double-Blind, and Open-Label Extension Study (Marguerite RoAD)}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2024},
  doi     = {10.3233/jad-240221},
  pmid    = {39177596},
  url     = {https://doi.org/10.3233/jad-240221}
}

@article{gwizdala2021-33856613,
  author  = {Gwizdala, Kathryn L and Ferguson, David P and Kovan, Jeffery and Novak, Vera and Pontifex, Matthew B},
  title   = {{Placebo controlled phase II clinical trial: Safety and efficacy of combining intranasal insulin \& acute exercise}},
  journal = {Metabolic brain disease},
  year    = {2021},
  doi     = {10.1007/s11011-021-00727-2},
  pmid    = {33856613},
  url     = {https://doi.org/10.1007/s11011-021-00727-2}
}

@article{mok2024-38631737,
  author  = {Mok, P. L. H. and Carr, M. J. and Guthrie, B. and Morales, D. R. and Sheikh, A. and Elliott, R. A. and Camacho, E. M. and van Staa, T. and Avery, A. J. and Ashcroft, D. M.},
  title   = {{Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study}},
  journal = {BMJ},
  year    = {2024},
  doi     = {10.1136/bmj-2023-076268},
  pmid    = {38631737},
  url     = {https://doi.org/10.1136/bmj-2023-076268}
}

@article{wang2025-40172303,
  author  = {Wang, H. and Serap Monkul Nery, E. and Ardayfio, P. and Khanna, R. and Otero Svaldi, D. and Gueorguieva, I. and Shcherbinin, S. and Andersen, S. W. and Hauck, P. M. and Engle, S. E. and others},
  title   = {{Modified titration of donanemab reduces ARIA risk and maintains amyloid reduction}},
  journal = {Alzheimer's \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.70062},
  pmid    = {40172303},
  url     = {https://doi.org/10.1002/alz.70062}
}

@article{sampson2007-17006875,
  author  = {Sampson, E. L. and Raven, P. R. and Ndhlovu, P. N. and Vallance, A. and Garlick, N. and Watts, J. and Blanchard, M. R. and Bruce, A. and others},
  title   = {{A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement}},
  journal = {International journal of geriatric psychiatry},
  year    = {2007},
  doi     = {10.1002/gps.1679},
  pmid    = {17006875},
  url     = {https://doi.org/10.1002/gps.1679}
}

@article{farlow2012-22672770,
  author  = {Farlow, M. and Arnold, S. E. and van Dyck, C. H. and Aisen, P. S. and Snider, B. J. and Porsteinsson, A. P. and Friedrich, S. and Dean, R. A. and others},
  title   = {{Safety and biomarker effects of solanezumab in patients with Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2012},
  doi     = {10.1016/j.jalz.2011.09.224},
  pmid    = {22672770},
  url     = {https://doi.org/10.1016/j.jalz.2011.09.224}
}

@article{qiao2023-37213538,
  author  = {Qiao, Y. and Chi, Y. and Zhang, Q. and Ma, Y.},
  title   = {{Safety and efficacy of lecanemab for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials}},
  journal = {Frontiers in aging neuroscience},
  year    = {2023},
  doi     = {10.3389/fnagi.2023.1169499},
  pmid    = {37213538},
  url     = {https://doi.org/10.3389/fnagi.2023.1169499}
}

@article{hossain2024-38867460,
  author  = {Hossain, M. F. and Husna, A. U. and Kharel, M.},
  title   = {{Use of lecanemab for the treatment of Alzheimer's disease: A systematic review}},
  journal = {Brain and behavior},
  year    = {2024},
  doi     = {10.1002/brb3.3592},
  pmid    = {38867460},
  url     = {https://doi.org/10.1002/brb3.3592}
}

@article{farlow2019-30530975,
  author  = {Farlow, Martin R and Thompson, Richard E and Wei, Lee-Jen and Tuchman, Alan J and Grenier, Elaine and Crockford, David and Wilke, Susanne and Benison, Jeffrey and others},
  title   = {{A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2019},
  doi     = {10.3233/jad-180759},
  pmid    = {30530975},
  url     = {https://doi.org/10.3233/jad-180759}
}

@article{ebell2024-38253509,
  author  = {Ebell, M. H. and Barry, H. C. and Baduni, K. and Grasso, G.},
  title   = {{Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-Analysis}},
  journal = {Annals of Family Medicine},
  year    = {2024},
  doi     = {10.1370/afm.3050},
  pmid    = {38253509},
  url     = {https://doi.org/10.1370/afm.3050}
}

@article{coric2012-22892585,
  author  = {Coric, V. and van Dyck, C. H. and Salloway, S. and Andreasen, N. and Brody, M. and Richter, R. W. and Soininen, H. and Thein, S. and others},
  title   = {{Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {2012},
  doi     = {10.1001/archneurol.2012.2194},
  pmid    = {22892585},
  url     = {https://doi.org/10.1001/archneurol.2012.2194}
}

@article{cummings2018-29695589,
  author  = {Cummings, J. L. and Cohen, S. and van Dyck, C. H. and Brody, M. and Curtis, C. and Cho, W. and Ward, M. and Friesenhahn, M. and others},
  title   = {{ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease}},
  journal = {Neurology},
  year    = {2018},
  doi     = {10.1212/wnl.0000000000005550},
  pmid    = {29695589},
  url     = {https://doi.org/10.1212/wnl.0000000000005550}
}

@article{coupland2019-31233095,
  author  = {Coupland, C. A. C. and Hill, T. and Dening, T. and Morriss, R. and Moore, M. and Hippisley-Cox, J.},
  title   = {{Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study}},
  journal = {JAMA internal medicine},
  year    = {2019},
  doi     = {10.1001/jamainternmed.2019.0677},
  pmid    = {31233095},
  url     = {https://doi.org/10.1001/jamainternmed.2019.0677}
}

@article{thyrian2017-28746708,
  author  = {Thyrian, JR. and Hertel, J. and Wucherer, D. and Eichler, T. and Michalowsky, B. and Dreier-Wolfgramm, A. and Zwingmann, I. and Kilimann, I. and others},
  title   = {{Effectiveness and Safety of Dementia Care Management in Primary Care: A Randomized Clinical Trial}},
  journal = {JAMA psychiatry},
  year    = {2017},
  doi     = {10.1001/jamapsychiatry.2017.2124},
  pmid    = {28746708},
  url     = {https://doi.org/10.1001/jamapsychiatry.2017.2124}
}

@article{schneider2006-16505124,
  author  = {Schneider, L. S. and Dagerman, K. and Insel, P. S.},
  title   = {{Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials}},
  journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry},
  year    = {2006},
  doi     = {10.1097/01.jgp.0000200589.01396.6d},
  pmid    = {16505124},
  url     = {https://doi.org/10.1097/01.jgp.0000200589.01396.6d}
}

@article{zhong2007-17316169,
  author  = {Zhong, K. X. and Tariot, P. N. and Mintzer, J. and Minkwitz, M. C. and Devine, N. A.},
  title   = {{Quetiapine to treat agitation in dementia: a randomized, double-blind, placebo-controlled study}},
  journal = {Current Alzheimer research},
  year    = {2007},
  doi     = {10.2174/156720507779939805},
  pmid    = {17316169},
  url     = {https://doi.org/10.2174/156720507779939805}
}

@article{delnomdedieu2016-26925577,
  author  = {Delnomdedieu, M. and Duvvuri, S. and Li, D. J. and Atassi, N. and Lu, M. and Brashear, H. R. and Liu, E. and Ness, S. and others},
  title   = {{First-In-Human safety and long-term exposure data for AAB-003 (PF-05236812) and biomarkers after intravenous infusions of escalating doses in patients with mild to moderate Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2016},
  doi     = {10.1186/s13195-016-0177-y},
  pmid    = {26925577},
  url     = {https://doi.org/10.1186/s13195-016-0177-y}
}

@article{chen2025-41070709,
  author  = {Chen, S. and Ou, R. and Wei, Q. and Li, C. and Song, W. and Zhao, B. and Yang, J. and Fu, J. and others},
  title   = {{Lecanemab treatment for Alzheimer's Disease of varying severities and associated plasma biomarkers monitoring: A multi-center real-world study in China}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2025},
  doi     = {10.1002/alz.70750},
  pmid    = {41070709},
  url     = {https://doi.org/10.1002/alz.70750}
}

@article{rogers1996-8915035,
  author  = {Rogers, S. L. and Friedhoff, L. T.},
  title   = {{The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group}},
  journal = {Dementia (Basel, Switzerland)},
  year    = {1996},
  doi     = {10.1159/000106895},
  pmid    = {8915035},
  url     = {https://doi.org/10.1159/000106895}
}

@article{lanctot2003-12975222,
  author  = {Lanctôt, K. L. and Herrmann, N. and Yau, K. K. and Khan, L. R. and Liu, B. A. and LouLou, M. M. and Einarson, T. R.},
  title   = {{Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis}},
  journal = {CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne},
  year    = {2003},
  pmid    = {12975222}
}

@article{mummery2026-41787076,
  author  = {Mummery, C. J. and Mayorga, A. J. and Simmons, A. and Chow, T. W. and Burgess, B. and Nguyen, T. and Gao, J. and Budda, B. and Park, L. Q. and Gupta, R. and Li, C. and Shi, L. and others},
  title   = {{The TREM2 agonistic antibody AL002 in early Alzheimer's disease: a phase 2 randomized trial}},
  journal = {Nature Medicine},
  year    = {2026},
  doi     = {10.1038/s41591-026-04273-1},
  pmid    = {41787076},
  url     = {https://doi.org/10.1038/s41591-026-04273-1}
}

@article{sperling2021-33464300,
  author  = {Sperling, R. and Henley, D. and Aisen, P. S. and Raman, R. and Donohue, M. C. and Ernstrom, K. and Rafii, M. S. and Streffer, J. and others},
  title   = {{Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2021},
  doi     = {10.1001/jamaneurol.2020.4857},
  pmid    = {33464300},
  url     = {https://doi.org/10.1001/jamaneurol.2020.4857}
}

@article{rege2021-33763822,
  author  = {Rege, Sanika and Carnahan, Ryan M and Johnson, Michael L and Chen, Hua and Holmes, Holly M and Aparasu, Rajender R},
  title   = {{Antipsychotic Initiation Among Older Dementia Patients Using Cholinesterase Inhibitors: A National Retrospective Cohort Study}},
  journal = {Drugs \& aging},
  year    = {2021},
  doi     = {10.1007/s40266-021-00851-9},
  pmid    = {33763822},
  url     = {https://doi.org/10.1007/s40266-021-00851-9}
}

@article{fleisher2024-38386949,
  author  = {Fleisher, A. S. and Munsie, L. M. and Perahia, D. G. S. and Andersen, S. W. and Higgins, I. A. and Hauck, P. M. and Lo, A. C. and Sims, JR. and others},
  title   = {{Assessment of Efficacy and Safety of Zagotenemab: Results From PERISCOPE-ALZ, a Phase 2 Study in Early Symptomatic Alzheimer Disease}},
  journal = {Neurology},
  year    = {2024},
  doi     = {10.1212/wnl.0000000000208061},
  pmid    = {38386949},
  url     = {https://doi.org/10.1212/wnl.0000000000208061}
}

@article{filippi2022-35099507,
  author  = {Filippi, M. and Cecchetti, G. and Spinelli, E. G. and Vezzulli, P. and Falini, A. and Agosta, F.},
  title   = {{Amyloid-Related Imaging Abnormalities and β-Amyloid-Targeting Antibodies: A Systematic Review}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2021.5205},
  pmid    = {35099507},
  url     = {https://doi.org/10.1001/jamaneurol.2021.5205}
}

@article{sha2019-30383097,
  author  = {Sha, S. J. and Deutsch, G. K. and Tian, L. and Richardson, K. and Coburn, M. and Gaudioso, J. L. and Marcal, T. and Solomon, E. and others},
  title   = {{Safety, Tolerability, and Feasibility of Young Plasma Infusion in the Plasma for Alzheimer Symptom Amelioration Study: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2019},
  doi     = {10.1001/jamaneurol.2018.3288},
  pmid    = {30383097},
  url     = {https://doi.org/10.1001/jamaneurol.2018.3288}
}

@article{wang2005-16319382,
  author  = {Wang, P. S. and Schneeweiss, S. and Avorn, J. and Fischer, M. A. and Mogun, H. and Solomon, D. H. and Brookhart, M. A.},
  title   = {{Risk of death in elderly users of conventional vs. atypical antipsychotic medications}},
  journal = {The New England journal of medicine},
  year    = {2005},
  doi     = {10.1056/nejmoa052827},
  pmid    = {16319382},
  url     = {https://doi.org/10.1056/nejmoa052827}
}

@article{gill2007-17548409,
  author  = {Gill, S. S. and Bronskill, S. E. and Normand, S. L. and Anderson, G. M. and Sykora, K. and Lam, K. and Bell, C. M. and Lee, P. E. and others},
  title   = {{Antipsychotic drug use and mortality in older adults with dementia}},
  journal = {Annals of internal medicine},
  year    = {2007},
  doi     = {10.7326/0003-4819-146-11-200706050-00006},
  pmid    = {17548409},
  url     = {https://doi.org/10.7326/0003-4819-146-11-200706050-00006}
}

@article{cummings2026-41865758,
  author  = {Cummings, Jeffrey L and Atri, Alireza and Sano, Mary and Zetterberg, Henrik and Scheltens, Philip and Knop, Filip K and Johannsen, Peter and Wichmann, Christian Ahmad and others},
  title   = {{Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials}},
  journal = {The Lancet},
  year    = {2026},
  doi     = {10.1016/s0140-6736(26)00459-9},
  pmid    = {41865758},
  url     = {https://doi.org/10.1016/s0140-6736(26)00459-9}
}

@article{ballard2006-16437455,
  author  = {Ballard, C. and Waite, J.},
  title   = {{The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease}},
  journal = {The Cochrane database of systematic reviews},
  year    = {2006},
  doi     = {10.1002/14651858.cd003476.pub2},
  pmid    = {16437455},
  url     = {https://doi.org/10.1002/14651858.cd003476.pub2}
}

@article{wang2025-40308765,
  author  = {Wang, H. and Pan, J. and Zhang, M. and Tan, Z.},
  title   = {{Re-evaluation of the efficacy and safety of anti-Aβ monoclonal antibodies (lecanemab/donanemab) in the treatment of early Alzheimer's disease}},
  journal = {Frontiers in pharmacology},
  year    = {2025},
  doi     = {10.3389/fphar.2025.1599048},
  pmid    = {40308765},
  url     = {https://doi.org/10.3389/fphar.2025.1599048}
}

@article{salloway2018-29914022,
  author  = {Salloway, S. P. and Sperling, R. and Fox, N. C. and Sabbagh, M. N. and Honig, L. S. and Porsteinsson, A. P. and Rofael, H. and Ketter, N. and others},
  title   = {{Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2018},
  doi     = {10.3233/jad-171157},
  pmid    = {29914022},
  url     = {https://doi.org/10.3233/jad-171157}
}

@article{abdelazim2024-38565747,
  author  = {Abdelazim, K. and Allam, A. A. and Afifi, B. and Abdulazeem, H. and Elbehiry, A. I.},
  title   = {{The efficacy and safety of lecanemab 10 mg/kg biweekly compared to a placebo in patients with Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials}},
  journal = {Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology},
  year    = {2024},
  doi     = {10.1007/s10072-024-07477-w},
  pmid    = {38565747},
  url     = {https://doi.org/10.1007/s10072-024-07477-w}
}

@article{chundu2025-40621323,
  author  = {Chundu, U. C. and Thiriveedhi, SR. and Bhatti, C. and Mupparaju, J. S. and Otinashvili, N. and Gelishvili, E.},
  title   = {{A Systematic Review of the Efficacy and Safety of Anti-amyloid Monoclonal Antibodies in Alzheimer's Disease}},
  journal = {Cureus},
  year    = {2025},
  doi     = {10.7759/cureus.85377},
  pmid    = {40621323},
  url     = {https://doi.org/10.7759/cureus.85377}
}

@article{noguchishinohara2025-41276859,
  author  = {Noguchi-Shinohara, M. and Yoshinobu, T. and Ozaki, T. and Muramatsu, D. and Shima, A. and Sakashita, Y. and Tada, Y. and Yamaguchi, H. and others},
  title   = {{Higher phosphorylated tau levels predict cognitive decline and amyloid-related imaging abnormalities during lecanemab treatment: clinical practice data}},
  journal = {Alzheimer's research \& therapy},
  year    = {2025},
  doi     = {10.1186/s13195-025-01912-6},
  pmid    = {41276859},
  url     = {https://doi.org/10.1186/s13195-025-01912-6}
}

@article{paczynski2025-40354064,
  author  = {Paczynski, M. and Hofmann, A. and Posey, Z. and Gregersen, M. and Rudman, M. and Ellington, D. and Aldinger, M. and Musiek, E. S. and Holtzman, D. M. and Bateman, R. J. and others},
  title   = {{Lecanemab Treatment in a Specialty Memory Clinic}},
  journal = {JAMA Neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2025.1232},
  pmid    = {40354064},
  url     = {https://doi.org/10.1001/jamaneurol.2025.1232}
}

@article{rafii2022-35532913,
  author  = {Rafii, M. S. and Sol, O. and Mobley, W. C. and Delpretti, S. and Skotko, B. G. and Burke, A. D. and Sabbagh, M. N. and Yuan, S. H. and others},
  title   = {{Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.0983},
  pmid    = {35532913},
  url     = {https://doi.org/10.1001/jamaneurol.2022.0983}
}

@article{jeong2025-40112274,
  author  = {Jeong, S. Y. and Suh, C. H. and Lim, J. S. and Shim, W. H. and Heo, H. and Choi, Y. and Kim, H. S. and Kim, S. J. and others},
  title   = {{Incidence of Amyloid-Related Imaging Abnormalities in Phase III Clinical Trials of Anti-Amyloid-β Immunotherapy: An Updated Meta-Analysis}},
  journal = {Neurology},
  year    = {2025},
  doi     = {10.1212/wnl.0000000000213483},
  pmid    = {40112274},
  url     = {https://doi.org/10.1212/wnl.0000000000213483}
}

@article{maust2015-25786075,
  author  = {Maust, D. T. and Kim, H. M. and Seyfried, L. S. and Chiang, C. and Kavanagh, J. and Schneider, L. S. and Kales, H. C.},
  title   = {{Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm}},
  journal = {JAMA psychiatry},
  year    = {2015},
  doi     = {10.1001/jamapsychiatry.2014.3018},
  pmid    = {25786075},
  url     = {https://doi.org/10.1001/jamapsychiatry.2014.3018}
}

@article{richardson2018-29695481,
  author  = {Richardson, K. and Fox, C. and Maidment, I. and Steel, N. and Loke, Y. K. and Arthur, A. and Myint, P. K. and Grossi, C. M. and others},
  title   = {{Anticholinergic drugs and risk of dementia: case-control study}},
  journal = {BMJ (Clinical research ed.)},
  year    = {2018},
  doi     = {10.1136/bmj.k1315},
  pmid    = {29695481},
  url     = {https://doi.org/10.1136/bmj.k1315}
}

@article{lacorte2022-35275549,
  author  = {Lacorte, E. and Ancidoni, A. and Zaccaria, V. and Remoli, G. and Tariciotti, L. and Bellomo, G. and Sciancalepore, F. and Corbo, M. and others},
  title   = {{Safety and Efficacy of Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2022},
  doi     = {10.3233/jad-220046},
  pmid    = {35275549},
  url     = {https://doi.org/10.3233/jad-220046}
}

@article{villain2022-36184326,
  author  = {Villain, N. and Planche, V. and Levy, R.},
  title   = {{High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects}},
  journal = {Revue neurologique},
  year    = {2022},
  doi     = {10.1016/j.neurol.2022.06.012},
  pmid    = {36184326},
  url     = {https://doi.org/10.1016/j.neurol.2022.06.012}
}

@article{green2019-30652263,
  author  = {Green, A. R. and Reifler, L. M. and Bayliss, E. A. and Weffald, L. A. and Boyd, C. M.},
  title   = {{Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study}},
  journal = {Drugs \& aging},
  year    = {2019},
  doi     = {10.1007/s40266-018-00630-z},
  pmid    = {30652263},
  url     = {https://doi.org/10.1007/s40266-018-00630-z}
}

@article{nguyen2018-30080934,
  author  = {Nguyen, C. and Lairson, D. R. and Swartz, M. D. and Du, X. L.},
  title   = {{Risks of Major Long-Term Side Effects Associated with Androgen-Deprivation Therapy in Men with Prostate Cancer}},
  journal = {Pharmacotherapy},
  year    = {2018},
  doi     = {10.1002/phar.2168},
  pmid    = {30080934},
  url     = {https://doi.org/10.1002/phar.2168}
}

@article{chen2024-38640313,
  author  = {Chen, Yan and Lai, Min and Tao, Ming},
  title   = {{Evaluating the efficacy and safety of Alzheimer's disease drugs: A meta-analysis and systematic review}},
  journal = {Medicine},
  year    = {2024},
  doi     = {10.1097/md.0000000000037799},
  pmid    = {38640313},
  url     = {https://doi.org/10.1097/md.0000000000037799}
}

@article{gao2024-38439609,
  author  = {Gao, Yaqi and Liu, Yulin and Li, Yanfang},
  title   = {{Safety and efficacy of acetylcholinesterase inhibitors for Alzheimer's disease: A systematic review and meta-analysis}},
  journal = {Advances in clinical and experimental medicine : official organ Wroclaw Medical University},
  year    = {2024},
  doi     = {10.17219/acem/176051},
  pmid    = {38439609},
  url     = {https://doi.org/10.17219/acem/176051}
}

@article{carney2019-31921965,
  author  = {Carney, Greg and Bassett, Ken and Wright, James M and Maclure, Malcolm and McGuire, Nicolette and Dormuth, Colin R},
  title   = {{Comparison of cholinesterase inhibitor safety in real-world practice}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2019},
  doi     = {10.1016/j.trci.2019.09.011},
  pmid    = {31921965},
  url     = {https://doi.org/10.1016/j.trci.2019.09.011}
}

@article{abouelmagd2025-41188985,
  author  = {Abouelmagd, Moaz Elsayed and Almosilhy, Nereen A and Makhlouf, Hamdy A and Hassan, Amr K and Osman, Ahmed S A and Hindawi, Mahmoud Diaa and Elshahat, Ahmed and Alnajjar, Asmaa Zakria and others},
  title   = {{Comparative safety of cholinesterase inhibitors and memantine for dementia: a protocol for a network meta-analysis of randomized controlled trials}},
  journal = {Systematic reviews},
  year    = {2025},
  doi     = {10.1186/s13643-025-02961-6},
  pmid    = {41188985},
  url     = {https://doi.org/10.1186/s13643-025-02961-6}
}

@article{sheehan2015-26330451,
  author  = {Sheehan, Rory and Hassiotis, Angela and Walters, Kate R and Osborn, David and Strydom, André and Horsfall, Laura},
  title   = {{Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study}},
  journal = {BMJ},
  year    = {2015},
  doi     = {10.1136/bmj.h4326},
  pmid    = {26330451},
  url     = {https://doi.org/10.1136/bmj.h4326}
}

@article{geldmacher2011-20837824,
  author  = {Geldmacher, D. S. and Fritsch, T. and McClendon, M. J. and Landreth, G.},
  title   = {{A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {2011},
  doi     = {10.1001/archneurol.2010.229},
  pmid    = {20837824},
  url     = {https://doi.org/10.1001/archneurol.2010.229}
}

@article{ancelin2006-16452102,
  author  = {Ancelin, M. L. and Artero, S. and Portet, F. and Dupuy, A. M. and Touchon, J. and Ritchie, K.},
  title   = {{Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study}},
  journal = {BMJ (Clinical research ed.)},
  year    = {2006},
  doi     = {10.1136/bmj.38740.439664.de},
  pmid    = {16452102},
  url     = {https://doi.org/10.1136/bmj.38740.439664.de}
}

@article{dubois2012-22915447,
  author  = {Dubois, B. and Tolosa, E. and Katzenschlager, R. and Emre, M. and Lees, A. J. and Schumann, G. and Pourcher, E. and Gray, J. and others},
  title   = {{Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study}},
  journal = {Movement disorders : official journal of the Movement Disorder Society},
  year    = {2012},
  doi     = {10.1002/mds.25098},
  pmid    = {22915447},
  url     = {https://doi.org/10.1002/mds.25098}
}

@article{rahman2023-36775284,
  author  = {Rahman, Afroza and Hossen, Md Anwar and Chowdhury, Mirza Farhana Iqbal and Bari, Sadia and Tamanna, Nuzhat and Sultana, Syeda Salima and Haque, Sharar Naiarin and Masud, Abdullah Al and others},
  title   = {{Aducanumab for the treatment of Alzheimer's disease: a systematic review}},
  journal = {Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society},
  year    = {2023},
  doi     = {10.1111/psyg.12944},
  pmid    = {36775284},
  url     = {https://doi.org/10.1111/psyg.12944}
}

@article{shang2025-41250246,
  author  = {Shang, Jia and Zhong, Siyan and Shang, Li and Zeng, Qingze and Zhao, Shuai and Luo, Xiao and Li, Kaicheng and Zhang, Xinyi and others},
  title   = {{Real-world application of lecanemab in early-stage alzheimer's disease: a single-center prospective cohort analysis}},
  journal = {Alzheimer's research \& therapy},
  year    = {2025},
  doi     = {10.1186/s13195-025-01886-5},
  pmid    = {41250246},
  url     = {https://doi.org/10.1186/s13195-025-01886-5}
}

@article{shimasaki2026-41936348,
  author  = {Shimasaki, Ryosuke and Kurihara, Masanori and Bannai, Taro and Hatano, Keiko and Suzuki, Fumio and Tokumaru, Aya Midori and Ishii, Kenji and Ihara, Ryoko and others},
  title   = {{Amyloid-related imaging abnormalities in Japanese patients with Alzheimer's disease treated with Lecanemab: A real-world study}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2026},
  doi     = {10.1016/j.tjpad.2026.100562},
  pmid    = {41936348},
  url     = {https://doi.org/10.1016/j.tjpad.2026.100562}
}

@article{vanetten2026-912127c4,
  author  = {van Etten, E. S. and others},
  title   = {{Amyloid-Related Imaging Abnormalities (ARIA) in Anti-Amyloid Therapies for Alzheimer's Disease: An Update from the Alzheimer's Association ARIA Workgroup}},
  journal = {Alzheimer's \& Dementia},
  year    = {2026}
}

@article{fleisher2008-18695053,
  author  = {Fleisher, A. S. and Raman, R. and Siemers, E. R. and Becerra, L. and Clark, C. M. and Dean, R. A. and Farlow, M. R. and Galvin, J. E. and others},
  title   = {{Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {2008},
  doi     = {10.1001/archneur.65.8.1031},
  pmid    = {18695053},
  url     = {https://doi.org/10.1001/archneur.65.8.1031}
}

@article{watt2020-32546202,
  author  = {Watt, J. A. and Goodarzi, Z. and Veroniki, A. A. and Nincic, V. and Khan, P. A. and Ghassemi, M. and Thompson, Y. and Lai, Y. and others},
  title   = {{Safety of pharmacologic interventions for neuropsychiatric symptoms in dementia: a systematic review and network meta-analysis}},
  journal = {BMC geriatrics},
  year    = {2020},
  doi     = {10.1186/s12877-020-01607-7},
  pmid    = {32546202},
  url     = {https://doi.org/10.1186/s12877-020-01607-7}
}

@article{billiotidegage2014-25208536,
  author  = {Billioti de Gage, S. and Moride, Y. and Ducruet, T. and Kurth, T. and Verdoux, H. and Tournier, M. and Pariente, A. and Bégaud, B.},
  title   = {{Benzodiazepine use and risk of Alzheimer's disease: case-control study}},
  journal = {BMJ (Clinical research ed.)},
  year    = {2014},
  doi     = {10.1136/bmj.g5205},
  pmid    = {25208536},
  url     = {https://doi.org/10.1136/bmj.g5205}
}

@article{jeong2022-36038268,
  author  = {Jeong, S. Y. and Suh, C. H. and Shim, W. H. and Lim, J. S. and Lee, J. H. and Kim, S. J.},
  title   = {{Incidence of Amyloid-Related Imaging Abnormalities in Patients With Alzheimer Disease Treated With Anti-β-Amyloid Immunotherapy: A Meta-analysis}},
  journal = {Neurology},
  year    = {2022},
  doi     = {10.1212/wnl.0000000000201019},
  pmid    = {36038268},
  url     = {https://doi.org/10.1212/wnl.0000000000201019}
}

@article{herzig2016-26889839,
  author  = {Herzig, S. J. and Rothberg, M. B. and Guess, JR. and Stevens, J. P. and Marshall, J. and Gurwitz, J. H. and Marcantonio, E. R.},
  title   = {{Antipsychotic Use in Hospitalized Adults: Rates, Indications, and Predictors}},
  journal = {Journal of the American Geriatrics Society},
  year    = {2016},
  doi     = {10.1111/jgs.13943},
  pmid    = {26889839},
  url     = {https://doi.org/10.1111/jgs.13943}
}

@article{weintraub2016-26999262,
  author  = {Weintraub, D. and Chiang, C. and Kim, H. M. and Wilkinson, J. and Marras, C. and Stanislawski, B. and Mamikonyan, E. and Kales, H. C.},
  title   = {{Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease}},
  journal = {JAMA neurology},
  year    = {2016},
  doi     = {10.1001/jamaneurol.2016.0031},
  pmid    = {26999262},
  url     = {https://doi.org/10.1001/jamaneurol.2016.0031}
}

@article{kim2011-21649634,
  author  = {Kim, D. H. and Brown, R. T. and Ding, E. L. and Kiel, D. P. and Berry, S. D.},
  title   = {{Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials}},
  journal = {Journal of the American Geriatrics Society},
  year    = {2011},
  doi     = {10.1111/j.1532-5415.2011.03450.x},
  pmid    = {21649634},
  url     = {https://doi.org/10.1111/j.1532-5415.2011.03450.x}
}

@article{arroyopacheco2025-39638097,
  author  = {Arroyo-Pacheco, N. and Sarmiento-Blanco, S. and Vergara-Cadavid, G. and Castro-Leones, M. and Contreras-Puentes, N.},
  title   = {{Monoclonal therapy with lecanemab in the treatment of mild Alzheimer's disease: A systematic review and meta-analysis}},
  journal = {Ageing research reviews},
  year    = {2025},
  doi     = {10.1016/j.arr.2024.102620},
  pmid    = {39638097},
  url     = {https://doi.org/10.1016/j.arr.2024.102620}
}

@article{andreasen2015-25789616,
  author  = {Andreasen, N. and Simeoni, M. and Ostlund, H. and Lisjo, P. I. and Fladby, T. and Loercher, A. E. and Byrne, G. J. and Murray, F. and others},
  title   = {{First administration of the Fc-attenuated anti-β amyloid antibody GSK933776 to patients with mild Alzheimer's disease: a randomized, placebo-controlled study}},
  journal = {PloS one},
  year    = {2015},
  doi     = {10.1371/journal.pone.0098153},
  pmid    = {25789616},
  url     = {https://doi.org/10.1371/journal.pone.0098153}
}

@article{martens2018-28956123,
  author  = {Martens, R. M. and Bechten, A. and Ingala, S. and van Schijndel, R. A. and Machado, V. B. and de Jong, M. C. and Sanchez, E. and Purcell, D. and others},
  title   = {{The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer's patients: An interobserver study}},
  journal = {European radiology},
  year    = {2018},
  doi     = {10.1007/s00330-017-5022-6},
  pmid    = {28956123},
  url     = {https://doi.org/10.1007/s00330-017-5022-6}
}

@article{islam2016-28013304,
  author  = {Islam, M. M. and Iqbal, U. and Walther, B. and Atique, S. and Dubey, N. K. and Nguyen, P. A. and Poly, T. N. and Masud, J. H. and others},
  title   = {{Benzodiazepine Use and Risk of Dementia in the Elderly Population: A Systematic Review and Meta-Analysis}},
  journal = {Neuroepidemiology},
  year    = {2016},
  doi     = {10.1159/000454881},
  pmid    = {28013304},
  url     = {https://doi.org/10.1159/000454881}
}

@article{schneider2006-17035647,
  author  = {Schneider, L. S. and Tariot, P. N. and Dagerman, K. S. and Davis, S. M. and Hsiao, J. K. and Ismail, M. S. and Lebowitz, B. D. and Lyketsos, C. G. and others},
  title   = {{Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease}},
  journal = {The New England journal of medicine},
  year    = {2006},
  doi     = {10.1056/nejmoa061240},
  pmid    = {17035647},
  url     = {https://doi.org/10.1056/nejmoa061240}
}

@article{wang2025-40619285,
  author  = {Wang, Hong and Nery, Emel Serap Monkul and Ardayfio, Paul and Khanna, Rashna and Svaldi, Diana Otero and Shcherbinin, Sergey and Xu, Wen and Andersen, Scott W and others},
  title   = {{The effect of modified donanemab titration on amyloid-related imaging abnormalities with edema/effusions and amyloid reduction: 18-month results from TRAILBLAZER-ALZ 6}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100266},
  pmid    = {40619285},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100266}
}

@article{liu2018-29429971,
  author  = {Liu, E. and Wang, D. and Sperling, R. and Salloway, S. and Fox, N. C. and Blennow, K. and Scheltens, P. and Schmidt, M. E. and others},
  title   = {{Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab}},
  journal = {Neurology},
  year    = {2018},
  doi     = {10.1212/wnl.0000000000005060},
  pmid    = {29429971},
  url     = {https://doi.org/10.1212/wnl.0000000000005060}
}

@article{matsunaga2018-30222469,
  author  = {Matsunaga, Shinji and Kishi, Taro and Nomura, Ikuo and Sakuma, Kenji and Okuya, Makoto and Ikuta, Toshikazu and Iwata, Nakao},
  title   = {{The efficacy and safety of memantine for the treatment of Alzheimer's disease}},
  journal = {Expert opinion on drug safety},
  year    = {2018},
  doi     = {10.1080/14740338.2018.1524870},
  pmid    = {30222469},
  url     = {https://doi.org/10.1080/14740338.2018.1524870}
}

@article{antolini2021-34531298,
  author  = {Antolini, L. and DiFrancesco, J. C. and Zedde, M. and Basso, G. and Arighi, A. and Shima, A. and Cagnin, A. and Caulo, M. and others},
  title   = {{Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Prospective Longitudinal Cohort Study}},
  journal = {Neurology},
  year    = {2021},
  doi     = {10.1212/wnl.0000000000012778},
  pmid    = {34531298},
  url     = {https://doi.org/10.1212/wnl.0000000000012778}
}

@article{kishnani2009-19606472,
  author  = {Kishnani, P. S. and Sommer, B. R. and Handen, B. L. and Seltzer, B. and Capone, G. T. and Spiridigliozzi, G. A. and Heller, J. H. and Richardson, S. and others},
  title   = {{The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome}},
  journal = {American journal of medical genetics. Part A},
  year    = {2009},
  doi     = {10.1002/ajmg.a.32953},
  pmid    = {19606472},
  url     = {https://doi.org/10.1002/ajmg.a.32953}
}

@article{boon2025-41109234,
  author  = {Boon, B. D. C. and Piura, Y. D. and Moloney, C. M. and Chalk, J. L. and Lincoln, S. J. and Rutledge, M. H. and Rothberg, D. M. and Kouri, N. and others},
  title   = {{Neuropathological changes and amyloid-related imaging abnormalities in Alzheimer's disease treated with aducanumab versus untreated: a retrospective case-control study}},
  journal = {The Lancet. Neurology},
  year    = {2025},
  doi     = {10.1016/s1474-4422(25)00313-8},
  pmid    = {41109234},
  url     = {https://doi.org/10.1016/s1474-4422(25)00313-8}
}

@article{lonergan2007-17443602,
  author  = {Lonergan, E. and Britton, A. M. and Luxenberg, J. and Wyller, T.},
  title   = {{Antipsychotics for delirium}},
  journal = {The Cochrane database of systematic reviews},
  year    = {2007},
  doi     = {10.1002/14651858.cd005594.pub2},
  pmid    = {17443602},
  url     = {https://doi.org/10.1002/14651858.cd005594.pub2}
}

@article{vu2021-32723537,
  author  = {Vu, M. and Sileanu, F. E. and Aspinall, S. L. and Niznik, J. D. and Springer, S. P. and Mor, M. K. and Zhao, X. and Ersek, M. and others},
  title   = {{Antihypertensive Deprescribing in Older Adult Veterans at End of Life Admitted to Veteran Affairs Nursing Homes}},
  journal = {Journal of the American Medical Directors Association},
  year    = {2021},
  doi     = {10.1016/j.jamda.2020.05.060},
  pmid    = {32723537},
  url     = {https://doi.org/10.1016/j.jamda.2020.05.060}
}

@article{wang2022-35320578,
  author  = {Wang, D. and Kowalewski, E. K. and Koch, G.},
  title   = {{Application of Meta-analysis to Evaluate Relationships Among ARIA-E Rate, Amyloid Reduction Rate, and Clinical Cognitive Response in Amyloid Therapeutic Clinical Trials for Early Alzheimer's Disease}},
  journal = {Therapeutic innovation \& regulatory science},
  year    = {2022},
  doi     = {10.1007/s43441-022-00390-4},
  pmid    = {35320578},
  url     = {https://doi.org/10.1007/s43441-022-00390-4}
}

@article{kales2011-22193526,
  author  = {Kales, Helen C. and Kim, Hyungjin Myra and Zivin, Kara and Valenstein, Marcia M. and Seyfried, Lisa S. and Chiang, Claire and Cunningham, Francesca E. and Schneider, Lon S. S. and others},
  title   = {{Risk of Mortality Among Individual Antipsychotics in Patients With Dementia}},
  journal = {American Journal of Psychiatry},
  year    = {2011},
  doi     = {10.1176/appi.ajp.2011.11030347},
  pmid    = {22193526},
  url     = {https://doi.org/10.1176/appi.ajp.2011.11030347}
}

@article{tariot2001-11843990,
  author  = {Tariot, P. N. and Cummings, J. L. and Katz, I. R. and Mintzer, J. and Perdomo, C. A. and Schwam, E. M. and Whalen, E.},
  title   = {{A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting}},
  journal = {Journal of the American Geriatrics Society},
  year    = {2001},
  doi     = {10.1111/j.1532-5415.2001.49266.x},
  pmid    = {11843990},
  url     = {https://doi.org/10.1111/j.1532-5415.2001.49266.x}
}

@article{rogers2000-10793322,
  author  = {Rogers, S. L. and Doody, R. S. and Pratt, R. D. and Ieni, JR.},
  title   = {{Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study}},
  journal = {European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology},
  year    = {2000},
  doi     = {10.1016/s0924-977x(00)00067-5},
  pmid    = {10793322},
  url     = {https://doi.org/10.1016/s0924-977x(00)00067-5}
}

@article{scheltens2018-30309389,
  author  = {Scheltens, P. and Hallikainen, M. and Grimmer, T. and Duning, T. and Gouw, A. A. and Teunissen, C. E. and Wink, A. M. and Maruff, P. and others},
  title   = {{Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a study}},
  journal = {Alzheimer's research \& therapy},
  year    = {2018},
  doi     = {10.1186/s13195-018-0431-6},
  pmid    = {30309389},
  url     = {https://doi.org/10.1186/s13195-018-0431-6}
}

@article{pisani2009-19050611,
  author  = {Pisani, M. A. and Murphy, T. E. and Araujo, K. L. and Slattum, P. and Van Ness, P. H. and Inouye, S. K.},
  title   = {{Benzodiazepine and opioid use and the duration of intensive care unit delirium in an older population}},
  journal = {Critical care medicine},
  year    = {2009},
  doi     = {10.1097/ccm.0b013e318192fcf9},
  pmid    = {19050611},
  url     = {https://doi.org/10.1097/ccm.0b013e318192fcf9}
}

@article{logovinsky2016-27048170,
  author  = {Logovinsky, V. and Satlin, A. and Lai, R. and Swanson, C. and Kaplow, J. and Osswald, G. and Basun, H. and Lannfelt, L.},
  title   = {{Safety and tolerability of BAN2401--a clinical study in Alzheimer's disease with a protofibril selective Aβ antibody}},
  journal = {Alzheimer's research \& therapy},
  year    = {2016},
  doi     = {10.1186/s13195-016-0181-2},
  pmid    = {27048170},
  url     = {https://doi.org/10.1186/s13195-016-0181-2}
}

@article{foroutan2019-30904037,
  author  = {Foroutan, N. and Hopkins, R. B. and Tarride, J. E. and Florez, I. D. and Levine, M.},
  title   = {{Safety and efficacy of active and passive immunotherapy in mild-to-moderate Alzheimer's disease: A systematic review and network meta-analysis}},
  journal = {Clinical and investigative medicine. Medecine clinique et experimentale},
  year    = {2019},
  doi     = {10.25011/cim.v42i1.32393},
  pmid    = {30904037},
  url     = {https://doi.org/10.25011/cim.v42i1.32393}
}

@article{ashmawy2025-40232258,
  author  = {Ashmawy, R. E. and Okesanya, O. J. and Ukoaka, B. M. and Daniel, F. M. and Ezedigwe, S. G. and Agboola, A. O. and Ahmed, M. M. and Ogaya, J. B. and others},
  title   = {{Exploring the efficacy and safety of lecanemab in the management of early Alzheimer's disease: A systematic review of clinical evidence}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2025},
  doi     = {10.1177/13872877251331640},
  pmid    = {40232258},
  url     = {https://doi.org/10.1177/13872877251331640}
}

@article{doody2001-11255446,
  author  = {Doody, R. S. and Geldmacher, D. S. and Gordon, B. and Perdomo, C. A. and Pratt, R. D. and {Donepezil Study Group}},
  title   = {{Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {2001},
  doi     = {10.1001/archneur.58.3.427},
  pmid    = {11255446},
  url     = {https://doi.org/10.1001/archneur.58.3.427}
}

@article{kang2026-42642841,
  author  = {Kang, Heekyoung and Jang, Hyemin and Ahn, Jehyun and Na, Duk L and Lee, Jae-Hong and Kim, Eun-Joo and Chun, Min Young and Cho, Soo Hyun and others},
  title   = {{APOE-guided lecanemab dosing dissociates ARIA-E from ARIA-H: The K-ROAD study}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2026},
  doi     = {10.1002/alz.71765},
  pmid    = {42642841},
  url     = {https://doi.org/10.1002/alz.71765}
}

@article{josephmathurin2022-36151869,
  author  = {Joseph-Mathurin, N. and Llibre-Guerra, J. J. and Li, Y. and McCullough, A. A. and Hofmann, C. and Wojtowicz, J. and Park, E. and Wang, G. and others},
  title   = {{Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease}},
  journal = {Annals of neurology},
  year    = {2022},
  doi     = {10.1002/ana.26511},
  pmid    = {36151869},
  url     = {https://doi.org/10.1002/ana.26511}
}

@article{jeste2008-17637610,
  author  = {Jeste, D. V. and Blazer, D. and Casey, D. and Meeks, T. and Salzman, C. and Schneider, L. and Tariot, P. and Yaffe, K.},
  title   = {{ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia}},
  journal = {Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology},
  year    = {2008},
  doi     = {10.1038/sj.npp.1301492},
  pmid    = {17637610},
  url     = {https://doi.org/10.1038/sj.npp.1301492}
}

@article{rogers1998-9452942,
  author  = {Rogers, S. L. and Friedhoff, L. T.},
  title   = {{Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study}},
  journal = {European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology},
  year    = {1998},
  doi     = {10.1016/s0924-977x(97)00079-5},
  pmid    = {9452942},
  url     = {https://doi.org/10.1016/s0924-977x(97)00079-5}
}

@article{betz2024-39531391,
  author  = {Betz, M. E. and Portz, J. and Knoepke, C. and Ranney, M. L. and Fischer, S. M. and Peterson, R. A. and Johnson, R. L. and Omeragic, F. and Castaneda, M. and Greenway, E. and Matlock, D.},
  title   = {{The Effect of the "Safety in Dementia" Online Tool to Assist Decision Making for Caregivers of Persons With Dementia and Access to Firearms: A Randomized Trial}},
  journal = {Annals of Internal Medicine},
  year    = {2024},
  doi     = {10.7326/ANNALS-24-00763},
  pmid    = {39531391},
  url     = {https://doi.org/10.7326/ANNALS-24-00763}
}

@article{dyer2020-31604674,
  author  = {Dyer, A. H. and Murphy, C. and Lawlor, B. and Kennelly, S. P. and {NILVAD Study Group}},
  title   = {{Cognitive Outcomes of Long-term Benzodiazepine and Related Drug (BDZR) Use in People Living With Mild to Moderate Alzheimer's Disease: Results From NILVAD}},
  journal = {Journal of the American Medical Directors Association},
  year    = {2020},
  doi     = {10.1016/j.jamda.2019.08.006},
  pmid    = {31604674},
  url     = {https://doi.org/10.1016/j.jamda.2019.08.006}
}

@article{wilcock2000-11110737,
  author  = {Wilcock, G. K. and Lilienfeld, S. and Gaens, E.},
  title   = {{Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group}},
  journal = {BMJ (Clinical research ed.)},
  year    = {2000},
  doi     = {10.1136/bmj.321.7274.1445},
  pmid    = {11110737},
  url     = {https://doi.org/10.1136/bmj.321.7274.1445}
}

@article{huston2016-28661865,
  author  = {Huston, P. and McFarlane, B.},
  title   = {{Health benefits of tai chi: What is the evidence?}},
  journal = {Canadian family physician Medecin de famille canadien},
  year    = {2016},
  pmid    = {28661865}
}

@article{yaari2022-36281665,
  author  = {Yaari, R. and Holdridge, K. C. and Choi, J. and Donohue, M. C. and Kantarci, K. and Jack, C. R. and Zuk, S. M. and Sims, JR. and others},
  title   = {{Amyloid-Related Imaging Abnormalities and Other MRI Findings in a Cognitively Unimpaired Population With and Without Cerebral Amyloid}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2022},
  doi     = {10.14283/jpad.2022.56},
  pmid    = {36281665},
  url     = {https://doi.org/10.14283/jpad.2022.56}
}

@article{hansen2008-18686744,
  author  = {Hansen, R. A. and Gartlehner, G. and Webb, A. P. and Morgan, L. C. and Moore, C. G. and Jonas, D. E.},
  title   = {{Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis}},
  journal = {Clinical interventions in aging},
  year    = {2008},
  pmid    = {18686744}
}

@article{mintun2023-3d9d0576,
  author  = {Mintun, Mark A. and Ritchie, Craig William and Solomon, Paul R. and Sims, John Randall and Salloway, Stephen and Hansson, Oskar and Apostolova, Liana G. and Zimmer, Jennifer A. and others},
  title   = {{Donanemab in Early Symptomatic Alzheimer’s Disease: Efficacy and Safety in TRAILBLAZER‐ALZ 2, a Phase 3 Randomized Clinical Trial}},
  journal = {Alzheimer s \& Dementia},
  year    = {2023},
  doi     = {10.1002/alz.082733},
  url     = {https://doi.org/10.1002/alz.082733}
}

@article{vandyck2025-41355080,
  author  = {van Dyck, C. H. and Sperling, R. and Johnson, K. and Dhadda, S. and Kanekiyo, M. and Li, D. and Gee, M. and Hersch, S. and Irizarry, M. and Kramer, L.},
  title   = {{Long-term safety and efficacy of lecanemab in early Alzheimer's disease: Results from the Clarity AD open-label extension study}},
  journal = {Alzheimer's \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.70905},
  pmid    = {41355080},
  url     = {https://doi.org/10.1002/alz.70905}
}

@article{ballard2008-18674411,
  author  = {Ballard, C. and Sauter, M. and Scheltens, P. and He, Y. and Barkhof, F. and van Straaten, E. C. and van der Flier, W. M. and Hsu, C. and others},
  title   = {{Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study}},
  journal = {Current medical research and opinion},
  year    = {2008},
  doi     = {10.1185/03007990802328142},
  pmid    = {18674411},
  url     = {https://doi.org/10.1185/03007990802328142}
}

@article{ernst2002-11777363,
  author  = {Ernst, E.},
  title   = {{The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava}},
  journal = {Annals of internal medicine},
  year    = {2002},
  doi     = {10.7326/0003-4819-136-1-200201010-00010},
  pmid    = {11777363},
  url     = {https://doi.org/10.7326/0003-4819-136-1-200201010-00010}
}

@article{risacher2016-27088965,
  author  = {Risacher, S. L. and McDonald, B. C. and Tallman, E. F. and West, J. D. and Farlow, M. R. and Unverzagt, F. W. and Gao, S. and Boustani, M. and others},
  title   = {{Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults}},
  journal = {JAMA neurology},
  year    = {2016},
  doi     = {10.1001/jamaneurol.2016.0580},
  pmid    = {27088965},
  url     = {https://doi.org/10.1001/jamaneurol.2016.0580}
}

@article{hanlon2020-32152019,
  author  = {Hanlon, P. and Quinn, T. J. and Gallacher, K. I. and Myint, P. K. and Jani, B. D. and Nicholl, B. I. and Lowrie, R. and Soiza, R. L. and others},
  title   = {{Assessing Risks of Polypharmacy Involving Medications With Anticholinergic Properties}},
  journal = {Annals of family medicine},
  year    = {2020},
  doi     = {10.1370/afm.2501},
  pmid    = {32152019},
  url     = {https://doi.org/10.1370/afm.2501}
}

@article{hakim2026-42661728,
  author  = {Hakim, Ryan and Harris, Kristofer and Merrill, Livia and Falk-Vargas, Amanda and Whalen, Eileen and Xia, Tianxu and Ochoa, Olga and Hunter, David and others},
  title   = {{Real-world evidence for amyloid-targeted therapies: Lecanemab and donanemab}},
  journal = {Alzheimer's \& dementia (Amsterdam, Netherlands)},
  year    = {2026},
  doi     = {10.1002/dad2.70404},
  pmid    = {42661728},
  url     = {https://doi.org/10.1002/dad2.70404}
}

@article{sperling2012-22305802,
  author  = {Sperling, R. and Salloway, S. and Brooks, D. J. and Tampieri, D. and Barakos, J. and Fox, N. C. and Raskind, M. and Sabbagh, M. and others},
  title   = {{Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis}},
  journal = {The Lancet. Neurology},
  year    = {2012},
  doi     = {10.1016/s1474-4422(12)70015-7},
  pmid    = {22305802},
  url     = {https://doi.org/10.1016/s1474-4422(12)70015-7}
}

@article{guthrie2020-32568196,
  author  = {Guthrie, H. and Honig, L. S. and Lin, H. and Sink, K. M. and Blondeau, K. and Quartino, A. and Dolton, M. and Carrasco-Triguero, M. and others},
  title   = {{Safety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-to-Moderate Alzheimer's Disease Treated with Escalating Doses for up to 133 Weeks}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2020},
  doi     = {10.3233/jad-200134},
  pmid    = {32568196},
  url     = {https://doi.org/10.3233/jad-200134}
}

@article{carlson2016-27239538,
  author  = {Carlson, C. and Siemers, E. and Hake, A. and Case, M. and Hayduk, R. and Suhy, J. and Oh, J. and Barakos, J.},
  title   = {{Amyloid-related imaging abnormalities from trials of solanezumab for Alzheimer's disease}},
  journal = {Alzheimer's \& dementia (Amsterdam, Netherlands)},
  year    = {2016},
  doi     = {10.1016/j.dadm.2016.02.004},
  pmid    = {27239538},
  url     = {https://doi.org/10.1016/j.dadm.2016.02.004}
}

@article{brody2016-27589523,
  author  = {Brody, M. and Liu, E. and Di, J. and Lu, M. and Margolin, R. A. and Werth, J. L. and Booth, K. and Shadman, A. and others},
  title   = {{A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer's disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2016},
  doi     = {10.3233/jad-160369},
  pmid    = {27589523},
  url     = {https://doi.org/10.3233/jad-160369}
}

@article{cai2013-23183138,
  author  = {Cai, X. and Campbell, N. and Khan, B. and Callahan, C. and Boustani, M.},
  title   = {{Long-term anticholinergic use and the aging brain}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2013},
  doi     = {10.1016/j.jalz.2012.02.005},
  pmid    = {23183138},
  url     = {https://doi.org/10.1016/j.jalz.2012.02.005}
}

@article{gerlach2025-41085983,
  author  = {Gerlach, L. B. and Zhang, L. and Kim, H. M. and Teno, J. and Maust, D. T.},
  title   = {{Benzodiazepine or Antipsychotic Use and Mortality Risk Among Patients With Dementia in Hospice Care}},
  journal = {JAMA Network Open},
  year    = {2025},
  doi     = {10.1001/jamanetworkopen.2025.37551},
  pmid    = {41085983},
  url     = {https://doi.org/10.1001/jamanetworkopen.2025.37551}
}

@article{rosenberg2025-41350162,
  author  = {Rosenberg, P. B. and Amjad, H. and Burhanullah, H. and Nowrangi, M. and Vandrey, R. and Pierre, M. J. and Outen, J. D. and Schultz, M. and Marano, C. and Agronin, M. and others},
  title   = {{A Randomized Controlled Trial of the Safety and Efficacy of Dronabinol for Agitation in Alzheimer's Disease}},
  journal = {The American Journal of Geriatric Psychiatry},
  year    = {2025},
  doi     = {10.1016/j.jagp.2025.10.011},
  pmid    = {41350162},
  url     = {https://doi.org/10.1016/j.jagp.2025.10.011}
}

@article{landen2013-23334070,
  author  = {Landen, J. W. and Zhao, Q. and Cohen, S. and Borrie, M. and Woodward, M. and Billing, C. B. and Bales, K. and Alvey, C. and others},
  title   = {{Safety and pharmacology of a single intravenous dose of ponezumab in subjects with mild-to-moderate Alzheimer disease: a phase I, randomized, placebo-controlled, double-blind, dose-escalation study}},
  journal = {Clinical neuropharmacology},
  year    = {2013},
  doi     = {10.1097/wnf.0b013e31827db49b},
  pmid    = {23334070},
  url     = {https://doi.org/10.1097/wnf.0b013e31827db49b}
}

@article{ballard2015-25523285,
  author  = {Ballard, C. and Thomas, A. and Gerry, S. and Yu, L. M. and Aarsland, D. and Merritt, C. and Corbett, A. and Davison, C. and others},
  title   = {{A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD)}},
  journal = {Journal of the American Medical Directors Association},
  year    = {2015},
  doi     = {10.1016/j.jamda.2014.11.002},
  pmid    = {25523285},
  url     = {https://doi.org/10.1016/j.jamda.2014.11.002}
}

@article{campbell2010-20625168,
  author  = {Campbell, N. L. and Boustani, M. A. and Lane, K. A. and Gao, S. and Hendrie, H. and Khan, B. A. and Murrell, JR. and Unverzagt, F. W. and others},
  title   = {{Use of anticholinergics and the risk of cognitive impairment in an African American population}},
  journal = {Neurology},
  year    = {2010},
  doi     = {10.1212/wnl.0b013e3181e7f2ab},
  pmid    = {20625168},
  url     = {https://doi.org/10.1212/wnl.0b013e3181e7f2ab}
}

@article{joshi2021-33985348,
  author  = {Joshi, Y. B. and Thomas, M. L. and Braff, D. L. and Green, M. F. and Gur, R. C. and Gur, R. E. and Nuechterlein, K. H. and Stone, W. S. and others},
  title   = {{Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia}},
  journal = {The American journal of psychiatry},
  year    = {2021},
  doi     = {10.1176/appi.ajp.2020.20081212},
  pmid    = {33985348},
  url     = {https://doi.org/10.1176/appi.ajp.2020.20081212}
}

@article{potter2021-33778150,
  author  = {Potter, H. and Woodcock, J. H. and Boyd, T. D. and Coughlan, C. M. and O'Shaughnessy, JR. and Borges, M. T. and Thaker, A. A. and Raj, B. A. and others},
  title   = {{Safety and efficacy of sargramostim (GM-CSF) in the treatment of Alzheimer's disease}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2021},
  doi     = {10.1002/trc2.12158},
  pmid    = {33778150},
  url     = {https://doi.org/10.1002/trc2.12158}
}

@article{albertyn2025-40479610,
  author  = {Albertyn, C. P. and Guu, T. W. and Chu, P. and Creese, B. and Young, A. and Velayudhan, L. and Bhattacharyya, S. and Jafari, H. and Kaur, S. and Kandangwa, P. and others},
  title   = {{Sativex (nabiximols) for the treatment of Agitation \& Aggression in Alzheimer's dementia in UK nursing homes: a randomised, double-blind, placebo-controlled feasibility trial}},
  journal = {Age and Ageing},
  year    = {2025},
  doi     = {10.1093/ageing/afaf149},
  pmid    = {40479610},
  url     = {https://doi.org/10.1093/ageing/afaf149}
}

@article{lenz2015-25973909,
  author  = {Lenz, R. A. and Pritchett, Y. L. and Berry, S. M. and Llano, D. A. and Han, S. and Berry, D. A. and Sadowsky, C. H. and Abi-Saab, W. M. and others},
  title   = {{Adaptive, dose-finding phase 2 trial evaluating the safety and efficacy of ABT-089 in mild to moderate Alzheimer disease}},
  journal = {Alzheimer disease and associated disorders},
  year    = {2015},
  doi     = {10.1097/wad.0000000000000093},
  pmid    = {25973909},
  url     = {https://doi.org/10.1097/wad.0000000000000093}
}

@article{mohamed2012-21939611,
  author  = {Mohamed, S. and Rosenheck, R. and Lyketsos, C. G. and Kaczynski, R. and Sultzer, D. L. and Schneider, L. S.},
  title   = {{Effect of second-generation antipsychotics on caregiver burden in Alzheimer's disease}},
  journal = {The Journal of clinical psychiatry},
  year    = {2012},
  doi     = {10.4088/jcp.10m06574},
  pmid    = {21939611},
  url     = {https://doi.org/10.4088/jcp.10m06574}
}

@article{jovicic2015-26308983,
  author  = {Jovičić, A. and Mertens, J. and Boeynaems, S. and Bogaert, E. and Chai, N. and Yamada, S. B. and Paul, J. W. and Sun, S. and others},
  title   = {{Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS}},
  journal = {Nature neuroscience},
  year    = {2015},
  doi     = {10.1038/nn.4085},
  pmid    = {26308983},
  url     = {https://doi.org/10.1038/nn.4085}
}

@article{jalbert2010-20142067,
  author  = {Jalbert, J. J. and Eaton, C. B. and Miller, S. C. and Lapane, K. L.},
  title   = {{Antipsychotic use and the risk of hip fracture among older adults afflicted with dementia}},
  journal = {Journal of the American Medical Directors Association},
  year    = {2010},
  doi     = {10.1016/j.jamda.2009.10.001},
  pmid    = {20142067},
  url     = {https://doi.org/10.1016/j.jamda.2009.10.001}
}

@article{turner2020-32468646,
  author  = {Turner, R. S. and Hebron, M. L. and Lawler, A. and Mundel, E. E. and Yusuf, N. and Starr, J. N. and Anjum, M. and Pagan, F. and others},
  title   = {{Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease}},
  journal = {Annals of neurology},
  year    = {2020},
  doi     = {10.1002/ana.25775},
  pmid    = {32468646},
  url     = {https://doi.org/10.1002/ana.25775}
}

@article{mo2017-29296624,
  author  = {Mo, J. J. and Li, J. Y. and Yang, Z. and Liu, Z. and Feng, J. S.},
  title   = {{Efficacy and safety of anti-amyloid- β immunotherapy for Alzheimer's disease: a systematic review and network meta-analysis}},
  journal = {Annals of clinical and translational neurology},
  year    = {2017},
  doi     = {10.1002/acn3.469},
  pmid    = {29296624},
  url     = {https://doi.org/10.1002/acn3.469}
}

@article{xing2025-39780222,
  author  = {Xing, X. and Zhang, X. and Wang, K. and Wang, Z. and Feng, Y. and Li, X. and Hua, Y. and Zhang, L. and others},
  title   = {{Post-marketing safety concerns with lecanemab: a pharmacovigilance study based on the FDA Adverse Event Reporting System database}},
  journal = {Alzheimer's research \& therapy},
  year    = {2025},
  doi     = {10.1186/s13195-024-01669-4},
  pmid    = {39780222},
  url     = {https://doi.org/10.1186/s13195-024-01669-4}
}

@article{kong2025-40520157,
  author  = {Kong, L. and Yang, X. and Xu, J.},
  title   = {{Comparison of safety of lecanemab and aducanumab: a real-world disproportionality analysis using the FDA adverse event reporting system}},
  journal = {Frontiers in pharmacology},
  year    = {2025},
  doi     = {10.3389/fphar.2025.1593989},
  pmid    = {40520157},
  url     = {https://doi.org/10.3389/fphar.2025.1593989}
}

@article{leng2026-41396015,
  author  = {Leng, L. and Liao, Z. and Lu, P. and Sun, Y. and Weng, Q. and Fan, W. and Zhu, H. and Wu, W. and others},
  title   = {{Real-world experience with baseline characteristics and safety of lecanemab for Alzheimer's disease in Eastern China}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2026},
  doi     = {10.1177/13872877251406619},
  pmid    = {41396015},
  url     = {https://doi.org/10.1177/13872877251406619}
}

@article{huybrechts2012-22362541,
  author  = {Huybrechts, K. F. and Gerhard, T. and Crystal, S. and Olfson, M. and Avorn, J. and Levin, R. and Lucas, J. A. and Schneeweiss, S.},
  title   = {{Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study}},
  journal = {BMJ (Clinical research ed.)},
  year    = {2012},
  doi     = {10.1136/bmj.e977},
  pmid    = {22362541},
  url     = {https://doi.org/10.1136/bmj.e977}
}

@article{wu2009-19546656,
  author  = {Wu, C. S. and Wang, S. C. and Chang, I. S. and Lin, K. M.},
  title   = {{The association between dementia and long-term use of benzodiazepine in the elderly: nested case-control study using claims data}},
  journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry},
  year    = {2009},
  doi     = {10.1097/jgp.0b013e3181a65210},
  pmid    = {19546656},
  url     = {https://doi.org/10.1097/jgp.0b013e3181a65210}
}

@article{zhang2002-12181083,
  author  = {Zhang, Z. and Wang, X. and Chen, Q. and Shu, L. and Wang, J. and Shan, G.},
  title   = {{[Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial]}},
  journal = {Zhonghua yi xue za zhi},
  year    = {2002},
  pmid    = {12181083}
}

@article{wang2016-27348499,
  author  = {Wang, W. and Wang, L. and Lu, J. and Siedlak, S. L. and Fujioka, H. and Liang, J. and Jiang, S. and Ma, X. and others},
  title   = {{The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity}},
  journal = {Nature medicine},
  year    = {2016},
  doi     = {10.1038/nm.4130},
  pmid    = {27348499},
  url     = {https://doi.org/10.1038/nm.4130}
}

@article{homma2000-11044775,
  author  = {Homma, A. and Takeda, M. and Imai, Y. and Udaka, F. and Hasegawa, K. and Kameyama, M. and Nishimura, T.},
  title   = {{Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group}},
  journal = {Dementia and geriatric cognitive disorders},
  year    = {2000},
  doi     = {10.1159/000017259},
  pmid    = {11044775},
  url     = {https://doi.org/10.1159/000017259}
}

@article{abushakra2025-41015981,
  author  = {Abushakra, Susan R. and Power, Aidan and Watson, David and Porsteinsson, Anton P. and Sabbagh, Marwan and MacSweeney, Emer and Cohen, Sharon and Boada, Merçé and others},
  title   = {{Clinical Efficacy, Safety and Imaging Effects of Oral Valiltramiprosate in APOEε4/ε4 Homozygotes with Early Alzheimer’s Disease: Results of the Phase III, Randomized, Double-Blind, Placebo-Controlled, 78-Week APOLLOE4 Trial}},
  journal = {Drugs},
  year    = {2025},
  doi     = {10.1007/s40265-025-02250-5},
  pmid    = {41015981},
  url     = {https://doi.org/10.1007/s40265-025-02250-5}
}

@article{chen2025-40189473,
  author  = {Chen, Christopher and Katayama, Sadao and Lee, Jae Hong and Lee, Jun-Young and Nakagawa, Masaki and Torii, Kentaro and Ogawa, Tomoo and Dash, Amitabh and others},
  title   = {{Clarity AD: Asian regional analysis of a phase III trial of lecanemab in early Alzheimer's disease}},
  journal = {The Journal of Prevention of Alzheimer s Disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100160},
  pmid    = {40189473},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100160}
}

@article{wong2017-28170377,
  author  = {Wong, Y. C. and Krainc, D.},
  title   = {{α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies}},
  journal = {Nature medicine},
  year    = {2017},
  doi     = {10.1038/nm.4269},
  pmid    = {28170377},
  url     = {https://doi.org/10.1038/nm.4269}
}

@article{barkhof2013-23436056,
  author  = {Barkhof, F. and Daams, M. and Scheltens, P. and Brashear, H. R. and Arrighi, H. M. and Bechten, A. and Morris, K. and McGovern, M. and others},
  title   = {{An MRI rating scale for amyloid-related imaging abnormalities with edema or effusion}},
  journal = {AJNR. American journal of neuroradiology},
  year    = {2013},
  doi     = {10.3174/ajnr.a3475},
  pmid    = {23436056},
  url     = {https://doi.org/10.3174/ajnr.a3475}
}

@article{tenkate2018-30376881,
  author  = {Ten Kate, M. and Ingala, S. and Schwarz, A. J. and Fox, N. C. and Chételat, G. and van Berckel, B. N. M. and Ewers, M. and Foley, C. and others},
  title   = {{Secondary prevention of Alzheimer's dementia: neuroimaging contributions}},
  journal = {Alzheimer's research \& therapy},
  year    = {2018},
  doi     = {10.1186/s13195-018-0438-z},
  pmid    = {30376881},
  url     = {https://doi.org/10.1186/s13195-018-0438-z}
}

@article{tan2014-24662102,
  author  = {Tan, C. C. and Yu, J. T. and Wang, H. F. and Tan, M. S. and Meng, X. F. and Wang, C. and Jiang, T. and Zhu, X. C. and others},
  title   = {{Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2014},
  doi     = {10.3233/jad-132690},
  pmid    = {24662102},
  url     = {https://doi.org/10.3233/jad-132690}
}

@article{kalischellett2014-25284144,
  author  = {Kalisch Ellett, L. M. and Pratt, N. L. and Ramsay, E. N. and Barratt, J. D. and Roughead, E. E.},
  title   = {{Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia}},
  journal = {Journal of the American Geriatrics Society},
  year    = {2014},
  doi     = {10.1111/jgs.13054},
  pmid    = {25284144},
  url     = {https://doi.org/10.1111/jgs.13054}
}

@article{devanand2012-21407047,
  author  = {Devanand, D. P. and Mintzer, J. and Schultz, S. and Sultzer, D. and de la Pena, D. and Gupta, S. and Colon, S. and Schimming, C. and others},
  title   = {{The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design}},
  journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry},
  year    = {2012},
  doi     = {10.1097/jgp.0b013e3182110563},
  pmid    = {21407047},
  url     = {https://doi.org/10.1097/jgp.0b013e3182110563}
}

@article{nevesbriard2024-39121445,
  author  = {Neves Briard, J. and Duquette, A. and Cayrol, R. and Lapalme-Remis, S.},
  title   = {{Refractory Status Epilepticus in a Patient With Aducanumab-Induced Amyloid-Related Imaging Abnormalities}},
  journal = {Neurology},
  year    = {2024},
  doi     = {10.1212/wnl.0000000000209582},
  pmid    = {39121445},
  url     = {https://doi.org/10.1212/wnl.0000000000209582}
}

@article{rohatgi2025-41038644,
  author  = {Rohatgi, Saurabh and Zhu, Shenghua and Calle, Esteban and Ford, Jeremy N. and Kozak, Benjamin M. and Chagui, Odette Ganem and Vejdani‐Jahromi, Maryam and Griffin, Harry R. and others},
  title   = {{Are Deep White Matter Hyperintensities Associated with Amyloid-Related Imaging Abnormalities in Patients with Alzheimer Disease Treated with Lecanemab?}},
  journal = {American Journal of Neuroradiology},
  year    = {2025},
  doi     = {10.3174/ajnr.a8822},
  pmid    = {41038644},
  url     = {https://doi.org/10.3174/ajnr.a8822}
}

@article{smith2025-40967729,
  author  = {Smith, Holly Christina and Petersen, Irene and Hayes, Joseph and Jordan, Kelvin P. and Boman, Magnus and Banerjee, Sube and Walters, Kate R and Cooper, Claudia and others},
  title   = {{Antipsychotic prescriptions in people with dementia in primary care: a cohort study investigating adherence of dose and duration to UK clinical guidelines}},
  journal = {The Lancet Psychiatry},
  year    = {2025},
  doi     = {10.1016/s2215-0366(25)00261-5},
  pmid    = {40967729},
  url     = {https://doi.org/10.1016/s2215-0366(25)00261-5}
}

@article{yeon2025-40696527,
  author  = {Yeon, Jeon So and Sheng-Min, Wang and Woong, Roh Hyun and You, Kim Keun and Young, Chang Yoon and Eosu, Kim and Jae-Nam, Bae and Seung-Ho, Ryu},
  title   = {{Practical Guide of the Korean Association for Geriatric Psychiatry to Anti-Amyloid Monoclonal Antibody Therapy for Alzheimer's Disease: Focused on Lecanemab}},
  journal = {Journal of Korean medical science},
  year    = {2025},
  doi     = {10.3346/jkms.2025.40.e215},
  pmid    = {40696527},
  url     = {https://doi.org/10.3346/jkms.2025.40.e215}
}

@article{liao2026-41823189,
  author  = {Liao, Wang and Yu, Qun and Chen, Bin and Chen, Hualin and Zou, Liangyu and Xie, Haiqun and Chen, Haobo and Wang, Chenyang and others},
  title   = {{Effectiveness, safety, and biomarker dynamics of lecanemab in Chinese Alzheimer's disease population: a multicenter real-world study}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2026},
  doi     = {10.1002/alz.71231},
  pmid    = {41823189},
  url     = {https://doi.org/10.1002/alz.71231}
}

@article{nordestgaard2022-34613338,
  author  = {Nordestgaard, L. T. and Christoffersen, M. and Lauridsen, B. K. and Afzal, S. and Nordestgaard, B. G. and Frikke-Schmidt, R. and Tybjærg-Hansen, A.},
  title   = {{Long-term Benefits and Harms Associated With Genetic Cholesteryl Ester Transfer Protein Deficiency in the General Population}},
  journal = {JAMA cardiology},
  year    = {2022},
  doi     = {10.1001/jamacardio.2021.3728},
  pmid    = {34613338},
  url     = {https://doi.org/10.1001/jamacardio.2021.3728}
}

@article{almaraz2009-19590387,
  author  = {Almaraz, A. C. and Driver-Dunckley, E. D. and Woodruff, B. K. and Wellik, K. E. and Caselli, R. J. and Demaerschalk, B. M. and Adler, C. H. and Caviness, J. N. and others},
  title   = {{Efficacy of rivastigmine for cognitive symptoms in Parkinson disease with dementia}},
  journal = {The neurologist},
  year    = {2009},
  doi     = {10.1097/nrl.0b013e3181a968df},
  pmid    = {19590387},
  url     = {https://doi.org/10.1097/nrl.0b013e3181a968df}
}

@article{cioltan2017-28122506,
  author  = {Cioltan, H. and Alshehri, S. and Howe, C. and Lee, J. and Fain, M. and Eng, H. and Schachter, K. and Mohler, J.},
  title   = {{Variation in use of antipsychotic medications in nursing homes in the United States: A systematic review}},
  journal = {BMC geriatrics},
  year    = {2017},
  doi     = {10.1186/s12877-017-0428-1},
  pmid    = {28122506},
  url     = {https://doi.org/10.1186/s12877-017-0428-1}
}

@article{han2001-11322844,
  author  = {Han, L. and McCusker, J. and Cole, M. and Abrahamowicz, M. and Primeau, F. and Elie, M.},
  title   = {{Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients}},
  journal = {Archives of internal medicine},
  year    = {2001},
  doi     = {10.1001/archinte.161.8.1099},
  pmid    = {11322844},
  url     = {https://doi.org/10.1001/archinte.161.8.1099}
}

@article{zhang2009-19383787,
  author  = {Zhang, Y. J. and Xu, Y. F. and Cook, C. and Gendron, T. F. and Roettges, P. and Link, C. D. and Lin, W. L. and Tong, J. and others},
  title   = {{Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity}},
  journal = {Proceedings of the National Academy of Sciences of the United States of America},
  year    = {2009},
  doi     = {10.1073/pnas.0900688106},
  pmid    = {19383787},
  url     = {https://doi.org/10.1073/pnas.0900688106}
}

@article{barroeta2025-40528298,
  author  = {Barroeta, Isabel and Videla, Laura and Carmona‐Iragui, María and Fortea, Juan and Rafii, Michael S.},
  title   = {{Current advances and unmet needs in Alzheimer's disease trials for individuals with Down syndrome: Navigating new therapeutic frontiers}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.70258},
  pmid    = {40528298},
  url     = {https://doi.org/10.1002/alz.70258}
}

@article{sperling2011-21784348,
  author  = {Sperling, Reisa Anne and Jack, Clifford R. and Black, Sandra E. and Frosch, Matthew P. and Greenberg, Steven Mark and Hyman, Bradley T. and Scheltens, Philip and Carrillo, María C. and Thies, William H. and Bednar, Martin M. and Black, Ronald S. and Brashear, H. Robert and Grundman, Michael and Siemers, Eric and Feldman, Howard and Schindler, Rachel J.},
  title   = {{Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup}},
  journal = {Alzheimer s \& Dementia},
  year    = {2011},
  doi     = {10.1016/j.jalz.2011.05.2351},
  pmid    = {21784348},
  url     = {https://doi.org/10.1016/j.jalz.2011.05.2351}
}

@article{gill2005-15668211,
  author  = {Gill, S. S. and Rochon, P. A. and Herrmann, N. and Lee, P. E. and Sykora, K. and Gunraj, N. and Normand, S. L. and Gurwitz, J. H. and others},
  title   = {{Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study}},
  journal = {BMJ (Clinical research ed.)},
  year    = {2005},
  doi     = {10.1136/bmj.38330.470486.8f},
  pmid    = {15668211},
  url     = {https://doi.org/10.1136/bmj.38330.470486.8f}
}

@article{majid2024-39207112,
  author  = {Majid, O. and Cao, Y. and Willis, B. A. and Hayato, S. and Takenaka, O. and Lalovic, B. and Sreerama Reddy, S. H. and Penner, N. and others},
  title   = {{Population pharmacokinetics and exposure-response analyses of safety (ARIA-E and isolated ARIA-H) of lecanemab in subjects with early Alzheimer's disease}},
  journal = {CPT: pharmacometrics \& systems pharmacology},
  year    = {2024},
  doi     = {10.1002/psp4.13224},
  pmid    = {39207112},
  url     = {https://doi.org/10.1002/psp4.13224}
}

@article{aldea2022-35676943,
  author  = {Aldea, R. and Grimm, H. P. and Gieschke, R. and Hofmann, C. and Lott, D. and Bullain, S. and Delmar, P. and Klein, G. and others},
  title   = {{In silico exploration of amyloid-related imaging abnormalities in the gantenerumab open-label extension trials using a semi-mechanistic model}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2022},
  doi     = {10.1002/trc2.12306},
  pmid    = {35676943},
  url     = {https://doi.org/10.1002/trc2.12306}
}

@article{ray1989-2573741,
  author  = {Ray, W. A. and Griffin, M. R. and Downey, W.},
  title   = {{Benzodiazepines of long and short elimination half-life and the risk of hip fracture}},
  journal = {JAMA},
  year    = {1989},
  doi     = {10.1001/jama.1989.03430230088031},
  pmid    = {2573741},
  url     = {https://doi.org/10.1001/jama.1989.03430230088031}
}

@article{oosthoek2025-40696469,
  author  = {Oosthoek, Marlies and Vijverberg, Everard G B and Blujdea, Elena R and Veld, Sjors G J G In't and Avilés, Martín Pucheu and Zsadanyi, Sára E and Hok-A-Hin, Yanaika S and Visser, Allerdien and others},
  title   = {{CHIT1 and DDAH1 levels relate to amyloid-related imaging abnormalities risk profile in Alzheimer's disease patients}},
  journal = {Alzheimer's research \& therapy},
  year    = {2025},
  doi     = {10.1186/s13195-025-01799-3},
  pmid    = {40696469},
  url     = {https://doi.org/10.1186/s13195-025-01799-3}
}

@article{briesacher2020-30724582,
  author  = {Briesacher, Becky A and Mui, Brianne and Devlin, John W and Koethe, Benjamin},
  title   = {{Nursing homes underreport antipsychotic prescribing}},
  journal = {Aging \& mental health},
  year    = {2020},
  doi     = {10.1080/13607863.2019.1571015},
  pmid    = {30724582},
  url     = {https://doi.org/10.1080/13607863.2019.1571015}
}

@article{cummings2014-a7c335d7,
  author  = {Cummings, Jeffrey L. and Cho, William and Ward, Michael Emmerson and Friesenhahn, Michel J. and Brunstein, Flávia and Honigberg, Lee A. and Clayton, David and Mortensen, Deborah L. and others},
  title   = {{O4‐11‐06: A RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CRENEZUMAB IN PATIENTS WITH MILD TO MODERATE ALZHEIMER'S DISEASE}},
  journal = {Alzheimer s \& Dementia},
  year    = {2014},
  doi     = {10.1016/j.jalz.2014.04.450},
  url     = {https://doi.org/10.1016/j.jalz.2014.04.450}
}

@article{lasser2015-f0473682,
  author  = {Lasser, Robert A. and Ostrowitzki, Susanne and Scheltens, Philip and Boada, Merçé and Dubois, Bruno and Dorflinger, Ernest E. and Balas, Bogdan and Nikolcheva, Tania and others},
  title   = {{DT‐01‐03: Efficacy and safety of gantenerumab in prodromal Alzheimer's disease: Results from scarlet road—a global, multicenter trial}},
  journal = {Alzheimer s \& Dementia},
  year    = {2015},
  doi     = {10.1016/j.jalz.2015.08.153},
  url     = {https://doi.org/10.1016/j.jalz.2015.08.153}
}

@article{hopkinson2026-42302797,
  author  = {Hopkinson, Olivia K and Chobanov, Jan and Goordeen, Darshna and Man, Kenneth K C and Wong, Ian C K and Reeve, Emily and Bell, J Simon and Wei, Li and others},
  title   = {{Abrupt discontinuation and tapering of antipsychotics in older adults with dementia: a target trial emulation study}},
  journal = {The lancet. Healthy longevity},
  year    = {2026},
  doi     = {10.1016/j.lanhl.2026.100852},
  pmid    = {42302797},
  url     = {https://doi.org/10.1016/j.lanhl.2026.100852}
}

@article{luchsinger2025-40434891,
  author  = {Luchsinger, J. A. and Devanand, D. and Goldberg, T. E. and Cammack, S. and Hernández-Santiago, G. and Oishi, K. and Jagust, W. and Baker, S. and others},
  title   = {{Protocol for a Randomized Phase II/III Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Extended-Release Metformin in Amnestic Mild Cognitive Impairment: Metformin in Alzheimer Dementia Prevention (MAP)}},
  journal = {Alzheimer disease and associated disorders},
  year    = {2025},
  doi     = {10.1097/wad.0000000000000677},
  pmid    = {40434891},
  url     = {https://doi.org/10.1097/wad.0000000000000677}
}

@article{bayer2005-15642910,
  author  = {Bayer, A. J. and Bullock, R. and Jones, R. W. and Wilkinson, D. and Paterson, K. R. and Jenkins, L. and Millais, S. B. and Donoghue, S.},
  title   = {{Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD}},
  journal = {Neurology},
  year    = {2005},
  doi     = {10.1212/01.wnl.0000148604.77591.67},
  pmid    = {15642910},
  url     = {https://doi.org/10.1212/01.wnl.0000148604.77591.67}
}

@article{kales2011-21300946,
  author  = {Kales, H. C. and Zivin, K. and Kim, H. M. and Valenstein, M. and Chiang, C. and Ignacio, R. V. and Ganoczy, D. and Cunningham, F. and others},
  title   = {{Trends in antipsychotic use in dementia 1999-2007}},
  journal = {Archives of general psychiatry},
  year    = {2011},
  doi     = {10.1001/archgenpsychiatry.2010.200},
  pmid    = {21300946},
  url     = {https://doi.org/10.1001/archgenpsychiatry.2010.200}
}

@article{gitler2009-19182805,
  author  = {Gitler, A. D. and Chesi, A. and Geddie, M. L. and Strathearn, K. E. and Hamamichi, S. and Hill, K. J. and Caldwell, K. A. and Caldwell, G. A. and others},
  title   = {{Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity}},
  journal = {Nature genetics},
  year    = {2009},
  doi     = {10.1038/ng.300},
  pmid    = {19182805},
  url     = {https://doi.org/10.1038/ng.300}
}

@article{lashuel2013-23254192,
  author  = {Lashuel, H. A. and Overk, C. R. and Oueslati, A. and Masliah, E.},
  title   = {{The many faces of α-synuclein: from structure and toxicity to therapeutic target}},
  journal = {Nature reviews. Neuroscience},
  year    = {2013},
  doi     = {10.1038/nrn3406},
  pmid    = {23254192},
  url     = {https://doi.org/10.1038/nrn3406}
}

@article{jiang2016-27112497,
  author  = {Jiang, J. and Zhu, Q. and Gendron, T. F. and Saberi, S. and McAlonis-Downes, M. and Seelman, A. and Stauffer, J. E. and Jafar-Nejad, P. and others},
  title   = {{Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs}},
  journal = {Neuron},
  year    = {2016},
  doi     = {10.1016/j.neuron.2016.04.006},
  pmid    = {27112497},
  url     = {https://doi.org/10.1016/j.neuron.2016.04.006}
}

@article{welk2020-32167223,
  author  = {Welk, B. and McArthur, E.},
  title   = {{Increased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta-3 agonist: a population-based cohort study}},
  journal = {BJU international},
  year    = {2020},
  doi     = {10.1111/bju.15040},
  pmid    = {32167223},
  url     = {https://doi.org/10.1111/bju.15040}
}

@article{johnson2026-41617706,
  author  = {Johnson, L. A. and Saito, K. and Pallerla, A. V. and Funnell, J. L. and Ezzo, A. R. and Song, C. M. and Harrison, D. A. and Norton, N. J. and Moore, L. C. and Van Eldik, L. J. and others},
  title   = {{Clonal expansion of cytotoxic CD8⁺ T cells in lecanemab-associated ARIA}},
  journal = {Nature Communications},
  year    = {2026},
  doi     = {10.1038/s41467-026-68921-3},
  pmid    = {41617706},
  url     = {https://doi.org/10.1038/s41467-026-68921-3}
}

@article{monteverde1990-2121360,
  author  = {Monteverde, A. and Gnemmi, P. and Rossi, F. and Finali, G. C.},
  title   = {{Selegiline in the treatment of mild to moderate Alzheimer-type dementia}},
  journal = {Clinical therapeutics},
  year    = {1990},
  pmid    = {2121360}
}

@article{schneider2019-31282954,
  author  = {Schneider, L. S. and Thomas, R. G. and Hendrix, S. and Rissman, R. A. and Brewer, J. B. and Salmon, D. P. and Oltersdorf, T. and Okuda, T. and others},
  title   = {{Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease: A Phase 2 Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2019},
  doi     = {10.1001/jamaneurol.2019.1868},
  pmid    = {31282954},
  url     = {https://doi.org/10.1001/jamaneurol.2019.1868}
}

@article{carriere2009-19636034,
  author  = {Carrière, I. and Fourrier-Reglat, A. and Dartigues, J. F. and Rouaud, O. and Pasquier, F. and Ritchie, K. and Ancelin, M. L.},
  title   = {{Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study}},
  journal = {Archives of internal medicine},
  year    = {2009},
  doi     = {10.1001/archinternmed.2009.229},
  pmid    = {19636034},
  url     = {https://doi.org/10.1001/archinternmed.2009.229}
}

@article{sima2024-38345816,
  author  = {Sima, D. M. and Phan, T. V. and Van Eyndhoven, S. and Vercruyssen, S. and Magalhães, R. and Liseune, A. and Brys, A. and Frenyo, P. and others},
  title   = {{Artificial Intelligence Assistive Software Tool for Automated Detection and Quantification of Amyloid-Related Imaging Abnormalities}},
  journal = {JAMA network open},
  year    = {2024},
  doi     = {10.1001/jamanetworkopen.2023.55800},
  pmid    = {38345816},
  url     = {https://doi.org/10.1001/jamanetworkopen.2023.55800}
}

@article{hampel2023-37280110,
  author  = {Hampel, H. and Elhage, A. and Cho, M. and Apostolova, L. G. and Nicoll, J. A. R. and Atri, A.},
  title   = {{Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics}},
  journal = {Brain : a journal of neurology},
  year    = {2023},
  doi     = {10.1093/brain/awad188},
  pmid    = {37280110},
  url     = {https://doi.org/10.1093/brain/awad188}
}

@article{ferrero2016-29067304,
  author  = {Ferrero, J. and Williams, L. and Stella, H. and Leitermann, K. and Mikulskis, A. and O'Gorman, J. and Sevigny, J.},
  title   = {{First-in-human, double-blind, placebo-controlled, single-dose escalation study of aducanumab (BIIB037) in mild-to-moderate Alzheimer's disease}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2016},
  doi     = {10.1016/j.trci.2016.06.002},
  pmid    = {29067304},
  url     = {https://doi.org/10.1016/j.trci.2016.06.002}
}

@article{gibson2024-39215494,
  author  = {Gibson, A. W. and Elser, H. and Rosso, M. and Cornblath, E. J. and Fonkeu, Y. and Prasad, S. and Rothstein, A. and Nasrallah, I. M. and others},
  title   = {{Ischemic stroke associated with amyloid-related imaging abnormalities in a patient treated with lecanemab}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2024},
  doi     = {10.1002/alz.14223},
  pmid    = {39215494},
  url     = {https://doi.org/10.1002/alz.14223}
}

@article{yan2025-40242445,
  author  = {Yan, L. and Zhang, L. and Xu, Z. and Luo, Z.},
  title   = {{A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for lecanemab}},
  journal = {Frontiers in pharmacology},
  year    = {2025},
  doi     = {10.3389/fphar.2025.1559447},
  pmid    = {40242445},
  url     = {https://doi.org/10.3389/fphar.2025.1559447}
}

@article{bracoud2023-38026755,
  author  = {Bracoud, L. and Klein, G. and Lyons, M. and Scelsi, M. A. and Wojtowicz, J. and Bullain, S. and Purcell, D. and Fiebach, J. B. and others},
  title   = {{Validation of 3- and 5-point severity scales to assess ARIA-E}},
  journal = {Alzheimer's \& dementia (Amsterdam, Netherlands)},
  year    = {2023},
  doi     = {10.1002/dad2.12503},
  pmid    = {38026755},
  url     = {https://doi.org/10.1002/dad2.12503}
}

@article{yang2026-42410659,
  author  = {Yang, C. T. and Wilkins, J. M. and Kesselheim, A. S. and Kim, D. H. and Lin, K. J.},
  title   = {{Clinical outcomes after antipsychotic discontinuation in nursing home residents with dementia: a nationwide cohort study}},
  journal = {Alzheimer's Research \& Therapy},
  year    = {2026},
  doi     = {10.1186/s13195-026-02134-0},
  pmid    = {42410659},
  url     = {https://doi.org/10.1186/s13195-026-02134-0}
}

@article{rochon2008-18504337,
  author  = {Rochon, P. A. and Normand, S. L. and Gomes, T. and Gill, S. S. and Anderson, G. M. and Melo, M. and Sykora, K. and Lipscombe, L. and others},
  title   = {{Antipsychotic therapy and short-term serious events in older adults with dementia}},
  journal = {Archives of internal medicine},
  year    = {2008},
  doi     = {10.1001/archinte.168.10.1090},
  pmid    = {18504337},
  url     = {https://doi.org/10.1001/archinte.168.10.1090}
}

@article{sun2011-21541367,
  author  = {Sun, Z. and Diaz, Z. and Fang, X. and Hart, M. P. and Chesi, A. and Shorter, J. and Gitler, A. D.},
  title   = {{Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS}},
  journal = {PLoS biology},
  year    = {2011},
  doi     = {10.1371/journal.pbio.1000614},
  pmid    = {21541367},
  url     = {https://doi.org/10.1371/journal.pbio.1000614}
}

@article{dranitsaris2023-36964606,
  author  = {Dranitsaris, G. and Zhang, Q. and Mu, L. and Weyrer, C. and Drysdale, E. and Neumann, P. and Atri, A. and Monfared, A. A. T.},
  title   = {{Therapeutic preference for Alzheimer's disease treatments: a discrete choice experiment with caregivers and neurologists}},
  journal = {Alzheimer's research \& therapy},
  year    = {2023},
  doi     = {10.1186/s13195-023-01207-8},
  pmid    = {36964606},
  url     = {https://doi.org/10.1186/s13195-023-01207-8}
}

@article{bietry2017-28078633,
  author  = {Biétry, F. A. and Pfeil, A. M. and Reich, O. and Schwenkglenks, M. and Meier, C. R.},
  title   = {{Benzodiazepine Use and Risk of Developing Alzheimer's Disease: A Case-Control Study Based on Swiss Claims Data}},
  journal = {CNS drugs},
  year    = {2017},
  doi     = {10.1007/s40263-016-0404-x},
  pmid    = {28078633},
  url     = {https://doi.org/10.1007/s40263-016-0404-x}
}

@article{klein2022-36474747,
  author  = {Klein, Gregory and Scelsi, Marzia A and Barakos, Jerome and Fiebach, Jochen B and Bracoud, Luc and Suhy, Joyce and Delmar, Paul and Lyons, Marco and others},
  title   = {{Comparing ARIA-E severity scales and effects of treatment management thresholds}},
  journal = {Alzheimer's \& dementia (Amsterdam, Netherlands)},
  year    = {2022},
  doi     = {10.1002/dad2.12376},
  pmid    = {36474747},
  url     = {https://doi.org/10.1002/dad2.12376}
}

@article{schultz2017-28387023,
  author  = {Schultz, Brian R and Takeshita, Junji and Goebert, Deborah and Takeshita, Steven and Lu, Brett Y and Guilloux, Alexandre and Higa, Joy},
  title   = {{Simultaneous usage of dementia medications and anticholinergics among Asians and Pacific Islanders}},
  journal = {Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society},
  year    = {2017},
  doi     = {10.1111/psyg.12267},
  pmid    = {28387023},
  url     = {https://doi.org/10.1111/psyg.12267}
}

@article{voyer2015-f2ae00d2,
  author  = {Voyer, Philippe and McCusker, Jane and Cole, Martin G. and Monette, Johanne and Champoux, Nathalie and Ciampi, Antonio and Belzile, Eric and Richard, Hélène},
  title   = {{Behavioral and Psychological Symptoms of Dementia: How Long Does Every Behavior Last, and Are Particular Behaviors Associated With PRN Antipsychotic Agent Use?}},
  journal = {Journal of Gerontological Nursing},
  year    = {2015},
  doi     = {10.3928/00989134-20141030-01},
  url     = {https://doi.org/10.3928/00989134-20141030-01}
}

@article{lopezarrieta2000-10796667,
  author  = {López-Arrieta, J. M. and Rodríguez, J. L. and Sanz, F.},
  title   = {{Nicotine for Alzheimer's disease}},
  journal = {The Cochrane database of systematic reviews},
  year    = {2000},
  doi     = {10.1002/14651858.cd001749},
  pmid    = {10796667},
  url     = {https://doi.org/10.1002/14651858.cd001749}
}

@article{pelton2003-12611748,
  author  = {Pelton, G. H. and Devanand, D. P. and Bell, K. and Marder, K. and Marston, K. and Liu, X. and Cooper, T. B.},
  title   = {{Usefulness of plasma haloperidol levels for monitoring clinical efficacy and side effects in Alzheimer patients with psychosis and behavioral dyscontrol}},
  journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry},
  year    = {2003},
  doi     = {10.1176/appi.ajgp.11.2.186},
  pmid    = {12611748},
  url     = {https://doi.org/10.1176/appi.ajgp.11.2.186}
}

@article{chen2005-16183991,
  author  = {Chen, J. and Zhou, Y. and Mueller-Steiner, S. and Chen, L. F. and Kwon, H. and Yi, S. and Mucke, L. and Gan, L.},
  title   = {{SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling}},
  journal = {The Journal of biological chemistry},
  year    = {2005},
  doi     = {10.1074/jbc.m509329200},
  pmid    = {16183991},
  url     = {https://doi.org/10.1074/jbc.m509329200}
}

@article{zakarias2016-27567863,
  author  = {Zakarias, Johanne Købstrup and Jensen‐Dahm, Christina and Nørgaard, Ane and Stevnsborg, Lea and Gasse, Christiane and Andersen, Bodil Gramkow and Jakobsen, Søren and Waldorff, Frans Boch and others},
  title   = {{Geographical Variation in Antipsychotic Drug Use in Elderly Patients with Dementia: A Nationwide Study}},
  journal = {Journal of Alzheimer s Disease},
  year    = {2016},
  doi     = {10.3233/jad-160485},
  pmid    = {27567863},
  url     = {https://doi.org/10.3233/jad-160485}
}

@article{singh2026-42162487,
  author  = {Singh, Alpana and Denkinger, Marisa N. and Leuzy, Antoine and Dieckhoff, Kari and Liu, Jame and Marques, Tainá M. and Monuki, Edwin S. and Stark, Craig and others},
  title   = {{A plasma protein signature for cerebral amyloid angiopathy}},
  journal = {Acta Neuropathologica},
  year    = {2026},
  doi     = {10.1007/s00401-026-03030-5},
  pmid    = {42162487},
  url     = {https://doi.org/10.1007/s00401-026-03030-5}
}

@article{cummings2023-37357276,
  author  = {Cummings, Jeffrey L. and Apostolova, L and Rabinovici, Gil D. and Atri, A and Aisen, Pau and Greenberg, S and Hendrix, S and Selkoe, D and Weiner, M and Petersen, R.C. and Salloway, Stephen},
  title   = {{Lecanemab: Appropriate Use Recommendations}},
  journal = {The Journal of Prevention of Alzheimer s Disease},
  year    = {2023},
  doi     = {10.14283/jpad.2023.30},
  pmid    = {37357276},
  url     = {https://doi.org/10.14283/jpad.2023.30}
}

@article{betz2021-34550082,
  author  = {Betz, M. E. and Polzer, E. and Nearing, K. and Knoepke, C. E. and Johnson, R. L. and Meador, L. and Matlock, D. D.},
  title   = {{Feasibility and Acceptability of a Web-Based Caregiver Decision Aid (Safety in Dementia) for Firearm Access: Pilot Randomized Controlled Trial}},
  journal = {JMIR formative research},
  year    = {2021},
  doi     = {10.2196/30990},
  pmid    = {34550082},
  url     = {https://doi.org/10.2196/30990}
}

@article{withington2022-35401412,
  author  = {Withington, C. G. and Turner, R. S.},
  title   = {{Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer's Disease}},
  journal = {Frontiers in neurology},
  year    = {2022},
  doi     = {10.3389/fneur.2022.862369},
  pmid    = {35401412},
  url     = {https://doi.org/10.3389/fneur.2022.862369}
}

@article{schroeck2016-27751669,
  author  = {Schroeck, J. L. and Ford, J. and Conway, E. L. and Kurtzhalts, K. E. and Gee, M. E. and Vollmer, K. A. and Mergenhagen, K. A.},
  title   = {{Review of Safety and Efficacy of Sleep Medicines in Older Adults}},
  journal = {Clinical therapeutics},
  year    = {2016},
  doi     = {10.1016/j.clinthera.2016.09.010},
  pmid    = {27751669},
  url     = {https://doi.org/10.1016/j.clinthera.2016.09.010}
}

@article{hendriks2026-95d6b60f,
  author  = {Hendriks, J. and Antoniou, M. and Babic, I.},
  title   = {{Anti-Amyloid Monoclonal Antibodies and Amyloid-Related Imaging Abnormalities in Early Alzheimer Disease}},
  journal = {Zenodo (CERN European Organization for Nuclear Research)},
  year    = {2026},
  doi     = {10.5281/zenodo.22310607},
  url     = {https://doi.org/10.5281/zenodo.22310607}
}

@article{chen2023-37573807,
  author  = {Chen, L. and Zhen, Y. and Wang, X. and Wang, J. and Zhu, G.},
  title   = {{Neurovascular glial unit: A target of phytotherapy for cognitive impairments}},
  journal = {Phytomedicine : international journal of phytotherapy and phytopharmacology},
  year    = {2023},
  doi     = {10.1016/j.phymed.2023.155009},
  pmid    = {37573807},
  url     = {https://doi.org/10.1016/j.phymed.2023.155009}
}

@article{arrighi2016-25669746,
  author  = {Arrighi, H. M. and Barakos, J. and Barkhof, F. and Tampieri, D. and Jack, C. and Melançon, D. and Morris, K. and Ketter, N. and others},
  title   = {{Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysis}},
  journal = {Journal of neurology, neurosurgery, and psychiatry},
  year    = {2016},
  doi     = {10.1136/jnnp-2014-309493},
  pmid    = {25669746},
  url     = {https://doi.org/10.1136/jnnp-2014-309493}
}

@article{ji2024-39702440,
  author  = {Ji, S. and Rosenbloom, M.},
  title   = {{Intracerebral hemorrhage following mild ARIA-H in an APOE ε2 carrier receiving lecanemab}},
  journal = {Alzheimer's research \& therapy},
  year    = {2024},
  doi     = {10.1186/s13195-024-01640-3},
  pmid    = {39702440},
  url     = {https://doi.org/10.1186/s13195-024-01640-3}
}

@article{hu2025-40290431,
  author  = {Hu, H. and Zhao, Y. and Mao, J. and He, J. and Zhang, Y. and Ye, H. and Yang, X.},
  title   = {{A real-world pharmacovigilance study of adverse drug reactions associated with lecanemab and aducanumab based on WHO-VigiAccess and FAERS databases}},
  journal = {Frontiers in pharmacology},
  year    = {2025},
  doi     = {10.3389/fphar.2025.1561020},
  pmid    = {40290431},
  url     = {https://doi.org/10.3389/fphar.2025.1561020}
}

@article{wang2025-40624486,
  author  = {Wang, Y. and Yu, Q. and Chen, B. and Zhou, J. and Li, Z. and Liao, W. and Liu, J. and Yang, A.},
  title   = {{Two cases of Amyloid-Related Imaging Abnormalities (ARIA) following lecanemab treatment for alzheimer's disease and a literature review}},
  journal = {BMC neurology},
  year    = {2025},
  doi     = {10.1186/s12883-025-04302-5},
  pmid    = {40624486},
  url     = {https://doi.org/10.1186/s12883-025-04302-5}
}

@article{gomm2016-27567804,
  author  = {Gomm, W. and von Holt, K. and Thomé, F. and Broich, K. and Maier, W. and Weckbecker, K. and Fink, A. and Doblhammer, G. and others},
  title   = {{Regular Benzodiazepine and Z-Substance Use and Risk of Dementia: An Analysis of German Claims Data}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2016},
  doi     = {10.3233/jad-151006},
  pmid    = {27567804},
  url     = {https://doi.org/10.3233/jad-151006}
}

@article{weintraub2011-21747029,
  author  = {Weintraub, D. and Chen, P. and Ignacio, R. V. and Mamikonyan, E. and Kales, H. C.},
  title   = {{Patterns and trends in antipsychotic prescribing for Parkinson disease psychosis}},
  journal = {Archives of neurology},
  year    = {2011},
  doi     = {10.1001/archneurol.2011.139},
  pmid    = {21747029},
  url     = {https://doi.org/10.1001/archneurol.2011.139}
}

@article{rataj2024-38833712,
  author  = {Rataj, Alison C. and Alcusky, Matthew James and Baek, Jonggyu and Ott, Brian R. and Lapane, Kate L.},
  title   = {{Geographic Variation of Antidementia and Antipsychotic Medication Use Among US Nursing Home Residents With Dementia}},
  journal = {Medical Care},
  year    = {2024},
  doi     = {10.1097/mlr.0000000000002016},
  pmid    = {38833712},
  url     = {https://doi.org/10.1097/mlr.0000000000002016}
}

@article{zhou2025-41447712,
  author  = {Zhou, Jin and Andreozzi, Erica M. and Llibre‐Guerra, Jorge J. and Clifford, David B. and Li, David and Wang, Guoqiao and Schneider, Lon S. S. and McDade, Eric and others},
  title   = {{Safety of Lecanemab After 6‐Month Treatment in the DIAN‐TU‐001 Trial}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70859_105304},
  pmid    = {41447712},
  url     = {https://doi.org/10.1002/alz70859_105304}
}

@article{mur2025-41128551,
  author  = {Mur, Jure and Stirland, Lucy and Terrera, Graciela Muniz and Leist, Anja K.},
  title   = {{A simulation study comparing anticholinergic drug use with polypharmacy for risk of death, dementia, and delirium in UK Biobank}},
  journal = {The Journals of Gerontology Series A},
  year    = {2025},
  doi     = {10.1093/gerona/glaf232},
  pmid    = {41128551},
  url     = {https://doi.org/10.1093/gerona/glaf232}
}

@article{fujiwara2025-40961130,
  author  = {Fujiwara, Takeshi and Koshiaris, Constantinos and Cai, Ting and Wang, Ariel and Lee, Joseph Jonathan and Lay-Flurrie, Sarah L and Banerjee, Amitava and Clegg, Andrew Paul and others},
  title   = {{Associations between falls and other serious adverse events and antihypertensive medication in individuals with dementia: An observational cohort study}},
  journal = {PLoS Medicine},
  year    = {2025},
  doi     = {10.1371/journal.pmed.1004731},
  pmid    = {40961130},
  url     = {https://doi.org/10.1371/journal.pmed.1004731}
}

@article{serranopozo2016-26687817,
  author  = {Serrano-Pozo, A. and Betensky, R. A. and Frosch, M. P. and Hyman, B. T.},
  title   = {{Plaque-Associated Local Toxicity Increases over the Clinical Course of Alzheimer Disease}},
  journal = {The American journal of pathology},
  year    = {2016},
  doi     = {10.1016/j.ajpath.2015.10.010},
  pmid    = {26687817},
  url     = {https://doi.org/10.1016/j.ajpath.2015.10.010}
}

@article{roytman2023-36321981,
  author  = {Roytman, M. and Mashriqi, F. and Al-Tawil, K. and Schulz, P. E. and Zaharchuk, G. and Benzinger, T. L. S. and Franceschi, A. M.},
  title   = {{Amyloid-Related Imaging Abnormalities: An Update}},
  journal = {AJR. American journal of roentgenology},
  year    = {2023},
  doi     = {10.2214/ajr.22.28461},
  pmid    = {36321981},
  url     = {https://doi.org/10.2214/ajr.22.28461}
}

@article{caughey2022-e245af65,
  author  = {Caughey, Gillian Elizabeth and Lang, Catherine E. and Bray, Sarah Catherine Elizabeth and Sluggett, Janet Kathleen and Whitehead, Craig and Visvanathan, Renuka and Evans, Keith E. and Corlis, Megan E. and others},
  title   = {{Quality and safety indicators for home care recipients in Australia: development and cross-sectional analyses}},
  journal = {BMJ Open},
  year    = {2022},
  doi     = {10.1136/bmjopen-2022-063152},
  url     = {https://doi.org/10.1136/bmjopen-2022-063152}
}

@article{pagan2025-40565990,
  author  = {Pagán, Fernando and Torres-Yaghi, Yasar A. and Hebron, Michaeline L. and Wilmarth, Barbara and Turner, Raymond Scott and Matar, Sara and Liu, Xiaoguang and Ferrante, Dalila and others},
  title   = {{Safety, Cognitive, and Behavioral Outcomes in Patients with Dementia with Lewy Bodies Treated with Nilotinib}},
  journal = {Journal of Clinical Medicine},
  year    = {2025},
  doi     = {10.3390/jcm14124245},
  pmid    = {40565990},
  url     = {https://doi.org/10.3390/jcm14124245}
}

@article{yucel2016-26756903,
  author  = {Yücel, M. and Lorenzetti, V. and Suo, C. and Zalesky, A. and Fornito, A. and Takagi, M. J. and Lubman, D. I. and Solowij, N.},
  title   = {{Hippocampal harms, protection and recovery following regular cannabis use}},
  journal = {Translational psychiatry},
  year    = {2016},
  doi     = {10.1038/tp.2015.201},
  pmid    = {26756903},
  url     = {https://doi.org/10.1038/tp.2015.201}
}

@article{soderberg2024-38740836,
  author  = {Söderberg, L. and Johannesson, M. and Gkanatsiou, E. and Nygren, P. and Fritz, N. and Zachrisson, O. and Rachalski, A. and Svensson, A. S. and others},
  title   = {{Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities}},
  journal = {Scientific reports},
  year    = {2024},
  doi     = {10.1038/s41598-024-61691-2},
  pmid    = {38740836},
  url     = {https://doi.org/10.1038/s41598-024-61691-2}
}

@article{larson1987-2886086,
  author  = {Larson, E. B. and Kukull, W. A. and Buchner, D. and Reifler, B. V.},
  title   = {{Adverse drug reactions associated with global cognitive impairment in elderly persons}},
  journal = {Annals of internal medicine},
  year    = {1987},
  doi     = {10.7326/0003-4819-107-2-169},
  pmid    = {2886086},
  url     = {https://doi.org/10.7326/0003-4819-107-2-169}
}

@article{hamilton2011-21670370,
  author  = {Hamilton, H. and Gallagher, P. and Ryan, C. and Byrne, S. and O'Mahony, D.},
  title   = {{Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients}},
  journal = {Archives of internal medicine},
  year    = {2011},
  doi     = {10.1001/archinternmed.2011.215},
  pmid    = {21670370},
  url     = {https://doi.org/10.1001/archinternmed.2011.215}
}

@article{wagner2004-15277291,
  author  = {Wagner, A. K. and Zhang, F. and Soumerai, S. B. and Walker, A. M. and Gurwitz, J. H. and Glynn, R. J. and Ross-Degnan, D.},
  title   = {{Benzodiazepine use and hip fractures in the elderly: who is at greatest risk?}},
  journal = {Archives of internal medicine},
  year    = {2004},
  doi     = {10.1001/archinte.164.14.1567},
  pmid    = {15277291},
  url     = {https://doi.org/10.1001/archinte.164.14.1567}
}

@article{roe2002-12028169,
  author  = {Roe, C. M. and Anderson, M. J. and Spivack, B.},
  title   = {{Use of anticholinergic medications by older adults with dementia}},
  journal = {Journal of the American Geriatrics Society},
  year    = {2002},
  doi     = {10.1046/j.1532-5415.2002.50208.x},
  pmid    = {12028169},
  url     = {https://doi.org/10.1046/j.1532-5415.2002.50208.x}
}

@article{qudoos2026-41966037,
  author  = {Qudoos, Muhammad A and Elliott, David P},
  title   = {{Review of Donanemab and Lecanemab in Mild Dementia Stage of Alzheimer's Disease: Progress and Challenges}},
  journal = {The Senior care pharmacist},
  year    = {2026},
  doi     = {10.4140/tcp.n.2026.98},
  pmid    = {41966037},
  url     = {https://doi.org/10.4140/tcp.n.2026.98}
}

@article{khan2025-41388533,
  author  = {Khan, Ali R and Makhoul, Gennifer Wahbah and Raji, Mukaila A},
  title   = {{Mirtazapine for gastrointestinal side effects of glucagon-like peptide-1 receptor agonist therapy in older adults}},
  journal = {Endocrine regulations},
  year    = {2025},
  doi     = {10.2478/enr-2025-0030},
  pmid    = {41388533},
  url     = {https://doi.org/10.2478/enr-2025-0030}
}

@article{cook2022-35704875,
  author  = {Cook, Heather and Walker, Kathryn A and Lowry, Maria Felton},
  title   = {{Deprescribing Interventions by Palliative Care Clinical Pharmacists Surrounding Goals of Care Discussions}},
  journal = {Journal of palliative medicine},
  year    = {2022},
  doi     = {10.1089/jpm.2021.0560},
  pmid    = {35704875},
  url     = {https://doi.org/10.1089/jpm.2021.0560}
}

@article{sultzer2008-18519523,
  author  = {Sultzer, David L. and Thomas, Sonia and Tariot, Pierre N. and Dagerman, Karen and Lebowitz, Barry D. and Lyketsos, Constantine George and Rosenheck, Robert Alan and Hsiao, John and others},
  title   = {{Clinical Symptom Responses to Atypical Antipsychotic Medications in Alzheimer’s Disease: Phase 1 Outcomes From the CATIE-AD Effectiveness Trial}},
  journal = {American Journal of Psychiatry},
  year    = {2008},
  doi     = {10.1176/appi.ajp.2008.07111779},
  pmid    = {18519523},
  url     = {https://doi.org/10.1176/appi.ajp.2008.07111779}
}

@article{hu2006-16780671,
  author  = {Hu, H. T. and Zhang, Z. X. and Yao, J. L. and Yu, H. Z. and Wang, Y. H. and Tang, H. C. and Ji, C. J. and Xu, T.},
  title   = {{[Clinical efficacy and safety of akatinol memantine in treatment of mild to moderate Alzheimer disease: a donepezil-controlled, randomized trial]}},
  journal = {Zhonghua nei ke za zhi},
  year    = {2006},
  pmid    = {16780671}
}

@article{agarwal2023-37651273,
  author  = {Agarwal, A. and Gupta, V. and Brahmbhatt, P. and Desai, A. and Vibhute, P. and Joseph-Mathurin, N. and Bathla, G.},
  title   = {{Amyloid-related Imaging Abnormalities in Alzheimer Disease Treated with Anti-Amyloid-β Therapy}},
  journal = {Radiographics : a review publication of the Radiological Society of North America, Inc},
  year    = {2023},
  doi     = {10.1148/rg.230009},
  pmid    = {37651273},
  url     = {https://doi.org/10.1148/rg.230009}
}

@article{salzman2008-18494535,
  author  = {Salzman, C. and Jeste, D. V. and Meyer, R. E. and Cohen-Mansfield, J. and Cummings, J. and Grossberg, G. T. and Jarvik, L. and Kraemer, H. C. and others},
  title   = {{Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy}},
  journal = {The Journal of clinical psychiatry},
  year    = {2008},
  doi     = {10.4088/jcp.v69n0602},
  pmid    = {18494535},
  url     = {https://doi.org/10.4088/jcp.v69n0602}
}

@article{ray1993-8447709,
  author  = {Ray, W. A. and Taylor, J. A. and Meador, K. G. and Lichtenstein, M. J. and Griffin, M. R. and Fought, R. and Adams, M. L. and Blazer, D. G.},
  title   = {{Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education}},
  journal = {Archives of internal medicine},
  year    = {1993},
  doi     = {10.1001/archinte.1993.00410060023005},
  pmid    = {8447709},
  url     = {https://doi.org/10.1001/archinte.1993.00410060023005}
}

@article{smith2025-39893139,
  author  = {Smith, Eric Edward and Phillips, Natalie A. and Feldman, Howard and BORRIE, MICHAEL J. and Ganesh, Aravind and Henri‐Bhargava, Alexandre and Desmarais, Philippe and Frank, Andrew and others},
  title   = {{Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research}},
  journal = {The Journal of Prevention of Alzheimer s Disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100068},
  pmid    = {39893139},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100068}
}

@article{zhou2025-40087769,
  author  = {Zhou, Xiaoting and Liao, Jiaqi and Lei, Zipeng and Yao, Huiqin and Zhao, Le and Yang, Chun Cheng and Zu, Yan and Zhao, Yuliang},
  title   = {{Nickel-based nanomaterials: a comprehensive analysis of risk assessment, toxicity mechanisms, and future strategies for health risk prevention}},
  journal = {Journal of Nanobiotechnology},
  year    = {2025},
  doi     = {10.1186/s12951-025-03248-7},
  pmid    = {40087769},
  url     = {https://doi.org/10.1186/s12951-025-03248-7}
}

@article{liu2025-39750005,
  author  = {Liu, Xiaojuan and Graham, Laura A. and Jing, Bocheng and Dave, Chintan V. and Li, Yongmei and Tamura, Manjula Kurella and Steinman, Michael Alan and Lee, Sei J. and others},
  title   = {{Antihypertensive Deprescribing and Functional Status in VA Long‐Term Care Residents With and Without Dementia}},
  journal = {Journal of the American Geriatrics Society},
  year    = {2025},
  doi     = {10.1111/jgs.19342},
  pmid    = {39750005},
  url     = {https://doi.org/10.1111/jgs.19342}
}

@article{hojlund2021-33820580,
  author  = {Højlund, M. and Andersen, J. H. and Andersen, K. and Correll, C. U. and Hallas, J.},
  title   = {{Use of antipsychotics in Denmark 1997-2018: a nation-wide drug utilisation study with focus on off-label use and associated diagnoses}},
  journal = {Epidemiology and psychiatric sciences},
  year    = {2021},
  doi     = {10.1017/s2045796021000159},
  pmid    = {33820580},
  url     = {https://doi.org/10.1017/s2045796021000159}
}

@article{wang2022-35413950,
  author  = {Wang, C. and Fan, L. and Khawaja, R. R. and Liu, B. and Zhan, L. and Kodama, L. and Chin, M. and Li, Y. and others},
  title   = {{Microglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy}},
  journal = {Nature communications},
  year    = {2022},
  doi     = {10.1038/s41467-022-29552-6},
  pmid    = {35413950},
  url     = {https://doi.org/10.1038/s41467-022-29552-6}
}

@article{honig2023-36949897,
  author  = {Honig, L. S. and Barakos, J. and Dhadda, S. and Kanekiyo, M. and Reyderman, L. and Irizarry, M. and Kramer, L. D. and Swanson, C. J. and others},
  title   = {{ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2023},
  doi     = {10.1002/trc2.12377},
  pmid    = {36949897},
  url     = {https://doi.org/10.1002/trc2.12377}
}

@article{pizzo2025-40773560,
  author  = {Pizzo, M. E. and Plowey, E. D. and Khoury, N. and Kwan, W. and Abettan, J. and DeVos, S. L. and Discenza, C. B. and Earr, T. and others},
  title   = {{Transferrin receptor-targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA}},
  journal = {Science (New York, N.Y.)},
  year    = {2025},
  doi     = {10.1126/science.ads3204},
  pmid    = {40773560},
  url     = {https://doi.org/10.1126/science.ads3204}
}

@article{howe2023-37874098,
  author  = {Howe, M. D. and Britton, K. J. and Joyce, H. E. and Pappas, G. J. and Faust, M. A. and Dawson, B. C. and Riddle, M. C. and Salloway, S. P.},
  title   = {{Initial Experiences with Amyloid-Related Imaging Abnormalities in Patients Receiving Aducanumab Following Accelerated Approval}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2023},
  doi     = {10.14283/jpad.2023.96},
  pmid    = {37874098},
  url     = {https://doi.org/10.14283/jpad.2023.96}
}

@article{erichsen2023-37786483,
  author  = {Erichsen, J. and Craft, S.},
  title   = {{Targeting immunometabolic pathways for combination therapy in Alzheimer's disease}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2023},
  doi     = {10.1002/trc2.12423},
  pmid    = {37786483},
  url     = {https://doi.org/10.1002/trc2.12423}
}

@article{merkel2026-41904593,
  author  = {Merkel, J. and Perneczky, R. and Jessen, F. and Frölich, L. and Jansen, O. and Peters, S. and Berg, D. and Schulz, J. B. and others},
  title   = {{Amyloid-related imaging abnormalities (ARIA) in Alzheimer's disease: from pathophysiology to individualized risk assessment}},
  journal = {Alzheimer's research \& therapy},
  year    = {2026},
  doi     = {10.1186/s13195-026-02022-7},
  pmid    = {41904593},
  url     = {https://doi.org/10.1186/s13195-026-02022-7}
}

@article{guizzaro2026-41852829,
  author  = {Guizzaro, L. and Bałkowiec-Iskra, E. and Haberkamp, M. and Mol, P. G. M. and Moreau, A. and Mueller-Berghaus, J. and Philadelphy, D. and Balabanov, P. and others},
  title   = {{Balancing benefit and risk in early Alzheimer's disease: the European Medicines Agency (EMA) assessment of lecanemab and donanemab}},
  journal = {The Lancet regional health. Europe},
  year    = {2026},
  doi     = {10.1016/j.lanepe.2026.101644},
  pmid    = {41852829},
  url     = {https://doi.org/10.1016/j.lanepe.2026.101644}
}

@article{tian2017-28596794,
  author  = {Tian, J. and Shi, J. and Li, T. and Li, L. and Wang, Z. and Li, X. and Lv, Z. and Zheng, Q. and others},
  title   = {{Efficacy and Safety of an Herbal Therapy in Patients with Amnestic Mild Cognitive Impairment: A 24-Week Randomized Phase III Trial}},
  journal = {Evidence-based complementary and alternative medicine : eCAM},
  year    = {2017},
  doi     = {10.1155/2017/4251747},
  pmid    = {28596794},
  url     = {https://doi.org/10.1155/2017/4251747}
}

@article{ramkumar2016-27899849,
  author  = {Ramkumar, S. and Raghunath, A. and Raghunath, S.},
  title   = {{Statin Therapy: Review of Safety and Potential Side Effects}},
  journal = {Acta Cardiologica Sinica},
  year    = {2016},
  doi     = {10.6515/acs20160611a},
  pmid    = {27899849},
  url     = {https://doi.org/10.6515/acs20160611a}
}

@article{ostrerovagolts2000-10934254,
  author  = {Ostrerova-Golts, N. and Petrucelli, L. and Hardy, J. and Lee, J. M. and Farer, M. and Wolozin, B.},
  title   = {{The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity}},
  journal = {The Journal of neuroscience : the official journal of the Society for Neuroscience},
  year    = {2000},
  doi     = {10.1523/jneurosci.20-16-06048.2000},
  pmid    = {10934254},
  url     = {https://doi.org/10.1523/jneurosci.20-16-06048.2000}
}

@article{garvey2025-40496004,
  author  = {Garvey, Kayla and Griffith, Kobi and Carter, Emily L. and Craig, Wendy Y. and Gagnon, David J. and Riker, Richard R. and Centanni, Nicolette},
  title   = {{Guanfacine for the management of the behavioral manifestations of delirium in older hospitalized adults}},
  journal = {Mental Health Clinician},
  year    = {2025},
  doi     = {10.9740/mhc.2025.06.164},
  pmid    = {40496004},
  url     = {https://doi.org/10.9740/mhc.2025.06.164}
}

@article{hardy2024-38165303,
  author  = {Hardy, John and Schott, Jonathan M},
  title   = {{Identifying Genetic Risk for Amyloid-Related Imaging Abnormalities}},
  journal = {Neurology},
  year    = {2024},
  doi     = {10.1212/wnl.0000000000208096},
  pmid    = {38165303},
  url     = {https://doi.org/10.1212/wnl.0000000000208096}
}

@article{venneti2006-17156911,
  author  = {Venneti, S. and Lopresti, B. J. and Wiley, C. A.},
  title   = {{The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging}},
  journal = {Progress in neurobiology},
  year    = {2006},
  doi     = {10.1016/j.pneurobio.2006.10.002},
  pmid    = {17156911},
  url     = {https://doi.org/10.1016/j.pneurobio.2006.10.002}
}

@article{kang2025-41069006,
  author  = {Kang, Wenyan and Gao, Chao and Li, Xiaoyan and Wang, Xiaoxue and Zhong, Huizhu and Wei, Qiao and Tang, Yonghua and Huang, Peijian and others},
  title   = {{Safety and effectiveness of lecanemab in Chinese patients with early Alzheimer’s disease: Evidence from a multidimensional real-world study}},
  journal = {Chinese Medical Journal},
  year    = {2025},
  doi     = {10.1097/cm9.0000000000003888},
  pmid    = {41069006},
  url     = {https://doi.org/10.1097/cm9.0000000000003888}
}

@article{cummings2024-37955845,
  author  = {Cummings, J. and Osse, A. M. L. and Cammann, D. and Powell, J. and Chen, J.},
  title   = {{Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer's Disease}},
  journal = {BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy},
  year    = {2024},
  doi     = {10.1007/s40259-023-00633-2},
  pmid    = {37955845},
  url     = {https://doi.org/10.1007/s40259-023-00633-2}
}

@article{zhang2024-39174535,
  author  = {Zhang, J. and Zhang, Y. and Wang, J. and Xia, Y. and Chen, L.},
  title   = {{Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies}},
  journal = {Signal transduction and targeted therapy},
  year    = {2024},
  doi     = {10.1038/s41392-024-01911-3},
  pmid    = {39174535},
  url     = {https://doi.org/10.1038/s41392-024-01911-3}
}

@article{doran2024-38312931,
  author  = {Doran, S. J. and Sawyer, R. P.},
  title   = {{Risk factors in developing amyloid related imaging abnormalities (ARIA) and clinical implications}},
  journal = {Frontiers in neuroscience},
  year    = {2024},
  doi     = {10.3389/fnins.2024.1326784},
  pmid    = {38312931},
  url     = {https://doi.org/10.3389/fnins.2024.1326784}
}

@article{gueorguieva2023-36805552,
  author  = {Gueorguieva, I. and Willis, B. A. and Chua, L. and Chow, K. and Ernest, C. S. and Shcherbinin, S. and Ardayfio, P. and Mullins, G. R. and others},
  title   = {{Donanemab Population Pharmacokinetics, Amyloid Plaque Reduction, and Safety in Participants with Alzheimer's Disease}},
  journal = {Clinical pharmacology and therapeutics},
  year    = {2023},
  doi     = {10.1002/cpt.2875},
  pmid    = {36805552},
  url     = {https://doi.org/10.1002/cpt.2875}
}

@article{foley2024-38756535,
  author  = {Foley, K. E. and Wilcock, D. M.},
  title   = {{Three major effects of APOE ε4 on Aβ immunotherapy induced ARIA}},
  journal = {Frontiers in aging neuroscience},
  year    = {2024},
  doi     = {10.3389/fnagi.2024.1412006},
  pmid    = {38756535},
  url     = {https://doi.org/10.3389/fnagi.2024.1412006}
}

@article{taylor2024-39434125,
  author  = {Taylor, X. and Noristani, H. N. and Fitzgerald, G. J. and Oluoch, H. and Babb, N. and McGathey, T. and Carter, L. and Hole, J. T. and others},
  title   = {{Amyloid-β (Aβ) immunotherapy induced microhemorrhages are linked to vascular inflammation and cerebrovascular damage in a mouse model of Alzheimer's disease}},
  journal = {Molecular neurodegeneration},
  year    = {2024},
  doi     = {10.1186/s13024-024-00758-0},
  pmid    = {39434125},
  url     = {https://doi.org/10.1186/s13024-024-00758-0}
}

@article{sehlin2025-40425446,
  author  = {Sehlin, D. and Hultqvist, G. and Michno, W. and Aguilar, X. and Dahlén, A. D. and Cerilli, E. and Bucher, N. M. and Lopes van den Broek, S. and others},
  title   = {{Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100214},
  pmid    = {40425446},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100214}
}

@article{alkhalifa2025-41003140,
  author  = {Alkhalifa, A. E. and Al Mokhlf, A. and Ali, H. and Al-Ghraiybah, N. F. and Syropoulou, V.},
  title   = {{Anti-Amyloid Monoclonal Antibodies for Alzheimer's Disease: Evidence, ARIA Risk, and Precision Patient Selection}},
  journal = {Journal of personalized medicine},
  year    = {2025},
  doi     = {10.3390/jpm15090437},
  pmid    = {41003140},
  url     = {https://doi.org/10.3390/jpm15090437}
}

@article{jeong2024-39109501,
  author  = {Jeong, S. Y. and Suh, C. H. and Kim, S. J. and Lemere, C. A. and Lim, J. S. and Lee, J. H.},
  title   = {{Amyloid-Related Imaging Abnormalities in the Era of Anti-Amyloid Beta Monoclonal Antibodies for Alzheimer's Disease: Recent Updates on Clinical and Imaging Features and MRI Monitoring}},
  journal = {Korean journal of radiology},
  year    = {2024},
  doi     = {10.3348/kjr.2024.0105},
  pmid    = {39109501},
  url     = {https://doi.org/10.3348/kjr.2024.0105}
}

@article{bobbins2025-40051090,
  author  = {Bobbins, A. and Davies, M. and Lynn, E. and Roy, D. and Yeomans, A. and Shakir, S. A. W.},
  title   = {{Safety and effectiveness of the anti-amyloid monoclonal antibody (mAb) drug lecanemab for early Alzheimer's disease: The pharmacovigilance perspective}},
  journal = {British journal of clinical pharmacology},
  year    = {2025},
  doi     = {10.1002/bcp.70021},
  pmid    = {40051090},
  url     = {https://doi.org/10.1002/bcp.70021}
}

@article{park2024-39512702,
  author  = {Park, K. H. and Kim, G. H. and Kim, C. H. and Koh, S. H. and Moon, S. Y. and Park, Y. H. and Seo, S. W. and Yoon, B. and others},
  title   = {{Lecanemab: Appropriate Use Recommendations by Korean Dementia Association}},
  journal = {Dementia and neurocognitive disorders},
  year    = {2024},
  doi     = {10.12779/dnd.2024.23.4.165},
  pmid    = {39512702},
  url     = {https://doi.org/10.12779/dnd.2024.23.4.165}
}

@article{vukmir2024-38939962,
  author  = {Vukmir, R. B.},
  title   = {{Amyloid-related imaging abnormalities (ARIA): diagnosis, management, and care in the setting of amyloid-modifying therapy}},
  journal = {Annals of clinical and translational neurology},
  year    = {2024},
  doi     = {10.1002/acn3.52042},
  pmid    = {38939962},
  url     = {https://doi.org/10.1002/acn3.52042}
}

@article{yoon2024-38779110,
  author  = {Yoon, C. H. and Groff, C. and Criss, O.},
  title   = {{Lecanemab: A Second in Class Therapy for the Management of Early Alzheimer's Disease}},
  journal = {Innovations in pharmacy},
  year    = {2024},
  doi     = {10.24926/iip.v15i1.5787},
  pmid    = {38779110},
  url     = {https://doi.org/10.24926/iip.v15i1.5787}
}

@article{rabiei2025-41271757,
  author  = {Rabiei, K. and Petrella, JR. and Lenhart, S. and Liu, C. and Hao, W. and {Alzheimer Disease Neuroimaging Initiative}},
  title   = {{Data-driven modeling of amyloid-β targeted antibodies for Alzheimer's disease}},
  journal = {NPJ systems biology and applications},
  year    = {2025},
  doi     = {10.1038/s41540-025-00610-1},
  pmid    = {41271757},
  url     = {https://doi.org/10.1038/s41540-025-00610-1}
}

@article{schreiber2025-41042497,
  author  = {Schreiber, C. P. and Kovacik, A. and Bishop, J. and Helman, J.},
  title   = {{Amyloid-related Imaging Abnormalities (ARIA) in the Context of Alzheimer's Disease and Amyloid-targeting Therapies: An Introduction for Advanced Practice Providers}},
  journal = {Drugs \& aging},
  year    = {2025},
  doi     = {10.1007/s40266-025-01253-x},
  pmid    = {41042497},
  url     = {https://doi.org/10.1007/s40266-025-01253-x}
}

@article{drucker2024-38843460,
  author  = {Drucker, D. J.},
  title   = {{Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity}},
  journal = {Diabetes care},
  year    = {2024},
  doi     = {10.2337/dci24-0003},
  pmid    = {38843460},
  url     = {https://doi.org/10.2337/dci24-0003}
}

@article{mummery2026-41390238,
  author  = {Mummery, Catherine J and Rasmussen, Jill and Blackburn, Dan and Coulthard, Elizabeth and Davies, R Rhys and Dorsey, Rachel and Fox, Nick C and Hosseini, Akram A and others},
  title   = {{Lecanemab appropriate use recommendations for clinical practice in the UK}},
  journal = {Journal of neurology, neurosurgery, and psychiatry},
  year    = {2026},
  doi     = {10.1136/jnnp-2025-336597},
  pmid    = {41390238},
  url     = {https://doi.org/10.1136/jnnp-2025-336597}
}

@article{hagiwara2026-40820597,
  author  = {Hagiwara, Akifumi},
  title   = {{Balancing Speed and Sensitivity: Echo-Planar Accelerated MRI for ARIA-H Screening in Anti-Aβ Therapeutics}},
  journal = {Investigative radiology},
  year    = {2026},
  doi     = {10.1097/rli.0000000000001232},
  pmid    = {40820597},
  url     = {https://doi.org/10.1097/rli.0000000000001232}
}

@article{schnieder2026-42714614,
  author  = {Schnieder, Marlena},
  title   = {{[Antibody therapy in Alzheimer's disease]}},
  journal = {Zeitschrift fur Gerontologie und Geriatrie},
  year    = {2026},
  doi     = {10.1007/s00391-026-02640-8},
  pmid    = {42714614},
  url     = {https://doi.org/10.1007/s00391-026-02640-8}
}

@article{papaliagkas2025-41096797,
  author  = {Papaliagkas, Vasileios T.},
  title   = {{Anti-Amyloid Therapies for Alzheimer’s Disease: Progress, Pitfalls, and the Path Ahead}},
  journal = {International Journal of Molecular Sciences},
  year    = {2025},
  doi     = {10.3390/ijms26199529},
  pmid    = {41096797},
  url     = {https://doi.org/10.3390/ijms26199529}
}

@article{bonner2015-176aebdb,
  author  = {Bonner, Alice F. and Field, Terry S. and Lemay, Celeste A. and Mazor, Kathleen M. and Andersen, Daniel A. and Compher, Christina J. and Tjia, Jennifer and Gurwitz, Jerry H.},
  title   = {{Rationales that Providers and Family Members Cited for the Use of Antipsychotic Medications in Nursing Home Residents with Dementia}},
  journal = {Journal of the American Geriatrics Society},
  year    = {2015},
  doi     = {10.1111/jgs.13230},
  url     = {https://doi.org/10.1111/jgs.13230}
}

@article{hall2019-31126240,
  author  = {Hall, A. and Brown Wilson, C. and Stanmore, E. and Todd, C.},
  title   = {{Moving beyond 'safety' versus 'autonomy': a qualitative exploration of the ethics of using monitoring technologies in long-term dementia care}},
  journal = {BMC geriatrics},
  year    = {2019},
  doi     = {10.1186/s12877-019-1155-6},
  pmid    = {31126240},
  url     = {https://doi.org/10.1186/s12877-019-1155-6}
}

@article{yasuno2008-18514164,
  author  = {Yasuno, F. and Ota, M. and Kosaka, J. and Ito, H. and Higuchi, M. and Doronbekov, T. K. and Nozaki, S. and Fujimura, Y. and others},
  title   = {{Increased binding of peripheral benzodiazepine receptor in Alzheimer's disease measured by positron emission tomography with [11C]DAA1106}},
  journal = {Biological psychiatry},
  year    = {2008},
  doi     = {10.1016/j.biopsych.2008.04.021},
  pmid    = {18514164},
  url     = {https://doi.org/10.1016/j.biopsych.2008.04.021}
}

@article{gordiichuk2025-12954b56,
  author  = {Gordiichuk, O. and Bulekhovets, M. and Bezhuk, S. and Omelianchyk, N. and Popshe, D.},
  title   = {{Monoclonal antibodies for treatment Alzheimer`s disease}},
  journal = {Reports of Vinnytsia National Medical University},
  year    = {2025},
  doi     = {10.31393/reports-vnmedical-2025-29(4)-29},
  url     = {https://doi.org/10.31393/reports-vnmedical-2025-29(4)-29}
}

@article{unger2026-42684813,
  author  = {Unger, Robert H. and Rohatgi, Saurabh and Ferraciolli, Suely Fazio and Kako, Bashar and Omid‐Fard, Nima and Imbett, Rafael Eduardo Martinez and Dowling, Thomas and Zhu, Shenghua and others},
  title   = {{Real-World Challenges in the MRI Detection and Classification of Amyloid-Related Imaging Abnormalities}},
  journal = {American Journal of Roentgenology},
  year    = {2026},
  doi     = {10.2214/ajr.26.35478},
  pmid    = {42684813},
  url     = {https://doi.org/10.2214/ajr.26.35478}
}

@article{liougas2026-41784545,
  author  = {Liougas, Madalena P. and Grigorovich, Alisa and Bianchi, Andria and Haslam‐Larmer, Lynn and Shum, Leia C and Iaboni, Andrea and McMurray, Josephine},
  title   = {{Ethical Tensions in the Use of Real-Time Location Systems in Dementia Care: Balancing Safety, Privacy, and Autonomy}},
  journal = {The American Journal of Bioethics},
  year    = {2026},
  doi     = {10.1080/15265161.2026.2637089},
  pmid    = {41784545},
  url     = {https://doi.org/10.1080/15265161.2026.2637089}
}

@article{wang2019-31852125,
  author  = {Wang, H. and Liu, N. and Wei, Y. and Pei, H. and Liu, M. and Diao, X. and Zhang, H. and Li, H.},
  title   = {{Efficacy and safety of Shenmayizhi decoction as an adjuvant treatment for vascular dementia: Study protocol for a randomized controlled trial}},
  journal = {Medicine},
  year    = {2019},
  doi     = {10.1097/md.0000000000018326},
  pmid    = {31852125},
  url     = {https://doi.org/10.1097/md.0000000000018326}
}

@article{kim2015-29854930,
  author  = {Kim, H. J. and Seo, S. W. and Chang, J. W. and Lee, J. I. and Kim, C. H. and Chin, J. and Choi, S. J. and Kwon, H. and others},
  title   = {{Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: A phase 1 clinical trial}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2015},
  doi     = {10.1016/j.trci.2015.06.007},
  pmid    = {29854930},
  url     = {https://doi.org/10.1016/j.trci.2015.06.007}
}

@article{belar2021-33307989,
  author  = {Belar, A. and Arantzamendi, M. and Payne, S. and Preston, N. and Rijpstra, M. and Hasselaar, J. and Radbruch, L. and Vanderelst, M. and others},
  title   = {{How to measure the effects and potential adverse events of palliative sedation? An integrative review}},
  journal = {Palliative medicine},
  year    = {2021},
  doi     = {10.1177/0269216320974264},
  pmid    = {33307989},
  url     = {https://doi.org/10.1177/0269216320974264}
}

@article{xie2023-37859748,
  author  = {Xie, X. and Song, Q. and Dai, C. and Cui, S. and Tang, R. and Li, S. and Chang, J. and Li, P. and others},
  title   = {{Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer's disease: a phase I/II clinical trial}},
  journal = {General psychiatry},
  year    = {2023},
  doi     = {10.1136/gpsych-2023-101143},
  pmid    = {37859748},
  url     = {https://doi.org/10.1136/gpsych-2023-101143}
}

@article{douglas2008-18755769,
  author  = {Douglas, I. J. and Smeeth, L.},
  title   = {{Exposure to antipsychotics and risk of stroke: self controlled case series study}},
  journal = {BMJ (Clinical research ed.)},
  year    = {2008},
  doi     = {10.1136/bmj.a1227},
  pmid    = {18755769},
  url     = {https://doi.org/10.1136/bmj.a1227}
}

@article{soderberg2023-36253511,
  author  = {Söderberg, L. and Johannesson, M. and Nygren, P. and Laudon, H. and Eriksson, F. and Osswald, G. and Möller, C. and Lannfelt, L.},
  title   = {{Lecanemab, Aducanumab, and Gantenerumab - Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease}},
  journal = {Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics},
  year    = {2023},
  doi     = {10.1007/s13311-022-01308-6},
  pmid    = {36253511},
  url     = {https://doi.org/10.1007/s13311-022-01308-6}
}

@article{cummings2021-34585212,
  author  = {Cummings, J. and Aisen, P. and Apostolova, L. G. and Atri, A. and Salloway, S. and Weiner, M.},
  title   = {{Aducanumab: Appropriate Use Recommendations}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2021},
  doi     = {10.14283/jpad.2021.41},
  pmid    = {34585212},
  url     = {https://doi.org/10.14283/jpad.2021.41}
}

@article{cummings2023-37060386,
  author  = {Cummings, J.},
  title   = {{Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics}},
  journal = {Drugs},
  year    = {2023},
  doi     = {10.1007/s40265-023-01858-9},
  pmid    = {37060386},
  url     = {https://doi.org/10.1007/s40265-023-01858-9}
}

@article{siemers2010-20375655,
  author  = {Siemers, E. R. and Friedrich, S. and Dean, R. A. and Gonzales, C. R. and Farlow, M. R. and Paul, S. M. and Demattos, R. B.},
  title   = {{Safety and changes in plasma and cerebrospinal fluid amyloid beta after a single administration of an amyloid beta monoclonal antibody in subjects with Alzheimer disease}},
  journal = {Clinical neuropharmacology},
  year    = {2010},
  doi     = {10.1097/wnf.0b013e3181cb577a},
  pmid    = {20375655},
  url     = {https://doi.org/10.1097/wnf.0b013e3181cb577a}
}

@article{peng2023-37600514,
  author  = {Peng, Y. and Jin, H. and Xue, Y. H. and Chen, Q. and Yao, S. Y. and Du, M. Q. and Liu, S.},
  title   = {{Current and future therapeutic strategies for Alzheimer's disease: an overview of drug development bottlenecks}},
  journal = {Frontiers in aging neuroscience},
  year    = {2023},
  doi     = {10.3389/fnagi.2023.1206572},
  pmid    = {37600514},
  url     = {https://doi.org/10.3389/fnagi.2023.1206572}
}

@article{yadollahikhales2023-37490245,
  author  = {Yadollahikhales, G. and Rojas, J. C.},
  title   = {{Anti-Amyloid Immunotherapies for Alzheimer's Disease: A 2023 Clinical Update}},
  journal = {Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics},
  year    = {2023},
  doi     = {10.1007/s13311-023-01405-0},
  pmid    = {37490245},
  url     = {https://doi.org/10.1007/s13311-023-01405-0}
}

@article{taylor2023-37649100,
  author  = {Taylor, X. and Clark, I. M. and Fitzgerald, G. J. and Oluoch, H. and Hole, J. T. and DeMattos, R. B. and Wang, Y. and Pan, F.},
  title   = {{Amyloid-β (Aβ) immunotherapy induced microhemorrhages are associated with activated perivascular macrophages and peripheral monocyte recruitment in Alzheimer's disease mice}},
  journal = {Molecular neurodegeneration},
  year    = {2023},
  doi     = {10.1186/s13024-023-00649-w},
  pmid    = {37649100},
  url     = {https://doi.org/10.1186/s13024-023-00649-w}
}

@article{zago2013-23583235,
  author  = {Zago, W. and Schroeter, S. and Guido, T. and Khan, K. and Seubert, P. and Yednock, T. and Schenk, D. and Gregg, K. M. and others},
  title   = {{Vascular alterations in PDAPP mice after anti-Aβ immunotherapy: Implications for amyloid-related imaging abnormalities}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2013},
  doi     = {10.1016/j.jalz.2012.11.010},
  pmid    = {23583235},
  url     = {https://doi.org/10.1016/j.jalz.2012.11.010}
}

@article{sin2023-37959255,
  author  = {Sin, M. K. and Zamrini, E. and Ahmed, A. and Nho, K. and Hajjar, I.},
  title   = {{Anti-Amyloid Therapy, AD, and ARIA: Untangling the Role of CAA}},
  journal = {Journal of clinical medicine},
  year    = {2023},
  doi     = {10.3390/jcm12216792},
  pmid    = {37959255},
  url     = {https://doi.org/10.3390/jcm12216792}
}

@article{lu2023-37936917,
  author  = {Lu, O. and Kouser, T. and Skylar-Scott, I. A.},
  title   = {{Alzheimer's disease and epilepsy: shared neuropathology guides current and future treatment strategies}},
  journal = {Frontiers in neurology},
  year    = {2023},
  doi     = {10.3389/fneur.2023.1241339},
  pmid    = {37936917},
  url     = {https://doi.org/10.3389/fneur.2023.1241339}
}

@article{geldmacher2024-39620846,
  author  = {Geldmacher, David S},
  title   = {{Treatment of Alzheimer Disease}},
  journal = {Continuum (Minneapolis, Minn.)},
  year    = {2024},
  doi     = {10.1212/con.0000000000001503},
  pmid    = {39620846},
  url     = {https://doi.org/10.1212/con.0000000000001503}
}

@article{arai2025-40708311,
  author  = {Arai, Heii and Aiba, Satoko and Arai, Reiko},
  title   = {{Safety of switching from lecanemab to donanemab in 20 consecutive patients with Alzheimer's disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2025},
  doi     = {10.1177/13872877251361051},
  pmid    = {40708311},
  url     = {https://doi.org/10.1177/13872877251361051}
}

@article{hunter2024-39443750,
  author  = {Hunter, Philip},
  title   = {{The controversy around anti-amyloid antibodies for treating Alzheimer's disease : The European Medical Agency's ruling against the latest anti-amyloid drugs highlights the ongoing debate about their safety and efficacy}},
  journal = {EMBO reports},
  year    = {2024},
  doi     = {10.1038/s44319-024-00294-4},
  pmid    = {39443750},
  url     = {https://doi.org/10.1038/s44319-024-00294-4}
}

@article{song2024-38758223,
  author  = {Song, Tanya and Wang, Yunfei and Silverglate, Bret David and Grossberg, George T},
  title   = {{Pharmacokinetic evaluation of donanemab for the treatment of Alzheimer's}},
  journal = {Expert opinion on drug metabolism \& toxicology},
  year    = {2024},
  doi     = {10.1080/17425255.2024.2357637},
  pmid    = {38758223},
  url     = {https://doi.org/10.1080/17425255.2024.2357637}
}

@article{kaur2024-38095822,
  author  = {Kaur, Upinder and Reddy, Jaideep and Tiwari, Ashutosh and Chakrabarti, Sasanka and Chakrabarti, Sankha Shubhra},
  title   = {{Lecanemab: More Questions Than Answers!}},
  journal = {Clinical drug investigation},
  year    = {2024},
  doi     = {10.1007/s40261-023-01331-1},
  pmid    = {38095822},
  url     = {https://doi.org/10.1007/s40261-023-01331-1}
}

@article{yang2024-39990823,
  author  = {Yang, Xiyue and Li, Wanting and Yang, Xinglong and Chen, Qin and Li, Hongxia and Lyu, Su and Hu, Na},
  title   = {{[Radiological Identification and Evaluation of Amyloid-Related Imaging Abnormalities in Alzheimer's Disease]}},
  journal = {Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition},
  year    = {2024},
  doi     = {10.12182/20241160201},
  pmid    = {39990823},
  url     = {https://doi.org/10.12182/20241160201}
}

@article{cogswell2025-40210382,
  author  = {Cogswell, Petrice M and Burkett, Brian J and Johnson, Derek R and Pillai, Jay J},
  title   = {{Altered Clearance and Amyloid-Related Imaging Abnormalities}},
  journal = {Neuroimaging clinics of North America},
  year    = {2025},
  doi     = {10.1016/j.nic.2024.12.002},
  pmid    = {40210382},
  url     = {https://doi.org/10.1016/j.nic.2024.12.002}
}

@article{vandevrede2020-33072846,
  author  = {VandeVrede, Lawren and Gibbs, Daniel M and Koestler, Mary and La Joie, Renaud and Ljubenkov, Peter A and Provost, Karine and Soleimani-Meigooni, David and Strom, Amelia and others},
  title   = {{Symptomatic amyloid-related imaging abnormalities in an APOE ε4/ε4 patient treated with aducanumab}},
  journal = {Alzheimer's \& dementia (Amsterdam, Netherlands)},
  year    = {2020},
  doi     = {10.1002/dad2.12101},
  pmid    = {33072846},
  url     = {https://doi.org/10.1002/dad2.12101}
}

@article{sharma2025-40993929,
  author  = {Sharma, Chanchal and Mazumder, Avijit},
  title   = {{From Bench to Bedside: Cutting-Edge and Emerging Therapies for Alzheimer's Disease}},
  journal = {Central nervous system agents in medicinal chemistry},
  year    = {2025},
  doi     = {10.2174/0118715249388723250910140541},
  pmid    = {40993929},
  url     = {https://doi.org/10.2174/0118715249388723250910140541}
}

@article{besin2025-40951730,
  author  = {Besin, Valentinus and Humardani, Farizky Martriano and Yudiarto, Fenny Lanawati and Ong, Paulus Anam and Putra, Sulistyo Emantoko Dwi and Ningrum, Ratih Asmana},
  title   = {{Amyloid-Related Imaging Abnormality (ARIA) Beyond the APOE-ε4 Allele}},
  journal = {Chronic diseases and translational medicine},
  year    = {2025},
  doi     = {10.1002/cdt3.70006},
  pmid    = {40951730},
  url     = {https://doi.org/10.1002/cdt3.70006}
}

@article{zarei2025-40620322,
  author  = {Zarei, Malek and Sabetkasaei, Masoumeh and Mozafari, Masoud and Zaeri, Sasan},
  title   = {{The expanding role of semaglutide: beyond glycemic control}},
  journal = {Journal of diabetes and metabolic disorders},
  year    = {2025},
  doi     = {10.1007/s40200-025-01663-z},
  pmid    = {40620322},
  url     = {https://doi.org/10.1007/s40200-025-01663-z}
}

@article{banerjee2024-38427250,
  author  = {Banerjee, Sayani and Banerjee, Sugato},
  title   = {{Amyloid Beta-Mediated Neurovascular Toxicity in Alzheimer's Disease}},
  journal = {Methods in molecular biology (Clifton, N.J.)},
  year    = {2024},
  doi     = {10.1007/978-1-0716-3662-6_26},
  pmid    = {38427250},
  url     = {https://doi.org/10.1007/978-1-0716-3662-6_26}
}

@article{liu2023-37537902,
  author  = {Liu, Xin-qi and Huang, Jia and Song, Chao and Zhang, Tianliang and Liu, Yongping and Yu, Li Sheng},
  title   = {{Neurodevelopmental toxicity induced by PM2.5 Exposure and its possible role in Neurodegenerative and mental disorders}},
  journal = {Human \& Experimental Toxicology},
  year    = {2023},
  doi     = {10.1177/09603271231191436},
  pmid    = {37537902},
  url     = {https://doi.org/10.1177/09603271231191436}
}

@article{dorsey2010-20065205,
  author  = {Dorsey, E. R. and Rabbani, A. and Gallagher, S. A. and Conti, R. M. and Alexander, G. C.},
  title   = {{Impact of FDA black box advisory on antipsychotic medication use}},
  journal = {Archives of internal medicine},
  year    = {2010},
  doi     = {10.1001/archinternmed.2009.456},
  pmid    = {20065205},
  url     = {https://doi.org/10.1001/archinternmed.2009.456}
}

@article{verstappen2003-12887262,
  author  = {Verstappen, C. C. and Heimans, J. J. and Hoekman, K. and Postma, T. J.},
  title   = {{Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management}},
  journal = {Drugs},
  year    = {2003},
  doi     = {10.2165/00003495-200363150-00003},
  pmid    = {12887262},
  url     = {https://doi.org/10.2165/00003495-200363150-00003}
}

@article{landt2011-21403005,
  author  = {Landt, J. and D'Abrera, J. C. and Holland, A. J. and Aigbirhio, F. I. and Fryer, T. D. and Canales, R. and Hong, Y. T. and Menon, D. K. and others},
  title   = {{Using positron emission tomography and Carbon 11-labeled Pittsburgh Compound B to image Brain Fibrillar β-amyloid in adults with down syndrome: safety, acceptability, and feasibility}},
  journal = {Archives of neurology},
  year    = {2011},
  doi     = {10.1001/archneurol.2011.36},
  pmid    = {21403005},
  url     = {https://doi.org/10.1001/archneurol.2011.36}
}

@article{petrella2025-40738658,
  author  = {Petrella, Jeffrey R. and Liu, Ao and Wang, Li and Doraiswamy, Pudugramam Murali},
  title   = {{Artificial Intelligence–Assisted Detection of Amyloid-Related Imaging Abnormalities: Promise and Pitfalls}},
  journal = {American Journal of Neuroradiology},
  year    = {2025},
  doi     = {10.3174/ajnr.a8946},
  pmid    = {40738658},
  url     = {https://doi.org/10.3174/ajnr.a8946}
}

@article{hart2025-40200799,
  author  = {Hart, Danielle E. and Leggins, Brandon and Sanches, Clara and Guterman, Elan L. and Chiong, Winston},
  title   = {{Financial Toxicity in Dementia Caregiving: Sociodemographic Predictors in a U.S. Nationally Representative Survey}},
  journal = {The Gerontologist},
  year    = {2025},
  doi     = {10.1093/geront/gnaf092},
  pmid    = {40200799},
  url     = {https://doi.org/10.1093/geront/gnaf092}
}

@article{thal2006-16917204,
  author  = {Thal, L. J.},
  title   = {{Prevention of Alzheimer disease}},
  journal = {Alzheimer disease and associated disorders},
  year    = {2006},
  doi     = {10.1097/00002093-200607001-00015},
  pmid    = {16917204},
  url     = {https://doi.org/10.1097/00002093-200607001-00015}
}

@article{thomson2009-19170782,
  author  = {Thomson, M. S. and Gruneir, A. and Lee, M. and Baril, J. and Field, T. S. and Gurwitz, J. H. and Rochon, P. A.},
  title   = {{Nursing time devoted to medication administration in long-term care: clinical, safety, and resource implications}},
  journal = {Journal of the American Geriatrics Society},
  year    = {2009},
  doi     = {10.1111/j.1532-5415.2008.02101.x},
  pmid    = {19170782},
  url     = {https://doi.org/10.1111/j.1532-5415.2008.02101.x}
}

@article{adhikari2023-36515320,
  author  = {Adhikari, U. K. and Khan, R. and Mikhael, M. and Balez, R. and David, M. A. and Mahns, D. and Hardy, J. and Tayebi, M.},
  title   = {{Therapeutic anti-amyloid β antibodies cause neuronal disturbances}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2023},
  doi     = {10.1002/alz.12833},
  pmid    = {36515320},
  url     = {https://doi.org/10.1002/alz.12833}
}

@article{patel2026-1f71b223,
  author  = {Patel, Princy and Rana, Aarti and Pansuria, Mayur and Patel, Rutvik and Patel, Hemangini and Pirouzi, Peivand},
  title   = {{Perspectives and Insights on Anti-Amyloid Immunotherapy Agents: From Development to Submission of a New Drug Submission (NDS) in Canada}},
  journal = {Zenodo (CERN European Organization for Nuclear Research)},
  year    = {2026},
  doi     = {10.5281/zenodo.21339386},
  url     = {https://doi.org/10.5281/zenodo.21339386}
}

@article{petrella2026-42747213,
  author  = {Petrella, Jeffrey R. and Barkhof, Frederik and Benzinger, Tammie L.S. and Cogswell, Petrice M. and Franceschi, Ana Marija and Sabbagh, Marwan Noel and Salloway, Stephen and Zaharchuk, Greg and others},
  title   = {{Artificial Intelligence–Based Detection of ARIA on MRI During Alzheimer Disease Therapy: Expert Opinion on Responsible Clinical Integration}},
  journal = {American Journal of Roentgenology},
  year    = {2026},
  doi     = {10.2214/ajr.26.35514},
  pmid    = {42747213},
  url     = {https://doi.org/10.2214/ajr.26.35514}
}

@article{green2025-40856967,
  author  = {Green, Ariel R. and Boyd, Cynthia M. and Quiles, Rosalphie and Daddato, Andrea E. and Gleason, Kathy S. and Taylor-McPhail, Tobie and Wec, Aleksandra and Nothelle, Stephanie K. and others},
  title   = {{Deprescribing for People with Dementia: A Roadmap}},
  journal = {Drugs \& Aging},
  year    = {2025},
  doi     = {10.1007/s40266-025-01238-w},
  pmid    = {40856967},
  url     = {https://doi.org/10.1007/s40266-025-01238-w}
}

@article{brandt2017-28865038,
  author  = {Brandt, J. and Leong, C.},
  title   = {{Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research}},
  journal = {Drugs in R\&D},
  year    = {2017},
  doi     = {10.1007/s40268-017-0207-7},
  pmid    = {28865038},
  url     = {https://doi.org/10.1007/s40268-017-0207-7}
}

@article{steinberg2012-22952071,
  author  = {Steinberg, M. and Lyketsos, C. G.},
  title   = {{Atypical antipsychotic use in patients with dementia: managing safety concerns}},
  journal = {The American journal of psychiatry},
  year    = {2012},
  doi     = {10.1176/appi.ajp.2012.12030342},
  pmid    = {22952071},
  url     = {https://doi.org/10.1176/appi.ajp.2012.12030342}
}

@article{lopezalvarez2019-31866817,
  author  = {López-Álvarez, J. and Sevilla-Llewellyn-Jones, J. and Agüera-Ortiz, L.},
  title   = {{Anticholinergic Drugs in Geriatric Psychopharmacology}},
  journal = {Frontiers in neuroscience},
  year    = {2019},
  doi     = {10.3389/fnins.2019.01309},
  pmid    = {31866817},
  url     = {https://doi.org/10.3389/fnins.2019.01309}
}

@article{hartmann2018-30456350,
  author  = {Hartmann, H. and Hornburg, D. and Czuppa, M. and Bader, J. and Michaelsen, M. and Farny, D. and Arzberger, T. and Mann, M. and others},
  title   = {{Proteomics and C9orf72 neuropathology identify ribosomes as poly-GR/PR interactors driving toxicity}},
  journal = {Life science alliance},
  year    = {2018},
  doi     = {10.26508/lsa.201800070},
  pmid    = {30456350},
  url     = {https://doi.org/10.26508/lsa.201800070}
}

@article{greenberg2025-39794509,
  author  = {Greenberg, S. M. and Bax, F. and van Veluw, S. J.},
  title   = {{Amyloid-related imaging abnormalities: manifestations, metrics and mechanisms}},
  journal = {Nature reviews. Neurology},
  year    = {2025},
  doi     = {10.1038/s41582-024-01053-8},
  pmid    = {39794509},
  url     = {https://doi.org/10.1038/s41582-024-01053-8}
}

@article{cogswell2025-39179297,
  author  = {Cogswell, P. M. and Andrews, T. J. and Barakos, J. A. and Barkhof, F. and Bash, S. and Benayoun, M. D. and Chiang, G. C. and Franceschi, A. M. and others},
  title   = {{Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities}},
  journal = {AJNR. American journal of neuroradiology},
  year    = {2025},
  doi     = {10.3174/ajnr.a8469},
  pmid    = {39179297},
  url     = {https://doi.org/10.3174/ajnr.a8469}
}

@article{boncoraglio2015-25537009,
  author  = {Boncoraglio, G. B. and Piazza, F. and Savoiardo, M. and Farina, L. and DiFrancesco, J. C. and Prioni, S. and Tagliavini, F. and Parati, E. A. and others},
  title   = {{Prodromal Alzheimer's disease presenting as cerebral amyloid angiopathy-related inflammation with spontaneous amyloid-related imaging abnormalities and high cerebrospinal fluid anti-Aβ autoantibodies}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2015},
  doi     = {10.3233/jad-142376},
  pmid    = {25537009},
  url     = {https://doi.org/10.3233/jad-142376}
}

@article{brashear2018-30412493,
  author  = {Brashear, H. R. and Ketter, N. and Bogert, J. and Di, J. and Salloway, S. P. and Sperling, R.},
  title   = {{Clinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III Studies}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2018},
  doi     = {10.3233/jad-180675},
  pmid    = {30412493},
  url     = {https://doi.org/10.3233/jad-180675}
}

@article{ryan2015-25408217,
  author  = {Ryan, N. S. and Lashley, T. and Revesz, T. and Dantu, K. and Fox, N. C. and Morris, H. R.},
  title   = {{Spontaneous ARIA (amyloid-related imaging abnormalities) and cerebral amyloid angiopathy related inflammation in presenilin 1-associated familial Alzheimer's disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2015},
  doi     = {10.3233/jad-142325},
  pmid    = {25408217},
  url     = {https://doi.org/10.3233/jad-142325}
}

@article{pradier2018-30486882,
  author  = {Pradier, L. and Blanchard-Brégeon, V. and Bohme, A. and Debeir, T. and Menager, J. and Benoit, P. and Barneoud, P. and Taupin, V. and others},
  title   = {{SAR228810: an antibody for protofibrillar amyloid β peptide designed to reduce the risk of amyloid-related imaging abnormalities (ARIA)}},
  journal = {Alzheimer's research \& therapy},
  year    = {2018},
  doi     = {10.1186/s13195-018-0447-y},
  pmid    = {30486882},
  url     = {https://doi.org/10.1186/s13195-018-0447-y}
}

@article{francis2025-40940304,
  author  = {Francis, E. and Paylor, S. and Van, C. and Mathews, B. and Sobhanian, M. J. and Mansour, D. Z. and Hennawi, G. and Brandt, N. J.},
  title   = {{Review of anti-amyloid-beta (Aβ) monoclonal antibodies for the treatment of Alzheimer's disease}},
  journal = {Expert review of clinical pharmacology},
  year    = {2025},
  doi     = {10.1080/17512433.2025.2556122},
  pmid    = {40940304},
  url     = {https://doi.org/10.1080/17512433.2025.2556122}
}

@article{guo2025-41107537,
  author  = {Guo, X. and Yue, R. and Cui, Z. and Wang, S. and Jia, T. and Li, W. and Zhang, W. and Shan, L. and others},
  title   = {{Advances of therapeutic strategies for Alzheimer's disease}},
  journal = {Journal of neurology},
  year    = {2025},
  doi     = {10.1007/s00415-025-13456-8},
  pmid    = {41107537},
  url     = {https://doi.org/10.1007/s00415-025-13456-8}
}

@article{thussu2024-39291991,
  author  = {Thussu, S. and Naidu, A. and Manivannan, S. and Grossberg, G. T.},
  title   = {{Profiling aducanumab as a treatment option for Alzheimer's disease: an overview of efficacy, safety and tolerability}},
  journal = {Expert review of neurotherapeutics},
  year    = {2024},
  doi     = {10.1080/14737175.2024.2402058},
  pmid    = {39291991},
  url     = {https://doi.org/10.1080/14737175.2024.2402058}
}

@article{daly2024-39698778,
  author  = {Daly, T. and Olluri, A. and Kurkinen, M.},
  title   = {{Anti-amyloid treatments in Alzheimer's disease: elegance, evidence and ethics}},
  journal = {Advances in clinical and experimental medicine : official organ Wroclaw Medical University},
  year    = {2024},
  doi     = {10.17219/acem/198674},
  pmid    = {39698778},
  url     = {https://doi.org/10.17219/acem/198674}
}

@article{urbach2024-37995736,
  author  = {Urbach, H. and Linn, J. and Hattingen, E. and Fiebach, J.},
  title   = {{Imaging of Amyloid-Related Imaging Abnormalities (ARIA)}},
  journal = {RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin},
  year    = {2024},
  doi     = {10.1055/a-2185-8472},
  pmid    = {37995736},
  url     = {https://doi.org/10.1055/a-2185-8472}
}

@article{luna2018-29502200,
  author  = {Luna, E. and Decker, S. C. and Riddle, D. M. and Caputo, A. and Zhang, B. and Cole, T. and Caswell, C. and Xie, S. X. and others},
  title   = {{Differential α-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity}},
  journal = {Acta neuropathologica},
  year    = {2018},
  doi     = {10.1007/s00401-018-1829-8},
  pmid    = {29502200},
  url     = {https://doi.org/10.1007/s00401-018-1829-8}
}

@article{lorenzo1994-8152488,
  author  = {Lorenzo, A. and Razzaboni, B. and Weir, G. C. and Yankner, B. A.},
  title   = {{Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus}},
  journal = {Nature},
  year    = {1994},
  doi     = {10.1038/368756a0},
  pmid    = {8152488},
  url     = {https://doi.org/10.1038/368756a0}
}

@article{lustbader2004-15087549,
  author  = {Lustbader, J. W. and Cirilli, M. and Lin, C. and Xu, H. W. and Takuma, K. and Wang, N. and Caspersen, C. and Chen, X. and others},
  title   = {{ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease}},
  journal = {Science (New York, N.Y.)},
  year    = {2004},
  doi     = {10.1126/science.1091230},
  pmid    = {15087549},
  url     = {https://doi.org/10.1126/science.1091230}
}

@article{gao2021-33610756,
  author  = {Gao, Huanyao and Tripathi, Utkarsh and Trushin, Sergey and Okromelidze, Lela and Pichurin, Nicholas P and Wei, Lixuan and Zhuang, Yongxian and Wang, Liewei and others},
  title   = {{A genome-wide association study in human lymphoblastoid cells supports safety of mitochondrial complex I inhibitor}},
  journal = {Mitochondrion},
  year    = {2021},
  doi     = {10.1016/j.mito.2021.02.005},
  pmid    = {33610756},
  url     = {https://doi.org/10.1016/j.mito.2021.02.005}
}

@article{praschberger2023-36948206,
  author  = {Praschberger, Roman and Kuenen, Sabine and Schoovaerts, Nils and Kaempf, Natalie and Singh, Jeevanjot and Janssens, Jasper and Swerts, Jef and Nachman, Eliana and others},
  title   = {{Neuronal identity defines α-synuclein and tau toxicity}},
  journal = {Neuron},
  year    = {2023},
  doi     = {10.1016/j.neuron.2023.02.033},
  pmid    = {36948206},
  url     = {https://doi.org/10.1016/j.neuron.2023.02.033}
}

@article{sotoudeh2023-38249159,
  author  = {Sotoudeh, Houman and Alizadeh, Mohammadreza and Shahidi, Ramin and Shobeiri, Parnian and Saadatpour, Zahra and Wheeler, C Austin and Love, Marissa Natelson and Tanwar, Manoj},
  title   = {{Imaging spectrum of amyloid-related imaging abnormalities associated with aducanumab immunotherapy}},
  journal = {Frontiers in radiology},
  year    = {2023},
  doi     = {10.3389/fradi.2023.1305390},
  pmid    = {38249159},
  url     = {https://doi.org/10.3389/fradi.2023.1305390}
}

@article{bu2022-35964196,
  author  = {Bu, Kun and Patel, Devashru and Morris, Robert and Han, Weiru and Umeukeje, Gibret and Zhu, Tianrui and Cheng, Feng},
  title   = {{Dysphagia Risk in Patients Prescribed Rivastigmine: A Systematic Analysis of FDA Adverse Event Reporting System}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2022},
  doi     = {10.3233/jad-220583},
  pmid    = {35964196},
  url     = {https://doi.org/10.3233/jad-220583}
}

@article{nijskens2023-37125555,
  author  = {Nijskens, Charlotte and Henstra, Marieke and Rhodius-Meester, Hanneke and Yasar, Sevil and van Poelgeest, Eveline and Peters, Mike and Muller, Majon},
  title   = {{Cardiovascular Risk Management in Persons with Dementia}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2023},
  doi     = {10.3233/jad-230019},
  pmid    = {37125555},
  url     = {https://doi.org/10.3233/jad-230019}
}

@article{ntsapi2022-40396009,
  author  = {Ntsapi, Claudia M and du Toit, Andre and Loos, Ben},
  title   = {{Favorably against the odds - autophagy control despite advanced amyloid- ß toxicity}},
  journal = {Autophagy reports},
  year    = {2022},
  doi     = {10.1080/27694127.2022.2082631},
  pmid    = {40396009},
  url     = {https://doi.org/10.1080/27694127.2022.2082631}
}

@article{bathini2026-7ec97b6f,
  author  = {Bathini, P. and Schilling, S. and Rahfeld, J. and Holtzman, D. M. and Saido, T. C. and Lemere, C. A.},
  title   = {{Early Binding of Anti-Amyloid Antibodies to CAA Drives Complement Activation, Inflammation and ARIA in Mice}},
  journal = {Molecular neurodegeneration},
  year    = {2026},
  doi     = {10.64898/2026.03.04.709591},
  url     = {https://doi.org/10.64898/2026.03.04.709591}
}

@article{fu2015-25814669,
  author  = {Fu, W. and Shi, D. and Westaway, D. and Jhamandas, J. H.},
  title   = {{Bioenergetic mechanisms in astrocytes may contribute to amyloid plaque deposition and toxicity}},
  journal = {The Journal of biological chemistry},
  year    = {2015},
  doi     = {10.1074/jbc.m114.618157},
  pmid    = {25814669},
  url     = {https://doi.org/10.1074/jbc.m114.618157}
}

@article{tune2001-11584981,
  author  = {Tune, L. E.},
  title   = {{Anticholinergic effects of medication in elderly patients}},
  journal = {The Journal of clinical psychiatry},
  year    = {2001},
  pmid    = {11584981}
}

@article{kester2016-27841049,
  author  = {Kester, Rachel and Unützer, Jürgen and Hogan, Diane and Huang, Hsiang Yu},
  title   = {{Antipsychotic prescribing patterns in a Medicare Advantage population of older individuals with dementia}},
  journal = {Journal of Mental Health},
  year    = {2016},
  doi     = {10.1080/09638237.2016.1244720},
  pmid    = {27841049},
  url     = {https://doi.org/10.1080/09638237.2016.1244720}
}

@article{campbell2009-19554093,
  author  = {Campbell, N. and Boustani, M. and Limbil, T. and Ott, C. and Fox, C. and Maidment, I. and Schubert, C. C. and Munger, S. and others},
  title   = {{The cognitive impact of anticholinergics: a clinical review}},
  journal = {Clinical interventions in aging},
  year    = {2009},
  doi     = {10.2147/cia.s5358},
  pmid    = {19554093},
  url     = {https://doi.org/10.2147/cia.s5358}
}

@article{yan2001-11325798,
  author  = {Yan, J. J. and Cho, J. Y. and Kim, H. S. and Kim, K. L. and Jung, J. S. and Huh, S. O. and Suh, H. W. and Kim, Y. H. and others},
  title   = {{Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid}},
  journal = {British journal of pharmacology},
  year    = {2001},
  doi     = {10.1038/sj.bjp.0704047},
  pmid    = {11325798},
  url     = {https://doi.org/10.1038/sj.bjp.0704047}
}

@article{barakos2022-35542992,
  author  = {Barakos, J. and Purcell, D. and Suhy, J. and Chalkias, S. and Burkett, P. and Marsica Grassi, C. and Castrillo-Viguera, C. and Rubino, I. and others},
  title   = {{Detection and Management of Amyloid-Related Imaging Abnormalities in Patients with Alzheimer's Disease Treated with Anti-Amyloid Beta Therapy}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2022},
  doi     = {10.14283/jpad.2022.21},
  pmid    = {35542992},
  url     = {https://doi.org/10.14283/jpad.2022.21}
}

@article{difrancesco2015-26441825,
  author  = {DiFrancesco, J. C. and Longoni, M. and Piazza, F.},
  title   = {{Anti-Aβ Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer's Disease and Cerebral Amyloid Angiopathy}},
  journal = {Frontiers in neurology},
  year    = {2015},
  doi     = {10.3389/fneur.2015.00207},
  pmid    = {26441825},
  url     = {https://doi.org/10.3389/fneur.2015.00207}
}

@article{sakai2014-25195061,
  author  = {Sakai, K. and Boche, D. and Carare, R. and Johnston, D. and Holmes, C. and Love, S. and Nicoll, J. A.},
  title   = {{Aβ immunotherapy for Alzheimer's disease: effects on apoE and cerebral vasculopathy}},
  journal = {Acta neuropathologica},
  year    = {2014},
  doi     = {10.1007/s00401-014-1340-9},
  pmid    = {25195061},
  url     = {https://doi.org/10.1007/s00401-014-1340-9}
}

@article{yuksel2022-35879846,
  author  = {Yuksel, J. M. and Noviasky, J. and Britton, S.},
  title   = {{Aducanumab for Alzheimer's Disease: Summarized Data From EMERGE, ENGAGE, and PRIME Studies}},
  journal = {The Senior care pharmacist},
  year    = {2022},
  doi     = {10.4140/tcp.n.2022.329},
  pmid    = {35879846},
  url     = {https://doi.org/10.4140/tcp.n.2022.329}
}

@article{filippi2023-37382144,
  author  = {Filippi, M. and Cecchetti, G. and Agosta, F.},
  title   = {{MRI in the new era of antiamyloid mAbs for the treatment of Alzheimer's disease}},
  journal = {Current opinion in neurology},
  year    = {2023},
  doi     = {10.1097/wco.0000000000001177},
  pmid    = {37382144},
  url     = {https://doi.org/10.1097/wco.0000000000001177}
}

@article{genc2012-22523490,
  author  = {Genc, S. and Zadeoglulari, Z. and Fuss, S. H. and Genc, K.},
  title   = {{The adverse effects of air pollution on the nervous system}},
  journal = {Journal of toxicology},
  year    = {2012},
  doi     = {10.1155/2012/782462},
  pmid    = {22523490},
  url     = {https://doi.org/10.1155/2012/782462}
}

@article{schupbach2005-16291886,
  author  = {Schüpbach, W. M. and Chastan, N. and Welter, M. L. and Houeto, J. L. and Mesnage, V. and Bonnet, A. M. and Czernecki, V. and Maltête, D. and others},
  title   = {{Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up}},
  journal = {Journal of neurology, neurosurgery, and psychiatry},
  year    = {2005},
  doi     = {10.1136/jnnp.2005.063206},
  pmid    = {16291886},
  url     = {https://doi.org/10.1136/jnnp.2005.063206}
}

@article{valiyeva2008-18725616,
  author  = {Valiyeva, E. and Herrmann, N. and Rochon, P. A. and Gill, S. S. and Anderson, G. M.},
  title   = {{Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis}},
  journal = {CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne},
  year    = {2008},
  doi     = {10.1503/cmaj.071540},
  pmid    = {18725616},
  url     = {https://doi.org/10.1503/cmaj.071540}
}

@article{rabiei2025-32628a51,
  author  = {Rabiei, K. and Petrella, JR. and Lenhart, S. and Liu, C. and Doraiswamy, P. M. and Hao, W.},
  title   = {{Data-Driven Modeling of Amyloid-beta Targeted Antibodies for Alzheimer’s Disease}},
  journal = {NPJ systems biology and applications},
  year    = {2025},
  doi     = {10.21203/rs.3.rs-6316455/v1},
  url     = {https://doi.org/10.21203/rs.3.rs-6316455/v1}
}

@article{klucken2004-15044495,
  author  = {Klucken, Jochen and Shin, Youngah and Masliah, Eliezer and Hyman, Bradley T. and McLean, Pamela J.},
  title   = {{Hsp70 Reduces α-Synuclein Aggregation and Toxicity}},
  journal = {Journal of Biological Chemistry},
  year    = {2004},
  doi     = {10.1074/jbc.m400255200},
  pmid    = {15044495},
  url     = {https://doi.org/10.1074/jbc.m400255200}
}

@article{reus2016-27133416,
  author  = {Reus, Victor I. and Fochtmann, Laura J. and Eyler, A. Evan and Hilty, Donald M. and Horvitz-Lennon, Marcela V. and Jibson, Michael D. and López, Oscar L. and Mahoney, Jane and others},
  title   = {{The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia}},
  journal = {American Journal of Psychiatry},
  year    = {2016},
  doi     = {10.1176/appi.ajp.2015.173501},
  pmid    = {27133416},
  url     = {https://doi.org/10.1176/appi.ajp.2015.173501}
}

@article{oosthoek2023-37874087,
  author  = {Oosthoek, M. and Lili, A. and Almeida, A. and van Loosbroek, O. and van der Geest, R. and de Greef-van der Sandt, I. and van Bokhoven, P. and Sikkes, S. A. M. and others},
  title   = {{ASURE Clinical Trial Protocol: A Randomized, Placebo-Controlled, Proof-of-Concept Study Aiming to Evaluate Safety and Target Engagement following Administration of TW001 in Early Alzheimer's Disease Patients}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2023},
  doi     = {10.14283/jpad.2023.107},
  pmid    = {37874087},
  url     = {https://doi.org/10.14283/jpad.2023.107}
}

@article{kamble2009-19591523,
  author  = {Kamble, P. and Chen, H. and Sherer, J. T. and Aparasu, R. R.},
  title   = {{Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data}},
  journal = {Drugs \& aging},
  year    = {2009},
  doi     = {10.2165/00002512-200926060-00005},
  pmid    = {19591523},
  url     = {https://doi.org/10.2165/00002512-200926060-00005}
}

@article{dangpiaei2026-41885326,
  author  = {Dangpiaei, S. and Kamal, K. M. and Shoair, O. A. and Al-Mamun, M. A.},
  title   = {{Incidence of amyloid-related imaging abnormalities and health resource utilization in patients with Alzheimer disease receiving monoclonal antibody treatments: A real-world evidence study}},
  journal = {Journal of managed care \& specialty pharmacy},
  year    = {2026},
  doi     = {10.18553/jmcp.2026.32.4.470},
  pmid    = {41885326},
  url     = {https://doi.org/10.18553/jmcp.2026.32.4.470}
}

@article{hafez2026-42084750,
  author  = {Hafez, Mohamed Mahmoud and Abbas, Haidy A. and Shoman, Nabil A. and Soubh, Ayman A. and Aly, Omnia and Sallam, Mohamed F. and Seliem, Mahmoud A. and Malaak, Fady A.},
  title   = {{A new era in neuropharmacology: assessing the efficacy and safety of novel anti-amyloid and non-amyloid drug targets for Alzheimer's disease}},
  journal = {Journal of Neurology},
  year    = {2026},
  doi     = {10.1007/s00415-026-13829-7},
  pmid    = {42084750},
  url     = {https://doi.org/10.1007/s00415-026-13829-7}
}

@article{pagan2025-40939527,
  author  = {Pagán, Fernando and Torres-Yaghi, Yasar A. and Hebron, Michaeline L. and Wilmarth, Barbara and Liu, Xiaoguang and Ahn, Jaeil and Moussa, Charbel},
  title   = {{Safety, tolerability and potential biomarkers of vodobatinib in patients with dementia with Lewy bodies}},
  journal = {Parkinsonism \& Related Disorders},
  year    = {2025},
  doi     = {10.1016/j.parkreldis.2025.108020},
  pmid    = {40939527},
  url     = {https://doi.org/10.1016/j.parkreldis.2025.108020}
}

@article{gharibyan2020-31947546,
  author  = {Gharibyan, Anna L and Islam, Tohidul and Pettersson, Nina and Golchin, Solmaz A and Lundgren, Johanna and Johansson, Gabriella and Genot, Mélany and Schultz, Nina and others},
  title   = {{Apolipoprotein E Interferes with IAPP Aggregation and Protects Pericytes from IAPP-Induced Toxicity}},
  journal = {Biomolecules},
  year    = {2020},
  doi     = {10.3390/biom10010134},
  pmid    = {31947546},
  url     = {https://doi.org/10.3390/biom10010134}
}

@article{mohammad2017-28678552,
  author  = {Mohammad, Dana and Chan, Parco and Bradley, Janelle and Lanctôt, Krista and Herrmann, Nathan},
  title   = {{Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation}},
  journal = {Expert opinion on drug safety},
  year    = {2017},
  doi     = {10.1080/14740338.2017.1351540},
  pmid    = {28678552},
  url     = {https://doi.org/10.1080/14740338.2017.1351540}
}

@article{zhang2018-30349215,
  author  = {Zhang, Nan and Gordon, Marc L},
  title   = {{Clinical efficacy and safety of donepezil in the treatment of Alzheimer's disease in Chinese patients}},
  journal = {Clinical interventions in aging},
  year    = {2018},
  doi     = {10.2147/cia.s159920},
  pmid    = {30349215},
  url     = {https://doi.org/10.2147/cia.s159920}
}

@article{wen2019-31724518,
  author  = {Wen, Jinhua and Sawmiller, Darrell and Wheeldon, Brendan and Tan, Jun},
  title   = {{A Review for Lithium: Pharmacokinetics, Drug Design, and Toxicity}},
  journal = {CNS \& neurological disorders drug targets},
  year    = {2019},
  doi     = {10.2174/1871527318666191114095249},
  pmid    = {31724518},
  url     = {https://doi.org/10.2174/1871527318666191114095249}
}

@article{ferinistrambi2020-32025925,
  author  = {Ferini-Strambi, Luigi and Galbiati, Andrea and Casoni, Francesca and Salsone, Maria},
  title   = {{Therapy for Insomnia and Circadian Rhythm Disorder in Alzheimer Disease}},
  journal = {Current treatment options in neurology},
  year    = {2020},
  doi     = {10.1007/s11940-020-0612-z},
  pmid    = {32025925},
  url     = {https://doi.org/10.1007/s11940-020-0612-z}
}

@article{bailey2018-29409574,
  author  = {Bailey, Trista Askins and Panjwani, Sehrish},
  title   = {{Atypical Antipsychotics in Late-Life and Treatment-Resistant Depression}},
  journal = {The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists},
  year    = {2018},
  doi     = {10.4140/tcp.n.2018.83},
  pmid    = {29409574},
  url     = {https://doi.org/10.4140/tcp.n.2018.83}
}

@article{polinski2007-17485754,
  author  = {Polinski, Jennifer M. and Wang, Philip S. and Fischer, Michael A.},
  title   = {{Medicaid’s Prior Authorization Program And Access To Atypical Antipsychotic Medications}},
  journal = {Health Affairs},
  year    = {2007},
  doi     = {10.1377/hlthaff.26.3.750},
  pmid    = {17485754},
  url     = {https://doi.org/10.1377/hlthaff.26.3.750}
}

@article{finn2025-41260674,
  author  = {Finn, Quentin and Pascual, Belén and Schulz, Paul E. and Masdeu, Joseph C.},
  title   = {{β-Amyloid PET Signal Reduction in Prior ARIA-E Regions after Antiamyloid Therapy for Alzheimer Disease}},
  journal = {American Journal of Neuroradiology},
  year    = {2025},
  doi     = {10.3174/ajnr.a9111},
  pmid    = {41260674},
  url     = {https://doi.org/10.3174/ajnr.a9111}
}

@article{han2025-cbaaba6e,
  author  = {Han, Jayoung and Fang, Yuan and Campbell, Nicole},
  title   = {{Real-world safety profile of lecanemab: A disproportionality analysis of adverse events in the FDA adverse event reporting system}},
  journal = {JAPhA Pharmacotherapy},
  year    = {2025},
  doi     = {10.1016/j.japhar.2025.100015},
  url     = {https://doi.org/10.1016/j.japhar.2025.100015}
}

@article{serban2025-41433268,
  author  = {Serban, Alina‐Irina and Horrocks, Sophie and Walsh, Chloe and Harrison, Matthew and Soreq, Eyal and Marzuki, Amer and Woodbridge, Mark and Nilforooshan, Ramin and others},
  title   = {{Monitoring night‐time safety in households with dementia using ambient sensing technologies: a rule‐based decision algorithm}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70863_110614},
  pmid    = {41433268},
  url     = {https://doi.org/10.1002/alz70863_110614}
}

@article{smith2017-27940601,
  author  = {Smith, L. M. and Strittmatter, S. M.},
  title   = {{Binding Sites for Amyloid-β Oligomers and Synaptic Toxicity}},
  journal = {Cold Spring Harbor perspectives in medicine},
  year    = {2017},
  doi     = {10.1101/cshperspect.a024075},
  pmid    = {27940601},
  url     = {https://doi.org/10.1101/cshperspect.a024075}
}

@article{aisen2020-32463066,
  author  = {Aisen, P. S. and Cummings, J. and Doody, R. and Kramer, L. and Salloway, S. and Selkoe, D. J. and Sims, J. and Sperling, R. A. and others},
  title   = {{The Future of Anti-Amyloid Trials}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2020},
  doi     = {10.14283/jpad.2020.24},
  pmid    = {32463066},
  url     = {https://doi.org/10.14283/jpad.2020.24}
}

@article{heuer2017-28269776,
  author  = {Heuer, E. and Jacobs, J. and Du, R. and Wang, S. and Keifer, O. P. and Cintron, A. F. and Dooyema, J. and Meng, Y. and others},
  title   = {{Amyloid-Related Imaging Abnormalities in an Aged Squirrel Monkey with Cerebral Amyloid Angiopathy}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2017},
  doi     = {10.3233/jad-160981},
  pmid    = {28269776},
  url     = {https://doi.org/10.3233/jad-160981}
}

@article{mostafalou2017-27722929,
  author  = {Mostafalou, S. and Abdollahi, M.},
  title   = {{Pesticides: an update of human exposure and toxicity}},
  journal = {Archives of toxicology},
  year    = {2017},
  doi     = {10.1007/s00204-016-1849-x},
  pmid    = {27722929},
  url     = {https://doi.org/10.1007/s00204-016-1849-x}
}

@article{dong2020-31680350,
  author  = {Dong, X. and Zeng, Y. and Liu, Y. and You, L. and Yin, X. and Fu, J. and Ni, J.},
  title   = {{Aloe-emodin: A review of its pharmacology, toxicity, and pharmacokinetics}},
  journal = {Phytotherapy research : PTR},
  year    = {2020},
  doi     = {10.1002/ptr.6532},
  pmid    = {31680350},
  url     = {https://doi.org/10.1002/ptr.6532}
}

@article{huat2019-30664867,
  author  = {Huat, T. J. and Camats-Perna, J. and Newcombe, E. A. and Valmas, N. and Kitazawa, M. and Medeiros, R.},
  title   = {{Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation}},
  journal = {Journal of molecular biology},
  year    = {2019},
  doi     = {10.1016/j.jmb.2019.01.018},
  pmid    = {30664867},
  url     = {https://doi.org/10.1016/j.jmb.2019.01.018}
}

@article{daiello2007-17633594,
  author  = {Daiello, Lori A},
  title   = {{Atypical antipsychotics for the treatment of dementia-related behaviors: an update}},
  journal = {Medicine and health, Rhode Island},
  year    = {2007},
  pmid    = {17633594}
}

@article{simmons2016-27235760,
  author  = {Simmons, Sandra F and Schnelle, John F and Sathe, Nila A and Slagle, Jason M and Stevenson, David G and Carlo, Maria E and McPheeters, Melissa L},
  title   = {{Defining Safety in the Nursing Home Setting: Implications for Future Research}},
  journal = {Journal of the American Medical Directors Association},
  year    = {2016},
  doi     = {10.1016/j.jamda.2016.03.005},
  pmid    = {27235760},
  url     = {https://doi.org/10.1016/j.jamda.2016.03.005}
}

@article{hyemin2026-42449395,
  author  = {Hyemin, Jang and Woo, Kim Jae and Won, Hwang Jung and Da Woon, Jeong and Jeongeun, Ka and Da Min, Kang and Hyun, Suh Chong and Yangsean, Choi and others},
  title   = {{Real-world safety and implementation challenges of lecanemab therapy for Alzheimer's disease in South Korea: a single-center experience}},
  journal = {Alzheimer's research \& therapy},
  year    = {2026},
  doi     = {10.1186/s13195-026-02141-1},
  pmid    = {42449395},
  url     = {https://doi.org/10.1186/s13195-026-02141-1}
}

@article{thakurathi2012-22730476,
  author  = {Thakurathi, Neelam and Henderson, David C.},
  title   = {{Atypical antipsychotics are associated with incident diabetes in older adults without schizophrenia or bipolar disorder}},
  journal = {Evidence-Based Mental Health},
  year    = {2012},
  doi     = {10.1136/ebmental-2012-100740},
  pmid    = {22730476},
  url     = {https://doi.org/10.1136/ebmental-2012-100740}
}

@article{carr2022-36730660,
  author  = {Carr, Danielle N. and Macharia, Annliz and Hacker, Michele R. and Winkelman, William D.},
  title   = {{Despite Recommendations, Anticholinergics Account for the Majority of Prescriptions to Treat Overactive Bladder in the United States}},
  journal = {Urogynecology},
  year    = {2022},
  doi     = {10.1097/spv.0000000000001301},
  pmid    = {36730660},
  url     = {https://doi.org/10.1097/spv.0000000000001301}
}

@article{hendriks2026-4ee39e2d,
  author  = {Hendriks, J. and Antoniou, M. and Babic, I.},
  title   = {{Anti-Amyloid Monoclonal Antibodies and Amyloid-Related Imaging Abnormalities in Early Alzheimer Disease}},
  journal = {Zenodo (CERN European Organization for Nuclear Research)},
  year    = {2026},
  doi     = {10.5281/zenodo.22310606},
  url     = {https://doi.org/10.5281/zenodo.22310606}
}

@article{bilim2025-b898356f,
  author  = {Bilim, Atiye},
  title   = {{Demographic Analysis of Occupational Safety in the Construction Sector: Strategies and Insights for Risk Reduction}},
  journal = {Buildings},
  year    = {2025},
  doi     = {10.3390/buildings15040528},
  url     = {https://doi.org/10.3390/buildings15040528}
}

@article{bangerter2025-40903180,
  author  = {Bangerter, Lauren R. and Fong, Allan and Zabala, Garrett and Kim, Yijung K. and Tabaie, Azade and Werner, Nicole E. and De Jonge, Karl Eric and Ratwani, Raj M.},
  title   = {{Artificial intelligence approach to optimise safety for hospitalised patients with dementia}},
  journal = {BMJ Open Quality},
  year    = {2025},
  doi     = {10.1136/bmjoq-2024-003270},
  pmid    = {40903180},
  url     = {https://doi.org/10.1136/bmjoq-2024-003270}
}

@article{berger2006-16368705,
  author  = {Berger, Z. and Ravikumar, B. and Menzies, F. M. and Oroz, L. G. and Underwood, B. R. and Pangalos, M. N. and Schmitt, I. and Wullner, U. and others},
  title   = {{Rapamycin alleviates toxicity of different aggregate-prone proteins}},
  journal = {Human molecular genetics},
  year    = {2006},
  doi     = {10.1093/hmg/ddi458},
  pmid    = {16368705},
  url     = {https://doi.org/10.1093/hmg/ddi458}
}

@article{lanedonovan2015-26152694,
  author  = {Lane-Donovan, C. and Philips, G. T. and Wasser, C. R. and Durakoglugil, M. S. and Masiulis, I. and Upadhaya, A. and Pohlkamp, T. and Coskun, C. and others},
  title   = {{Reelin protects against amyloid β toxicity in vivo}},
  journal = {Science signaling},
  year    = {2015},
  doi     = {10.1126/scisignal.aaa6674},
  pmid    = {26152694},
  url     = {https://doi.org/10.1126/scisignal.aaa6674}
}

@article{stlaurentthibault2011-21605049,
  author  = {St-Laurent-Thibault, C. and Arseneault, M. and Longpré, F. and Ramassamy, C.},
  title   = {{Tyrosol and hydroxytyrosol, two main components of olive oil, protect N2a cells against amyloid-β-induced toxicity. Involvement of the NF-κB signaling}},
  journal = {Current Alzheimer research},
  year    = {2011},
  doi     = {10.2174/156720511796391845},
  pmid    = {21605049},
  url     = {https://doi.org/10.2174/156720511796391845}
}

@article{davies2015-25619317,
  author  = {Davies, E. A. and O'Mahony, M. S.},
  title   = {{Adverse drug reactions in special populations - the elderly}},
  journal = {British journal of clinical pharmacology},
  year    = {2015},
  doi     = {10.1111/bcp.12596},
  pmid    = {25619317},
  url     = {https://doi.org/10.1111/bcp.12596}
}

@article{alexopoulos2004-14994733,
  author  = {Alexopoulos, G. S. and Streim, J. and Carpenter, D. and Docherty, J. P. and {Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients}},
  title   = {{Using antipsychotic agents in older patients}},
  journal = {The Journal of clinical psychiatry},
  year    = {2004},
  pmid    = {14994733}
}

@article{airagnes2016-27549604,
  author  = {Airagnes, G. and Pelissolo, A. and Lavallée, M. and Flament, M. and Limosin, F.},
  title   = {{Benzodiazepine Misuse in the Elderly: Risk Factors, Consequences, and Management}},
  journal = {Current psychiatry reports},
  year    = {2016},
  doi     = {10.1007/s11920-016-0727-9},
  pmid    = {27549604},
  url     = {https://doi.org/10.1007/s11920-016-0727-9}
}

@article{diamond2000-10807109,
  author  = {Diamond, B. J. and Shiflett, S. C. and Feiwel, N. and Matheis, R. J. and Noskin, O. and Richards, J. A. and Schoenberger, N. E.},
  title   = {{Ginkgo biloba extract: mechanisms and clinical indications}},
  journal = {Archives of physical medicine and rehabilitation},
  year    = {2000},
  doi     = {10.1016/s0003-9993(00)90052-2},
  pmid    = {10807109},
  url     = {https://doi.org/10.1016/s0003-9993(00)90052-2}
}

@article{pauwels2012-22157754,
  author  = {Pauwels, K. and Williams, T. L. and Morris, K. L. and Jonckheere, W. and Vandersteen, A. and Kelly, G. and Schymkowitz, J. and Rousseau, F. and others},
  title   = {{Structural basis for increased toxicity of pathological aβ42:aβ40 ratios in Alzheimer disease}},
  journal = {The Journal of biological chemistry},
  year    = {2012},
  doi     = {10.1074/jbc.m111.264473},
  pmid    = {22157754},
  url     = {https://doi.org/10.1074/jbc.m111.264473}
}

@article{piazza2016-27031492,
  author  = {Piazza, F. and Winblad, B.},
  title   = {{Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers?}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2016},
  doi     = {10.3233/jad-160122},
  pmid    = {27031492},
  url     = {https://doi.org/10.3233/jad-160122}
}

@article{yang2015-25860060,
  author  = {Yang, C. and Xiao, S.},
  title   = {{New developments of clinical trial in immunotherapy for Alzheimer's disease}},
  journal = {Current pharmaceutical biotechnology},
  year    = {2015},
  doi     = {10.2174/138920101606150407112319},
  pmid    = {25860060},
  url     = {https://doi.org/10.2174/138920101606150407112319}
}

@article{valko2005-15892631,
  author  = {Valko, M. and Morris, H. and Cronin, M. T.},
  title   = {{Metals, toxicity and oxidative stress}},
  journal = {Current medicinal chemistry},
  year    = {2005},
  doi     = {10.2174/0929867053764635},
  pmid    = {15892631},
  url     = {https://doi.org/10.2174/0929867053764635}
}

@article{boisselier2009-19587967,
  author  = {Boisselier, E. and Astruc, D.},
  title   = {{Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity}},
  journal = {Chemical Society reviews},
  year    = {2009},
  doi     = {10.1039/b806051g},
  pmid    = {19587967},
  url     = {https://doi.org/10.1039/b806051g}
}

@article{bieschke2010-20385841,
  author  = {Bieschke, J. and Russ, J. and Friedrich, R. P. and Ehrnhoefer, D. E. and Wobst, H. and Neugebauer, K. and Wanker, E. E.},
  title   = {{EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity}},
  journal = {Proceedings of the National Academy of Sciences of the United States of America},
  year    = {2010},
  doi     = {10.1073/pnas.0910723107},
  pmid    = {20385841},
  url     = {https://doi.org/10.1073/pnas.0910723107}
}

@article{sakono2010-20148964,
  author  = {Sakono, M. and Zako, T.},
  title   = {{Amyloid oligomers: formation and toxicity of Abeta oligomers}},
  journal = {The FEBS journal},
  year    = {2010},
  doi     = {10.1111/j.1742-4658.2010.07568.x},
  pmid    = {20148964},
  url     = {https://doi.org/10.1111/j.1742-4658.2010.07568.x}
}

@article{behl1994-8004671,
  author  = {Behl, C. and Davis, J. B. and Lesley, R. and Schubert, D.},
  title   = {{Hydrogen peroxide mediates amyloid beta protein toxicity}},
  journal = {Cell},
  year    = {1994},
  doi     = {10.1016/0092-8674(94)90131-7},
  pmid    = {8004671},
  url     = {https://doi.org/10.1016/0092-8674(94)90131-7}
}

@article{stefani2003-12942175,
  author  = {Stefani, M. and Dobson, C. M.},
  title   = {{Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution}},
  journal = {Journal of molecular medicine (Berlin, Germany)},
  year    = {2003},
  doi     = {10.1007/s00109-003-0464-5},
  pmid    = {12942175},
  url     = {https://doi.org/10.1007/s00109-003-0464-5}
}

@article{reeve2015-26338170,
  author  = {Reeve, E. and Bell, J. S. and Hilmer, S. N.},
  title   = {{Barriers to Optimising Prescribing and Deprescribing in Older Adults with Dementia: A Narrative Review}},
  journal = {Current clinical pharmacology},
  year    = {2015},
  doi     = {10.2174/157488471003150820150330},
  pmid    = {26338170},
  url     = {https://doi.org/10.2174/157488471003150820150330}
}

@article{kolanowski2006-17010825,
  author  = {Kolanowski, A. and Fick, D. and Waller, J. L. and Ahern, F.},
  title   = {{Outcomes of antipsychotic drug use in community-dwelling elders with dementia}},
  journal = {Archives of psychiatric nursing},
  year    = {2006},
  doi     = {10.1016/j.apnu.2006.04.004},
  pmid    = {17010825},
  url     = {https://doi.org/10.1016/j.apnu.2006.04.004}
}

@article{jacobsen2015-e319eb2f,
  author  = {Jacobsen, Frederick M.},
  title   = {{Second-Generation Antipsychotics and Tardive Syndromes in Affective Illness: A Public Health Problem With Neuropsychiatric Consequences}},
  journal = {American Journal of Public Health},
  year    = {2015},
  doi     = {10.2105/ajph.2014.302439},
  url     = {https://doi.org/10.2105/ajph.2014.302439}
}

@article{hoilundcarlsen2022-35452007,
  author  = {Høilund-Carlsen, P. F. and Werner, T. J. and Alavi, A. and Revheim, M. E.},
  title   = {{Aducanumab-Related Amyloid-Related Imaging Abnormalities: Paean or Lament?}},
  journal = {Clinical nuclear medicine},
  year    = {2022},
  doi     = {10.1097/rlu.0000000000004250},
  pmid    = {35452007},
  url     = {https://doi.org/10.1097/rlu.0000000000004250}
}

@article{muralidharan2022-35285968,
  author  = {Muralidharan, K. K. and Karumanchi, S. and Kowalski, K. G. and Burkett, P. and Chapel, S. and Rajagovindan, R. and Nestorov, I.},
  title   = {{A Time-to-Event Exposure-Response Model for Amyloid-Related Imaging Abnormalities Following Administration of Aducanumab to Subjects With Early Alzheimer Disease}},
  journal = {Journal of clinical pharmacology},
  year    = {2022},
  doi     = {10.1002/jcph.2047},
  pmid    = {35285968},
  url     = {https://doi.org/10.1002/jcph.2047}
}

@article{hajibandeh2026-42025961,
  author  = {Hajibandeh, S. and Tao, Y. A. and Hsieh, M. H. and Liu, H. G. and Cheng, Y. F. and Lee, K. H. and Hsieh, S. Y. and Lu, C. H.},
  title   = {{Semaglutide for obesity management: A narrative review of efficacy, safety, and future directions}},
  journal = {Journal of the American Pharmacists Association : JAPhA},
  year    = {2026},
  doi     = {10.1016/j.japh.2026.103117},
  pmid    = {42025961},
  url     = {https://doi.org/10.1016/j.japh.2026.103117}
}

@article{lemere2025-41434072,
  author  = {Lemere, Cynthia Ann},
  title   = {{Mouse models for studying anti‐amyloid antibody‐induced ARIA}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70861_108865},
  pmid    = {41434072},
  url     = {https://doi.org/10.1002/alz70861_108865}
}

@article{ameen2025-2abd646d,
  author  = {Ameen, Taha Basit and Ali, Umair and Salma, Omme and Samee, Muhammad Abdul and Abbas, Syed Muhammad Iraj and Kashif, Syeda Naveera and Arifi, Muhammad Arif and Ali, Mashooque and others},
  title   = {{Amyloid solutions: lecanemab, gantenerumab, and donanemab in the treatment of Alzheimer's disease}},
  journal = {The Egyptian Journal of Neurology Psychiatry and Neurosurgery},
  year    = {2025},
  doi     = {10.1186/s41983-025-00968-3},
  url     = {https://doi.org/10.1186/s41983-025-00968-3}
}

@article{das2025-40639927,
  author  = {Das, S.K.},
  title   = {{Alzheimer’s disease basics: we all should know}},
  journal = {Neurological Research},
  year    = {2025},
  doi     = {10.1080/01616412.2025.2529560},
  pmid    = {40639927},
  url     = {https://doi.org/10.1080/01616412.2025.2529560}
}

@article{catalan2025-40188439,
  author  = {Catalán, Lucía and Oliveira, Déborah},
  title   = {{Preventable adverse events and related outcomes among people with dementia in hospital settings: scoping review}},
  journal = {Aging \& Mental Health},
  year    = {2025},
  doi     = {10.1080/13607863.2025.2484355},
  pmid    = {40188439},
  url     = {https://doi.org/10.1080/13607863.2025.2484355}
}

@article{pradier2013-c5f3311d,
  author  = {Pradier, Laurent and Cohen, Caroline and Blanchard, Veronique and Debeir, Thomas and Barnéoud, Pascal and Canton, Thierry and Ménager, Jean and Bohme, Andrees and others},
  title   = {{P4–285: SAR228810: An antiprotofibrillar beta‐amyloid antibody designed to reduce risk of amyloid‐related imaging abnormalities (ARIA)}},
  journal = {Alzheimer s \& Dementia},
  year    = {2013},
  doi     = {10.1016/j.jalz.2013.05.1678},
  url     = {https://doi.org/10.1016/j.jalz.2013.05.1678}
}

@article{nahal2026-41810890,
  author  = {Nahal, Danica Juričić and Mas, Petar and Cegec, Ivana and Bego, Margareta and Domjanović, Iva Klarica},
  title   = {{Anti‐amyloid antibodies in Europe: Where are we now?}},
  journal = {British Journal of Clinical Pharmacology},
  year    = {2026},
  doi     = {10.1002/bcp.70526},
  pmid    = {41810890},
  url     = {https://doi.org/10.1002/bcp.70526}
}

@article{masdeu2026-cc666680,
  author  = {Masdeu, Joseph and Finn, Quentin and Schulz, Paul and Pascual, Belén},
  title   = {{β-amyloid PET Signal Reduction in Regions with ARIA-E Following Anti-amyloid Therapy for Alzheimer Disease (P1-12.010)}},
  journal = {Neurology},
  year    = {2026},
  doi     = {10.1212/wnl.0000000000215645},
  url     = {https://doi.org/10.1212/wnl.0000000000215645}
}

@article{trushin2025-41450141,
  author  = {Trushin, Sergey A. and Ostroot, Mark A. and Trushina, Eugenia V.},
  title   = {{Partial Mitochondrial Complex I Inhibitors as a Therapy for Alzheimer Disease}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70859_105252},
  pmid    = {41450141},
  url     = {https://doi.org/10.1002/alz70859_105252}
}

@article{okoli2020-06e6a89b,
  author  = {Okoli, U and Kent, June Gooch and Gadhia, Sanket R.},
  title   = {{65 Improving Medicines Safety for Care Homes Residents}},
  journal = {Age and Ageing},
  year    = {2020},
  doi     = {10.1093/ageing/afz187.06},
  url     = {https://doi.org/10.1093/ageing/afz187.06}
}

@article{greenberg2025-74e40508,
  author  = {Greenberg, S.},
  title   = {{Vascular Considerations for Patients Receiving Amyloid Immunotherapy}},
  journal = {Innovation in Aging},
  year    = {2025},
  doi     = {10.1093/geroni/igaf122.1009},
  url     = {https://doi.org/10.1093/geroni/igaf122.1009}
}

@article{scrandis2019-30672861,
  author  = {Scrandis, Debra A. and Duarte, Ana Catarina},
  title   = {{Deprescribing benzodiazepines}},
  journal = {The Nurse Practitioner},
  year    = {2019},
  doi     = {10.1097/01.npr.0000550253.04526.30},
  pmid    = {30672861},
  url     = {https://doi.org/10.1097/01.npr.0000550253.04526.30}
}

@article{patel2026-08718bfc,
  author  = {Patel, Princy and Rana, Aarti and Pansuria, Mayur and Patel, Rutvik and Patel, Hemangini and Pirouzi, Peivand},
  title   = {{Perspectives and Insights on Anti-Amyloid Immunotherapy Agents: From Development to Submission of a New Drug Submission (NDS) in Canada}},
  journal = {Zenodo (CERN European Organization for Nuclear Research)},
  year    = {2026},
  doi     = {10.5281/zenodo.21339385},
  url     = {https://doi.org/10.5281/zenodo.21339385}
}

@article{study2025-41130241,
  title   = {{Neue Alzheimer-Therapien: Vortrag zu ARIA für eine sichere MRT-Diagnostik}},
  journal = {RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren},
  year    = {2025},
  doi     = {10.1055/a-2690-5210},
  pmid    = {41130241},
  url     = {https://doi.org/10.1055/a-2690-5210}
}

@article{study2025-41130242,
  title   = {{Interview – Interview zum Thema: Neue Alzheimer-Therapien: Warum Radiolog:innen ARIA kennen müssen}},
  journal = {RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren},
  year    = {2025},
  doi     = {10.1055/a-2690-4869},
  pmid    = {41130242},
  url     = {https://doi.org/10.1055/a-2690-4869}
}

@article{shi2025-63a87f31,
  author  = {Shi, Zihan and Xiang, Jinwei},
  title   = {{The Impact of Immunotherapy Drugs on the Human Nervous System}},
  journal = {MedScien},
  year    = {2025},
  doi     = {10.61173/mz7bfr42},
  url     = {https://doi.org/10.61173/mz7bfr42}
}

@article{carter2020-26f00cc1,
  author  = {Carter, Elizabeth Jeanne and Tan, Erwin J.},
  title   = {{Concomitant Cholinesterase Inhibitor and Anticholinergic Drug Use Among Older Adults With Dementia}},
  journal = {Innovation in Aging},
  year    = {2020},
  doi     = {10.1093/geroni/igaa057.842},
  url     = {https://doi.org/10.1093/geroni/igaa057.842}
}

@article{pescatore2024-7d44db82,
  author  = {Pescatore, Richard M.},
  title   = {{The Devastation of Falls among Older Patients}},
  journal = {Emergency Medicine News},
  year    = {2024},
  doi     = {10.1097/01.eem.0001024224.26476.2b},
  url     = {https://doi.org/10.1097/01.eem.0001024224.26476.2b}
}

@article{nakai2026-ba303595,
  author  = {Nakai, T. and Koseki, T. and Watanabe, H. and Yamada, S.},
  title   = {{Drug-Drug Interaction Signals Between Anti-Amyloid-β Antibodies and Antithrombotic Drugs for Amyloid-Related Imaging Abnormalities and Intracranial Hemorrhage: A FAERS Disproportionality Analysis}},
  journal = {medRxiv (preprint)},
  year    = {2026},
  doi     = {10.64898/2026.09.08.26362402},
  url     = {https://doi.org/10.64898/2026.09.08.26362402}
}

@article{rafieirezvani2026-50b7bf22,
  author  = {Rafiei Rezvani, F. and Azimi, D. and Nekouei, A. H. and Kim, H. and Sauer, C. C. and Wharton, W. and Qiu, D. and Goldstein and others},
  title   = {{Feasibility, Safety, and Preliminary Efficacy of Partnered Rhythmic Rehabilitation in Prodromal Alzheimer's Disease: A 12-Month Pilot Randomized Controlled Trial}},
  journal = {medRxiv (preprint)},
  year    = {2026},
  doi     = {10.64898/2026.09.11.26362767},
  url     = {https://doi.org/10.64898/2026.09.11.26362767}
}

@article{venturaantunes2026-4f28fca6,
  author  = {Ventura-Antunes, L. and Janve, V. A. and Womble, N. and Weasler, C. J. and Hai, S. A. and Brula, H. and Mobley, B. C. and Hohman, T. J. and others},
  title   = {{Serpin A3 is Increased in Cerebral Amyloid Angiopathy and ARIA}},
  journal = {bioRxiv},
  year    = {2026},
  doi     = {10.64898/2026.10.19.759840},
  url     = {https://doi.org/10.64898/2026.10.19.759840}
}

@article{basile2026-35f2647e,
  author  = {Basile, S. and Schipper, F. and Zimbone, S. and Vermorgen, S. M. and Bellia, F. and Parisi, C. and Sortino, S. and Walter, J. and others},
  title   = {{Mapping post-translational modifications across amyloid-β deposits in Alzheimer’s disease: A neuropathologic survey with in vitro functional analysis of nitration}},
  journal = {Research Square},
  year    = {2026},
  doi     = {10.21203/rs.3.rs-10769225/v1},
  url     = {https://doi.org/10.21203/rs.3.rs-10769225/v1}
}

@article{rezaii2026-4202aa20,
  author  = {Rezaii, N. and Dickson, JR. and Ford, J. N. and He, Y. and Katsumi, Y. and Ramirez-Gomez, L. and Lam, A. and Shah, H. and others},
  title   = {{Real-World Characterization of Amyloid-Related Imaging Abnormalities (ARIA) in Lecanemab Treatment at an Academic Health System}},
  journal = {medRxiv},
  year    = {2026},
  doi     = {10.64898/2026.01.23.26344739},
  url     = {https://doi.org/10.64898/2026.01.23.26344739}
}

@article{pallerla2026-922ec944,
  author  = {Pallerla, A. V. and Lucido, C. C. and Saito, K. and Nolt, G. L. and Arbones-Mainar, J. M. and Funnell, J. L. and Satish, D. and Smith, L. M. and others},
  title   = {{Anti-amyloid immunotherapy drives APOE4 specific increases in glial reactivity, perivascular immune activation, and ARIA-like events}},
  journal = {bioRxiv},
  year    = {2026},
  doi     = {10.64898/2026.06.26.734793},
  url     = {https://doi.org/10.64898/2026.06.26.734793}
}

@article{hill2026-16617b5e,
  author  = {Hill, C. and Morgan, H. and Michopoulou, S. and Niranjan, M. and Kipps, C. M.},
  title   = {{Dynamic Imaging Markers of ARIA-H Risk in the A4 Study: A Person-Interval Analysis of Current Lesion Burden and Recent Microhaemorrhage Activity}},
  journal = {medRxiv},
  year    = {2026},
  doi     = {10.64898/2026.05.30.26354521},
  url     = {https://doi.org/10.64898/2026.05.30.26354521}
}

@article{low2026-23d6501e,
  author  = {Low, Z. X. B. and Rowsthorn, E. and Nazem-Zadeh, M. and Francis, M. and Robb, C. and Whiriskey, R. and Howcroft, M. and Brodtmann, A. and others},
  title   = {{Automated quantification of cerebral microbleeds for ARIA-H monitoring in Aging and Alzheimer’s Disease: A multicenter deep learning validation}},
  journal = {medRxiv},
  year    = {2026},
  doi     = {10.64898/2026.05.19.26353364},
  url     = {https://doi.org/10.64898/2026.05.19.26353364}
}

@article{pikus2026-5846ffcd,
  author  = {Pikus, P. and Healey, G. S. and Xia, E. and Shautidze, G. and Siddapureddy, N. and Lee, Y. and Albanese, C. and Rodriguez, O. and others},
  title   = {{Intravenous anti-Aβ immunotherapy acutely increases cerebral amyloid angiopathy and vascular damages in APOE4 mice}},
  journal = {bioRxiv},
  year    = {2026},
  doi     = {10.64898/2026.02.09.704876},
  url     = {https://doi.org/10.64898/2026.02.09.704876}
}

@article{pittonrissardo2025-7b94959b,
  author  = {Pitton Rissardo, J. and Fornari Caprara, A. L.},
  title   = {{A Biophysical Framework for Neurodegeneration: Prioritizing Protein Homeostasis Over Aggregate Toxicity}},
  journal = {Preprints.org},
  year    = {2025},
  doi     = {10.20944/preprints202512.2722.v1},
  url     = {https://doi.org/10.20944/preprints202512.2722.v1}
}

@article{curd2025-b62fc105,
  author  = {Curd, B. C. and Zubrick, C. and Cliatt Brown, C. J. and Sorweid, M. K. and Dehoney, S. B. and Anzai, Y. and Minoshima, S. and Parks, A. L. and others},
  title   = {{Real-world experience with lecanemab therapy for Alzheimer’s disease in the Intermountain West}},
  journal = {medRxiv},
  year    = {2025},
  doi     = {10.1101/2025.09.30.25337002},
  url     = {https://doi.org/10.1101/2025.09.30.25337002}
}

@article{yadav2026-d0da0ad5,
  author  = {Yadav, D. K. and Connor, C. W. and Gabel, C. V.},
  title   = {{Early Amyloid-β Toxicity Disrupts Nervous System Connectivity During Aging in Caenorhabditis elegans}},
  journal = {bioRxiv},
  year    = {2026},
  doi     = {10.64898/2026.07.27.740981},
  url     = {https://doi.org/10.64898/2026.07.27.740981}
}

@article{wagner2026-f7d2ca48,
  author  = {Wagner, S. and Haigis, D. and Bilc, M. and Beiner, E. and Nieß, A. M. and Fallgatter, A. J. and Eschweiler, G. W. and Krauß, I. and others},
  title   = {{The effectiveness and safety of high-intensity interval training, yoga and intermittent hypoxia-hyperoxia exposure on cognitive performance and health in individuals with mild cognitive impairment (KAYH): a study protocol for a randomized, sham-controlled trial}},
  journal = {medRxiv},
  year    = {2026},
  doi     = {10.64898/2026.08.05.26359785},
  url     = {https://doi.org/10.64898/2026.08.05.26359785}
}

@article{zaareer2026-bd508402,
  author  = {Za'areer, M. A. and Jafari, A. A.},
  title   = {{Neuropsychiatric Adverse-Event Reporting With Brexpiprazole Across Approved Indications: A Disproportionality Analysis Using the FDA Adverse Event Reporting System (FAERS)}},
  journal = {Research Square},
  year    = {2026},
  doi     = {10.21203/rs.3.rs-10907540/v1},
  url     = {https://doi.org/10.21203/rs.3.rs-10907540/v1}
}

@article{liu2026-6e68a0ab,
  author  = {Liu, J. and Yuan, H.},
  title   = {{Early strong anticholinergic initiation and 30-day mortality in older inpatients with dementia: a target trial emulation}},
  journal = {Research Square},
  year    = {2026},
  doi     = {10.21203/rs.3.rs-10644330/v1},
  url     = {https://doi.org/10.21203/rs.3.rs-10644330/v1}
}